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Regulation of genes by telomere length over long distances
Jerry W. Shay
University of Texas Southwestern Medical Center, Dallas, Texas, USA
BMC Genomics 2016, 17(Suppl 6):O1
The ends of linear chromosomes are called telomeres that resemble
broken DNA. However, the telomeres are protected from the DNA
damage responses due to the formation of a looping structure (T-
loop) and by “capping” the telomeres with a series of shelterin
proteins. It is generally thought the main, if not only, function of telo-
meres is protection from DNA damage responses. When telomeres
get very short due to normal replicative aging, cells stop dividing
due to loss of the telomere end protective functions. We have previ-
ously reported that telomeres may also have additional functions in
human cells. Telomeres are characterized by a distinct chromatin
structure with spreading of heterochromatin into the subtelomeric
regions, but little is known about the chromatin conformation of hu-
man telomeres. We have previously shown, using a luciferase re-
porter introduced into telomeres, that there is a 10-fold decreased
expression of the reporter compared to the reporter introduced into
internal genomic loci. This phenomenon is known as Telomere Pos-
ition Effects (TPE). We have also found that a human gene, interferon
stimulating gene 15 (ISG15), (~1 M base pairs from the 1p36.33 telo-
mere) is silenced in young cells with long telomerase, upregulated in
cells with short telomeres and silenced again in old cells with experi-
mentally hTERT (telomerase) elongated telomeres. However, we ob-
served genes between ISG15 and the telomere are not regulated by
classic telomere position effects (TPE). To distinguish this type of
telomere length dependent regulation of gene expression from
classic TPE, we have termed this type of regulation Telomere Position
Effects Over Long Distances (TPE-OLD). We discovered using 3D co-
FISH and a modification of Hi-C (chromosome capture followed by
high-throughput sequencing), that there are a significant number of
genes within the first 10 M bases distal to the telomere on many
chromosomes regulated by telomere length with genes closer to the
telomere not being regulated by TPE.
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The microtubule destabilizer KIF2A regulates the postnatal
establishment of neuronal circuits in addition to prenatal cell
survival, cell migration, and axon elongation, and its loss leading
to malformation of cortical development and severe epilepsy
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Kinesin super family protein 2A (KIF2A) is an ATP-dependent micro-
tubule destabilizer, that belongs to the kinesin-13 family. It is highly
expressed in juvenile brains, but its postnatal function has not been
determined due to mortality in KIF2A-deficient mice. In addition,
KIF2A is a causal gene in human Malformation of Cortical Develop-
ment (MCD) with epilepsy, but the contribution of KIF2A to its
pathogenesis is not yet understood due to the small number of hu-
man patients. In this study, we first analyzed the prenatal function
of KIF2A using kif2a-KO mice. These mice were pale, breathed ir-
regularly, and exhibited frequent twitching in addition to malforma-
tions resembling those in kif2a-mutated human patients. To
determine the post-migration function of KIF2A, we generated
newly tamoxifen-inducible conditional knockout mice. Despite suc-
cessful neuronal migration, all offspring displayed hyper-activity,
weight loss, severe cortical/hippocampal-focus epilepsy, and died.
Interestingly, KIF2A was highly expressed in excitatory axons, in cor-
tical neurites in layers II/III/V and in dentate mossy fibers (MF). In
the cortex, the loss of KIF2A generated aberrant axon sprouting in
those layers. In the hippocampus, the loss of KIF2A resulted in the
development of hippocampal sclerosis, MF sprouting, and recurrent
excitatory circuits resembling but different from TLE. These pheno-
types developed without excitation. cKO granule cells exhibited
failed axon/dendrite determination, and developed multiple short
axons throughout the entire molecular layer. These results suggest
that KIF2A is crucial postnatally for establishing accurate neuronal
circuits, in addition to its role in prenatal cell survival, migration,
and axon elongation.
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Integration of metagenomics and metabolomics in gut
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than 100 trillion microorganisms in a well-balanced communication
with the host factors. The gut microbiota plays an essential role in a
wide range of biological functions such as digestion and the develop-
ment of immunological responses. The microbial community compos-
ition and diversity is important in maintaining the homeostatis in the
host. Factors, which may influence the gut microbial composition in-
clude diet, environmental exposures, age, genetics, and many more. Re-
cent advances in technology, particularly 16S rRNA sequencing and
mass spectrometry have enabled us to survey these microbial commu-
nities at the phylogenetic level and assess the host/microbes co-
metabolism. The metagenomic studies have shed light on the func-
tional composition of the gut microbiota and have determined that in
diseases such as inflammatory bowel disease (IBD) there is an increase
in functions of the auxotrophic and pathobiont bacteria. A number of
studies have also pointed to an increase in the sulfate-reducing bac-
teria, such as Desulfovibrio, in IBD. On the other hand, metabolomics
studies have revealed that taurine-conjugated bile acids increase the
availability of free sulfur causing an expansion of the sulfate-reducing
pathobiont Bilophila wadsworthia, which drive colitis in genetically sus-
ceptible IL10−/− but not wild-type mice. Furthermore, an increased in
glutathione transport and riboflavin metabolism and a decrease in bio-
synthesis of amino acids have been reported in ulcerative colitis pa-
tients, which is indicative of increased predisposition for managing
oxidative stress, a hallmark of an inflammatory environment. Our
current studies have explored the correlative nature of the microbe/
host co-metabolism to characterize the regulatory role of microbiota in
maintaining host health. These correlative host/microbial studies have
the potential to determine causality, response to treatment, risk predic-
tion, and keystone species for use as probiotics in diseases such as IBD
or colitis induced by immuno-radiotherapy.
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Central Nervous System Tumors (CNST) are a collection of neoplasms
that grow in the brain and the spinal cord. Long term survival for pa-
tients carrying these tumors can reach at best 14 % in countries that
provide optimal health operating systems. Despite advancement in can-
cer targeted therapy, surgery and radiation remain typically the main
methods of treatment, even though both are challenging and may affect
the quality of life of survivors adversely. Inventive approaches and dee-
per comprehensions of tumor characteristics are needed to transform
treatment options for CNST patients. We established a unique integrated
system to enable analysis of multiple bio-parameters of individual CNST.
Each sample recovered was prepared to preserve tissue and generate a
corresponding cell line with a purpose to process for genetic, biochem-
ical, cytological and pharmacological analysis. A collection of 84 tumors
were recovered, with a wide range of tumor types including Meningi-
omas, Astrocytomas, Oligodendrogliomas, Medulloblastomas and Glio-
blastomas. Generating a tumor type combined outlook facilitated access
to vital information, as exemplified by the analysis of sixteen primary
Meningiomas. Investigating the gene expression profile of uncultured
tumors samples while considering the live cell behavior in relation to
morphology, growth, stemness and sensitivity to chemotherapy, en-
abled the identification of possible novel prognostic markers for
Meningiomas, including the recently associated cancer stem cell marker
Anterior Gradient 2 Homolog (AGR2). This integrated analysis approach is
critical for the development of safe, efficacious and potent targeted
therapeutic modalities.O5
RPL27A is a target of miR-595 and deficiency contributes to
ribosomal dysgenesis
Heba Alkhatabi
Centre of Excellence in Genomic Medicine Research, King Abdulaziz
University, Jeddah, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):O5
Myelodysplasia with monosomy 7 or deletion 7q has a dismal prog-
nosis and high propensity for leukaemic transformation. The exact
pathogenesis of these disorders remains elusive. We investigated
functional consequences of deletion of microRNAs (miRNAs) residing
on chromosome 7q, focusing on miR-595. Using a novel assay, sev-
eral targets for miR-595 were identified, including a large ribosomal
subunit RPL27A. RPL27A downregulation induced p53 activation,
apoptosis and inhibited proliferation. Importantly, p53-independent
effects were identified secondary to a reduction in the ribosome sub-
unit 60s with associated ribosome dysgenesis. Of note, RPL27A over-
expression showed no significant effects on p53 mRNA levels but did
enhance proliferation. In normal CD34+ cells, RPL27A knockdown
preferentially blocked erythroid proliferation and differentiation.
Lastly, miR-595 appears significantly downregulated in MDS patient
samples possessing -7/-7q anomalies compared to those with normal
karyotype. We postulate that haploinsufficency of miR-595 in patients
with -7/del 7q may contribute to disease pathogenesis via RPL27A
modulation.O6
Next generation DNA sequencing panels for haemostatic and
platelet disorders and for Fanconi anaemia in routine diagnostic
service
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Next Generation sequencing (NGS) is transforming delivery of diag-
nostic molecular genetics. Gene panels are being utilised to analyse
groups of related disorders and to extend diagnostic capability in
comparison with previous Sanger sequencing. The aim of this study
is to examine the utility of gene panels for diagnostic/research NGS
analysis of haemostatic and platelet disorders and for Fanconi an-
aemia. Requests were received for all but one (F5) genes on the
haemostasis/platelet panel. Candidate pathogenic mutations were
identified in 24 of 39 patients (62 %), including 15/16 males diag-
nosed with haemophilia A and 3/7 individuals with possible von Will-
ebrand disease. Some analyses (e.g. ADAMTS13, MYH9, VWF) were
requested to help exclude specific diagnoses. In addition to analysis
of single genes, combinations were analysed simultaneously, e.g. F8
& F9 (possible carrier relative of deceased haemophilia patient; un-
known type); F8, F9, F13A1, F13B and VWF (baby died of bleeding
shortly after birth), F8 & VWF (low FVIII:C). In contrast, nearly all pa-
tients referred for FA analysis were seeking a diagnosis of the dis-
order and all 16 genes were analysed in most individuals
investigated (15/19). Biallelic mutations were identified in 7 cases
(33 %) in BRCA2, FANCA, FANCC, FANCD2 and FANCG. A single hetero-
zygous mutation was identified in 2 patients (13 %), 2 heterozygous
mutations in different genes in 1 case (7 %), homozygous mutations
in 2 (13 %) and no mutation in 5 (33 %). We can conclude that NGS
provides a single laboratory workflow for analysis of gene panels for
related disorders as well as for whole genomes/exomes. Data analysis
can include a single gene, such as ADAMTS13, or ≥ 1 gene for disor-
ders such as those affecting fibrinogen. For disorders potentially
caused by one of the several genes in a pathway such as FA, all can
be analysed simultaneously. Use of NGS provides a single laboratory
workflow for analysis of gene panels for many different disorders
and can dramatically reduce time to achieve a definitive diagnosis.
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Targeted sequencing panels and their utilization in personalized
medicine
Adel M. Abuzenadah
Center of Innovations in Personalized Medicine, King Abdulaziz
University, Jeddah, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):O7
Several milestones have to be achieved in order to introduce the
concept of personalized medicine to the healthcare system in Saudi
Arabia. There is a notable lack of publicly available information about
the “normal” genetic makeup of this population which is hindering
the complete elucidation of “disease” genomes. Therefore, it is im-
portant that considerable effort should be spent on the identification
of the genetic and epigenetic risk factors that predispose to the com-
mon diseases in the Kingdom of Saudi Arabia. Knowledge gained will
help in the elucidation of disease biomarkers and drug response
modifiers. Furthermore, providers of personalized medicine should
validate internationally-approved biomarkers and risk factor indi-
cators for use in the Kingdom of Saudi Arabia. Most importantly,
genetic tests offered to the public should be designed to be
cost-effective without compromising sensitivity or specificity and
with fast turnaround amenable to use in the clinic. Towards this
end, we at the Center of Innovations in Personalized Medicine
(CIPM) at King Abdulaziz University are utilizing the robustness of
the Ion Torrent Personal Genome Machine to design genetic tests
for afflictions common to the Kingdom of Saudi Arabia. We have
designed and tested custom Ampliseq panels as well as used
panels from the Life Technologies catalog. Our array of targeted
sequencing panel now covers conditions such as deafness, beta-
thalassemia, thrombophilia, inborn errors of metabolism, and can-
cer susceptibility. We will report on the progress achieved so far
and discuss the future of such platform in the delivery of individ-
ualized diagnostics.O8
International biobanking in the era of precision medicine
Jim Vaught
President, ISBER, Editor-in-Chief, Biopreservation & Biobanking, USA
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Biospecimens are collected from patients and other donors in a
variety of ways for basic, clinical and epidemiologic research
studies. Methods for collecting, processing, storing and analyz-
ing biospecimens have usually been developed locally for
diagnostic and research purposes, with little consideration for
standardization or long-term quality management. Biospecimen
management has developed into a more scientifically-based en-
deavor, as researchers have realized that biospecimens and data
of consistent quality are required as we enter the era of preci-
sion medicine.
Best practices have been developed by organizations such as the
International Society for Biological and Environmental and Reposi-
tories (ISBER), the U.S. National Cancer Institute (NCI), the Inter-
national Agency for Research on Cancer (IARC) and the European
Organization for Economic Cooperation and Development (OECD).
Biospecimen research programs have been developed to establish
evidence-based standard procedures to control the collection and
processing of biospecimens. Molecular data from the analysis of
biospecimens contribute directly to the diagnosis of disease and
treatment of patients. Various “pre-analytical” variables can affect
the quality of biospecimens. Among these variables are: the
amount of time that it takes for surgical removal of the biospeci-
men; the time the specimen spends at room temperature before
it is frozen or fixed with formalin; and many other variables that
can affect biospecimen quality. There is the potential for: incor-
rect diagnoses; incorrect treatment; irreproducible results; and
overall the potential for misinterpretation of artifacts as new bio-
markers. The adoption of best practices for biospecimen collec-
tion and processing is an important part of the strategy toadvance translational research and precision medicine. These
practices should include:
 Governance models with clearly stated technical standards,
ethical guidelines, access policies and procedures, scientific
rationale, and long-term custodianship plans.
 A strong quality management program with clearly defined
standard operating procedures, and regular audits to assure
compliance.
 A comprehensive business model that has a sustainable cost-
recovery plan, or a plan to assure consistent long-term financial
support.
 In general, adherence to a set of best practices governing both
technical and ethical/legal issues.
The future development of international collaboration in biobanking
will require cooperation among various nations to standardize and
harmonize their biospecimen practices.O9
Biobank and biodata for clinical and forensic applications
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With advances in molecular biology (i.e., OMICs) and computa-
tional capabilities, society is on the verge of demystifying the
causes of diseases with an expectation of better diagnostics,
prognostics, and possible therapeutics for health and well-being.
However, forensic science (for 30 years) embraced the field of
genetics and built an entire infrastructure relying on DNA typing
from biospecimen collection to final results integrated under
strict and formal quality assurance guidelines. Both the medical
and forensic disciplines rely on the accumulation of big data to
perform precision, or personalized, analyses. These two disciplines
have built biobanks and/or databanks with different rationales,
designs and governance. Databanks and databases can be
exploited to harness the power of emerging technologies and ei-
ther enable detection of putative genes or potential suspects, and
promote development of innovative biomarkers and treatments.
Both resources must provide value, have proper ethical/conduct
governance, develop capabilities to store and retrieve samples and
annotated data, and be managed and maintained. Medical data-
bases typically are governed by institutions (often not government
agencies, although constrained by laws) and can be either free to
those who donate samples or consumers pay for tests. Samples
and metadata are provided on a voluntary consent basis, and the
resource may be available to many interested parties. Forensic da-
tabases are controlled by the government, access is limited to law
enforcement, and sample donation often is mandatory. Medical
and forensic big data resources, views of data sharing, experiences
of both systems users are discussed. Another resource, the human
microbiome, should be considered. The composition of the micro-
biome can affect health and well-being. Indeed, the microbiome
may end up being a more flexible and dynamic manner to address
aspects of personalized medicine. Forensic genetics also may bene-
fit as the microbes may serve as genetic signatures that could
individualize humans and serve as another powerful identification
tool. Forensic and medical biobanks should begin considering on
how to sample, collect and store such samples in suitable core facil-
ities, the microbiome banks. Such integration of the microbiome to
either forensic and/or medical biobanks will revolutionize current
approaches towards individualized medicine and precision
forensics.
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Tissue microarray technique: a powerful adjunct tool for molecular
profiling of solid tumors
Jaudah Al-Maghrabi
Department of Pathology, Faculty of Medicine, King Abdulaziz University,
Jeddah, Saudi Arabia
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Tissue microarray (TMA) is one of the most revolutionary technolo-
gies introduced into research and routine laboratories during the
past decade. It is based on the idea of applying miniaturization and
a high throughput approach for tissue analysis. TMA is a method of
harvesting small disks of tissue from a range of standard histological
sections and placing them in an array on a recipient paraffin block
such that hundreds of cases can be analysed simultaneously saving
money and time. In this presentation we will go through the guide-
lines for conducting TMA, Advantages and disadvantages of TMA
and we will present our experience of TMA establishment in Saudi
Arabia. In the Kingdom of Saudi Arabia remains the Tissue Microarray
“TMA” technique almost absent in the laboratories of pathology, at
least, to our knowledge, in the western region of the Kingdom, and
therefore, this project will contribute in principle to establish this
modern technology, to help reduce expenses for materials and re-
agents used in research conducted in the field of cancer. So far, we
successfully transferred approximately 7723 FFPE blocks of different
types of solid tumors which, already archived at department of path-
ology, KAUH, during the last two decades to approximately 180 TMA
FFPE Blocks. In addition, we validated and estimated the concord-
ance rate between conventional FFPE full section and TMA FFPE
slides which, was realistic and of good quality. Moreover, we also val-
idated the TMA technique in an integrative and comprehensive ap-
proach with immunohistochemistry (IHC) for protein profiling of
different markers and Bright-field double in situ hybridization (BDISH)
for gene profiling in different solid tumors. The TMA technique
seems to us as feasible, reasonable, doable and multipurpose. How-
ever, hard work is considered necessary to procure the associated
clinic-pathologic and follow up data of these samples to make the
full package constructive and valuable for the scientists and research
community for further downstream molecular profiling and
characterization of solid tumors in order to initiate a basic platforms
(infrastructure) for prognostic and predictive genomic models (mo-
lecular signatures) to facilitate the approach towards personalized
oncology in Saudi Health System.
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Since the achievement of the Human Genome Project in 2003, a sig-
nificant increase in biobanks in terms of number, design, scale and
governance has been noticed worldwide in order to support effect-
ive genomic research. Biobanks/Biorepositories are the main core
around which OMICs scale research and advanced clinical applica-
tions have been performed to drive the Precision Medicine wave
toward shaping the future of human welfare. Consequently, a bio-
banking unit has been developed at the Center of Excellence in
Genomic Medicine (CEGMR) in 2008 to collect, store and release high
quality biospecimens with fully annotated clinico-pathological data
according to best practices established worldwide in order to deliver
personalized diagnostics and tailor individualized therapeutics for
the Saudi population. Despite promising milestones and over 150
publications in ISI journals using CEGMR Biobank Unit (CBU) biospeci-
mens, the awareness about biobanking and biospecimen donationremains the foremost challenge. Reaching the benefits of biobanks
rely on an educated public and well trained healthcare providers that
will enable the establishment of perpetual and comprehensive part-
nerships between several stakeholders involved in healthcare service.
A survey conducted by our CBU team targeted healthcare students
at King Abdulaziz University and showed that only 46 % of them
have heard about the “Human Genome Project”. Surprisingly, 72 %
of these future healthcare providers have never heard of the term
“biobank” which was significantly correlated with lower willingness
to donate biospecimens. Interestingly, around 50 % of healthcare
students were willing to donate biospecimens and believed that it
will advance medical research and benefit the whole society. Better
general health status, previous blood donation and higher scores of
biobanking knowledge were significantly associated with the willing-
ness to donate (p-value = 0.048, p-value = 0.043 and p-value < 0.001,
respectively). These findings highlight the urgency of developing a
multidisciplinary awareness strategy to integrate biobanking and
OMICs scale approaches in the healthcare students’ curricula, build-
ing up therefore well qualified healthcare providers’ competencies.
Simultaneously, a suitable and lifelong public outreach program
about biobanking tailored to the diverse communities in Saudi Ara-
bia must be launched to ensure their effective involvement in the
biobanking and precision medicine trend with adequate awareness
about benefits and risks.
O12
Phylomedicine of tumors
Sudhir Kumar, Sayaka Miura, and Karen Gomez
Institute for Genomics and Evolutionary Medicine, Temple University,
Philadelphia, PA 19122, USA
Correspondence: Sudhir Kumar (s.kumar@temple.edu) – Institute for
Genomics and Evolutionary Medicine, Temple University, Philadelphia,
PA 19122, USA
BMC Genomics 2016, 17(Suppl 6):O12
Comparative analysis of sequences is routinely employed in tracing
the origins, patterns, and evolutionary relationships of homologous
sequences from strains, populations, and species. Now, these ana-
lyses are poised to become key in oncology owing to escalating se-
quencing of tumors. They will reveal evolutionary history of clones
that comprise tumors, patterns of sequence diversity, and tempo and
mode of clonal evolution that underlie the origin and adaptive prolif-
eration of cancerous cells. I will present results from our evaluation
of the performance of many existing computational methods in cor-
rectly inferring tumor clones from multi-region sequencing data. I
will also present our new methods for inferring clone and tumor
histories, which establish that our new method accurately infers (a)
clusters of variants (clonotypes) that comprise a tumor, (b) evolution-
ary tree of clonotypes, and (c) estimates of their relative frequencies
in tumors. These methods are based on fundamental molecular
evolutionary principles and they will greatly facilitate cancer-related
research pursued by basic biologists and clinicians.
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Colorectal cancer (CRC) is the third most prevalent cancer in men
and the second in women worldwide and although a great improve-
ment in response rate and patient’s survival was recently achieved
through the introduction of new-targeted agents in combination
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still adverse effects and development of chemoresistance are import-
ant limitations to pharmacological therapy. Some biomarkers to
guide CRC treatment have been developed and some of them are
considered valid by the regulatory agencies and included in the tech-
nical sheet of the drugs but many others are still “probable valid”
needed of additional validation and cost-efficiency studies. Some of
the most promising biomarkers are still not translated to clinical
practice nor approved by the agencies. In addition, there is a lack of
integration in a common framework of biomarkers at different levels
(germline, somatic, epigenetic) limiting translation and cost-efficiency
analysis. Here we present a strategy for the translation to clinical
practice of pharmacogenomic biomarkers to predict response (both
efficacy and ADRs) and to guide treatment in colorectal cancer in-
cluding previous valid biomarkers approved by EMA, probable bio-
markers at germline and somatic level. The selected markers include
variants at DNA level (sequence level and methylation markers) and
RNA level (including miRNA). The use of specific CTC genomic alter-
ations associated with treatment resistance and recurrence to guide
the selection of target therapies in mCRC patients will be also dis-
cussed. The final goal is an integrative approach for a practical trans-
lation to clinical practice of CRC pharmacogenomics. To achieve this
goal cost efficiency studies will be performed and a pilot project has
been to organize workflow and optimize decision-making processes.
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From association to causality: translation of GWAS findings for
genomic medicine
Ahmed Rebai
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With the decrease of the cost of high throughput genotyping
and sequencing, Genome wide Association Studies (GWAS) have
become a good approach to identify sequence variations and
mainly Single nucleotide polymorphisms (SNP) that are related to
complex and common diseases. However, GWAS data allow only
associational inference and is only able to identify sequence vari-
ants that are statistically associated with the disease status. The
last seven years have seen an exponential growth in the number
of GWAS which resulted in over 15 thousand associated Single
Nucleotide polymorphisms (SNPs) identified in more than 2100
published studies. Although many statistical methods and algo-
rithms have been developed to increase the power to detect as-
sociation, testing causal relationship between the associated SNPs
and the disease risk was not given much attention. A causal vari-
ant is a ‘mutation’ that contributes to an increase in risk to dis-
ease. Establishing causality from association is thus a challenging
task, hindered by many complicating factors and remains a major
concern in identifying genetic causes of common diseases, par-
ticularly for clinical translation of GWAS findings. In order to es-
tablish causality, we generally need intervention, which means
not only observing the genotypes of some individuals but taking
actions that can manipulate these genotypes, which can only be
done in animal models. However, recent studies showed that, al-
though we cannot estimate causal effects using observations
alone, it is possible to use the classical framework of causality in-
ference to get estimate of lower bounds for these effects. Here I
build on recent works within the Bayesian networks modeling
framework, to present an original approach to test causality
based on observation data only. Based on standard GWAS data
alone, this approach provides a measure for ranking causal ef-
fects of associated variants. The accuracy and stability of this
measure is assessed and compared to other approaches. Select-
ing the most likely causal variants from GWAS results will allow
the prioritization and designs of targeted experiments to unravel
causal mechanisms underlying association and effective clinical
translation of GWAS findings for genomic medicine, including in-
dividual risk prediction, advanced clinical strategies and personal-
ized treatments.O15
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Genome-wide association study data is used widely to identify the
genetic variants associated with complex traits or common disease.
Genome-Wide Repository of Associations between SNPs and Pheno-
types (GRASP) is a refined database, containing ∼ 8.87 million SNP as-
sociations reported in 2044 studies and ~178 thousand phenotypes,
derived from GWAS data. GRASP v2.0 users face difficulties in access
and correlation of SNPs with traits. Thus we aimed to design an inter-
active database providing detailed information of SNPs required for
better data interpretation, communication between possible collabo-
rators and new hypotheses to be generated. To develop a web appli-
cation, we used ASP.net as front-end tool; SQL server, MatLab, D3.js,
D3Plus.js and jQuery data table as back-end tools; JavaScript and
Ajax for client-side purpose. MATLAB was used to analyse the statis-
tical replication and evolutionary information of each SNPs and all
SNPs were mapped to genome position of human genome build 38
(hg38) using LiftOver. We developed a new web application called E-
GRASP using an advance tool and different filter code to retrieve and
represent data in better way leading to fast and easy data analysis.
We retrieved and retained all information of GRASP in E-GRASP and
added new information including statistical replication and evolu-
tionary information of each SNPs. E-GRASP provides information
under following categories: (i) SNPs view- provides information about
SNPid, PMID, P-value, chromosome, position, number of studies and
phenotypes for each SNPs; (ii) Study view- explains about unique
SNPs replication in each studies and phenotypes, and (iii) Evolution-
ary view- describes evolutionary information including E-value for
SNP phenotype association, E-rank of the evolutionary rate and time
span of the position retrieved from the “E-rank Web Server” for each
SNP. Web application allows the users to computed P-rank and E-
rank using P-value and E-value respectively for each phenotype of
different studies. In conclusion, E-GRASP is more representative data-
base with additional information of SNPs replication and evolutionary
scores, facilitating the comprehensive qualitative and quantitative
analysis. In future, we aim add complete data sets of studies available
in GRASP and provide more filters to get refined information.
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Aziz is ranked No. 360 among the world’s Top 500 supercom-
puters. Aziz is also one of the top 10 supercomputers in Kingdom
of Saudi Arabia. Primary objective of Aziz is to support growing
number of researchers and scientists in King Abdul Aziz Univer-
sity and its partners across different geographical locations. The
compute facility consists of high-end compute nodes; intercon-
nect infrastructure, and storage capabilities. Compute nodes con-
sist of a total of 496 nodes (11,904 cores) for running large
parallel jobs as well as a large number of small parallel or serial
jobs. 380 nodes are standard compute nodes (9120 cores) with
96 GB (4GB per core) for running the majority of mixed HPC ap-
plications. The remaining 112 high memory compute nodes (2688
cores) with 256 GB (10.6GB per core) are intended for applica-
tions that require large memory for their execution. 2 NVidia
BMC Genomics 2016, Volume 17 Suppl 6 Page 6 of 78Tesla K20 GPGPU equipped compute nodes (2496 CUDA cores)
with 96GB for running applications with the ability to use GPU-
based accelerators. 2 Intel Phi 5110P Co-processor equipped
compute nodes (120 Xeon phi cores) with 96GB for running ap-
plications with the ability to use MIC based accelerators. Storage
space contains Fujitsu FEFS high-speed parallel file system of
2 PB acts as scratch space as well as storage for current running
jobs. A total of 28 I/O servers and Infiniband as interconnect en-
able high speed non-blocking storage access to compute nodes.
To address the needs of longer term storage capacity at KAU, a
total of 6 PB of usable permanent storage solution was provided
with automatic archival system. A NAS storage unit of total 22 TB
usable space acts as home directory and application space for
users. Infiniband network consists of Intel QDR which is used as
interconnect connecting computing nodes and FEFS high-speed
storage system. It Features like non-blocking configuration and
RDMA enables application use full potential of underlying inter-
connect and reach maximum performance, delivering results in
least possible time. We believe that Aziz will have a great effect
on accelerating scientific research and solving computationally in-
tensive problems at KAU.
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Twenty-five percent of male-factor cases present with no identifiable
cause of male infertility. Conventional semen analysis provides im-
portant but limited information in the laboratory diagnosis of male
infertility. While advanced sperm function tests provide additional in-
formation at the cellular level, understanding the underlying molecu-
lar mechanism of sperm dysfunction is important. The talk will
mainly focus on new research into the causes of male infertility. Pro-
teomics is the new frontier of research in male infertility as it allows
the identification of numerous sperm-specific proteins. In addition, it
provides a greater understanding of protein functions involved in
sperm processes such as motility, capacitation, acrosome reaction &
fertilization. Identification of alterations in major proteins associated
with dysfunctional sperm will help in our understanding of the path-
ology of male infertility. The speaker will examine, 1) the current
methodology and techniques used in the global proteomic analysis
of sperm and seminal plasma samples from infertile men with vari-
ous clinical diagnosis, 2) examine the bioinformatics tools and search
engines employed in analyzing the data; 3) discuss the key findings
of recent proteomics research published from his center. Finally, the
speaker will review the future of proteomics in male infertility and list
the major challenges in introducing proteomics in the laboratory
diagnosis of male infertility.
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The Klinefelter syndrome (KS), 47, XXY karyotype, is the most com-
mon chromosome aneuploidy in men characterized by hypogonad-
ism, infertility, and other comorbidities. The incidence of KS in the
general male population is 1:500, whereas in our ongoing project in
Saudi Arabia the incidence is 1:11 in selected patients with azoosper-
mia or low sperm counts.
Fertility
Until recently KS men were considered infertile as about 90 % of KS
men are azoospermic. Recently, sperm were obtained by testicular
sperm extraction for intracytoplasmic sperm injection into oocytes,
resulting in live-born children. Most of these children have a euploid
karyotype as these sperm derive from tubuli with euploid spermato-
gonial foci. As shown in a KS mouse model these spermatogonia get
lost during early development so that cryopreservation of testicular
biopsies from prepubertal boys for later gamete maturation in vitro is
discussed.
Comorbidities
KS is often associated with gynecomastia, metabolic syndrome, dia-
betes type II, cardiopathies, thrombosis, embolism, osteoporosis, and
epilepsy. Androgen receptor polymorphism influences the incidence
and together with smaller diameter of arteries in KS may aggravate
associated disorders. Paternal compared to maternal origin of X
chromosome is associated with a more pronounced risk of insulin re-
sistance, metabolic syndrome, and cardiac disorders.
Psycho-neurological function
Half of KS patients suffer from disturbed verbalization and legasthenia
causing difficulties in communication and learning, many develop aut-
ism spectrum disorders. Neuro-imaging showed anomalies in the brain
of KS patients. KS mice also exhibit cognition, memory, and learning
difficulties and help to elucidate the psycho-neurological shortcomings.
Testosterone treatment
All KS men develop a lack of testosterone sooner or later. Although
the capacity for biosynthesis of testosterone of the hyperplastic Ley-
dig cells is normal, the hormone seems to be trapped in the testis
due to impaired blood flow as shown in the KS mouse. Therefore,
testosterone substitution remains the prime option in treating KS
men. As current modalities of testosterone substitution cannot rem-
edy all symptoms, recent discussion focuses on when the treatment
should be initiated (prepubertal, pubertal, or adult?) and what the
optimal serum levels should be.
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Recent advances in the molecular biology made the genomic tech-
nologies widely available to the medical community. Reproductive
medicine is also adapting these changes into its practice. The impact
is more profound in the field of preimplantation genetic diagnosis
(PGD). The main limitation in PGD has been the availability of a small
quantity of genetic material hampering the use of genomic technolo-
gies. In recent years, improved whole genome amplification tech-
niques with more sensitive detection methods made possible to use
microarrays and next generation sequencing in PGD. We now can
identify single gene disorders in embryos along with screening all 23
chromosomal abnormalities. Currently, there are studies evaluating
the effect of chromosomal screening in improving the in vitro
fertilization outcomes. Another impact of genomic technologies will
be on understanding the mechanism of infertility. There is about
20 % of the infertility cases considered as “unexplained” with no
BMC Genomics 2016, Volume 17 Suppl 6 Page 7 of 78known causes according to the current tests available. Whole
genome sequencing might help to uncover the genetic bases of
these cases. We have recently shown TLE6 mutation the underlying
cause of repeated fertilization failure. The third impact of these tech-
nologies will be on treatment where drugs and dose could be indi-
vidualized according to the genetic background of a person. Some of
the genomic technologies are also being used in prenatal diagnosis
(PND) in the clinical settings. Namely, the noninvasive PND is now
available to the patients as a routine test. In this presentation, the
newly adapted genomic methodologies and their applications to the
reproductive medicine will be reviewed.
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Background
Wnt ligands and their receptors “Frizzleds’ constitute a pivotal signalling
that mediates a considerable number of cellular events during develop-
ment, in adulthood and cancer including fate determination, polarity,
tissue patterning, and proliferation. At least ten members of frizzled
transcription factors have been characterised each of which is known
as seven transmembrane G protein-coupled receptor. In cancer, frizzled
receptors expression is associated with tumour development and pa-
tient’s outcomes including recurrence and survival [1]. High level of Fiz-
zled6 expression in particular was reported during leukemogenesis [2].
Our current study aimed to analyse the expression pattern of a number
of frizzled receptors in Saudi Arabia breast cancer (BC) tissue and here
we present only FRIZZLED6 (FZD6) analysis.
Subjects and methods
BC tissue samples from more than 615 patients aged between 25-80
years who were reported for BC complications at King Abdulaziz
University Hospital, Jeddah, Saudi Arabia were used. All samples,
processed for paraffin sectioning, were subjected to tissue array tech-
nology and automated immunohistochemistry staining for Frizzled
genes according to the protocol described in detail in [3].
Results
Expression pattern analysis of Frizzled6 revealed that its expression is
mainly cytoplasmic while few cases showed, in addition, nuclear expres-
sion reflecting the heterogeneity of the tumour. The majority of BC tissues
(60 % of the samples) showed no/weak expression patterns while around
40 % of the samples showed moderate to high level of the expression.
Conclusions
We have analysed the expression pattern of a number of Wnt signalling
receptors (Frizzleds) in Saudi BC patients. Among these receptors is FZD6
which revealed in general weak expression. FZD6 expression is currently
further analysed and being correlated with patients clinico-pathological
features in order to evaluate its prognostic significance in BC.
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Background
Daily production of spermatozoa is a complex process and severely
affected by oxidative stress. Spermatogenesis is one of the most
gainful cell-producing systems in animals, generating 100 million
spermatozoa each day forming high levels of protein-protein interac-
tions (PPIs). Interactions depend on cell type, cell cycle phase, devel-
opmental stage, oxidative stress conditions, redox mediated protein
modifications, presence of cofactors, and other binding partners. To
better understand how sperm production is regulated, we performed
network analysis of redox mediated PPIs during spermatogenesis. In-
teractions between the major signaling pathways in germ cells yet to
be investigated [1]. Furthermore, interactions between antioxidant
defense proteins and sperm signaling pathways (e.g., energy produc-
tion, sperm-egg recognition, and fertilization) are not known.
Results
Our interactome analysis combined experimental and predicted PPIs
[2,3]. PPIs that were coming from different databases showed a small
overlap, and also male infertility proteins are not well known and
knowledge of their interactors are based on low throughput studies.
Only 26 proteins were found to be annotated in the ReactomeDB [4].
Our curated network representing Antioxidant Response pathway
proteins and their interactors consists of 101 nodes and 235 edges.
Conclusions
Almost 40 % of human genes do not have a PfamA or GO annota-
tion, no current studies provide a list of potential functions [3,4]. We
found that only two proteins, superoxide dismutase 1 and 2 (SOD1
and SOD2) had genetic interactions, while SOD3 had only one phys-
ical interaction which was inferred from mouse, also nitric oxidase 4
(NOX4) and glutathione peroxidase 5 (GPX5) didn’t show any interac-
tions Other proteins showed physical interactions and more than
90 % those proteins had minimum 4 unique interactors. Oxidative
stress response proteins with high number of interactions are in-
volved in biological processes in sperm, and by manipulating this PPI
network we simulated sperm specific conditions. Catalase (CAT) is
not present in mature sperm, in the absence of CAT, the interactome
would shift to new PPIs involving other antioxidants or alternative
pathways. Combining computational and experimental tools for iden-
tifying PPIs will enrich the maps of PPIs in germ cells, and help un-
derstanding molecular basis of the increase in infertile population.
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CAT 13 (50 %) 13 (50 %) 26 13 15
GPX1 1 (10 %) 9 (90 %) 10 4 3
GPX2 3 (100 %) 0 (0 %) 3 3 1
GPX3 0 (0 %) 1 (100 %) 1 1 1
GPX4 5 (100 %) 0 (0 %) 5 4 4
GPX5 0 (0 %) 0 (0 %) 0 0 0
GPX6 2 (100 %) 0 (0 %) 2 2 2
GPX7 2 (100 %) 0 (0 %) 2 2 2
NOS2 139 (79 %) 36 (21 %) 175 148 17
NOX4 0 (0 %) 0 (0 %) 0 0 0
NOX5 0 (0 %) 5 (100 %) 5 4 2
PRDX1 92 (78 %) 26 (22 %) 118 98 52
PRDX2 45 (75 %) 15 (25 %) 60 53 23
PRDX3 33 (73 %) 12 (27 %) 45 33 24
PRDX4 42 (78 %) 12 (22 %) 54 42 27
PRDX5 35 (100 %) 0 (0 %) 35 32 11
PRDX6 41 (75 %) 14 (25 %) 55 45 29
SOD1 18 (24 %) 58 (76 %) 76 44 31
SOD2 18 (78 %) 5 (22 %) 23 19 13
SOD3 0 (0 %) 1 (100 %) 1 1 1
SRXN1 35 (100 %) 0 (0 %) 35 35 2
TXN 52 (60 %) 35 (40 %) 87 61 39P3
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Background
Interleukin-18 (IL-18) is an important regulator of innate and acquired
immune responses with a proposed role in a variety of early inflam-
matory responses [1]. This cytokine is actively involved in the regula-
tion of immune responses in order to have a successful pregnancy
and enhances either T helper 1 (Th1) or Th2 differentiation depend-
ing on the immunologic state [2]. Alterations of IL-18 expression and
secretion were linked with the pathogenesis of pregnancy complica-
tions, such as recurrent pregnancy loss (RPL) [3].
Furthermore, genetic variants in IL-18 gene were identified to have
an impact on the level of IL-18 protein secretion [4].
In this study, we investigate the possible associations of Interleukin-
18 (IL-18) promoter single nucleotide polymorphisms (SNPs) with
idiopathic recurrent pregnancy loss (RPL).
Materials and methods
We evaluated −656C/A (rs1946519), −137G/C (rs187238), −119A/C
(rs360718), and −105G/A (rs360717) IL-18 promoter polymorphisms
(SNPs) by Taqman assays in 470 Tunisian women comprising 235 RPL
cases and 235 age-matched multiparous control women. The associ-
ation of IL-18 alleles, and genotypes with RPL was evaluated by Fish-
er’s exact test and regression analysis. A value of P < 0.05 will be
considered statistically significant.
Results
Genotype distribution of −656C/A, −137G/C, −119A/C, and −105G/A was
in Hardy–Weinberg equilibrium. The A allele of −105G/A (P < 0.001) and
the A allele of −656C/A (P < 0.01), but not the C allele of −119A/C (P =
0.93) or C allele of −137G/C (P = 0.32), were significantly associated with
RPL. Significant differences in −656C/A (P < 0.001) and −105G/A (P <
0.001), but not −119A/C (P = 0.78) or −137G/C (P = 0.12) regarding the
distribution of genotypes were noted between RPL cases and control
women. Since both variants were linked with reduced IL-18 availability
[4] our findings underscore the significance of reduced IL-18 in the main-
tenance of normal pregnancy [5], and in the pathogenesis of pregnancy
complications [6], including RPL [4]. Our results confirm the lack of associ-
ation between rs187238and RPL in southern Iranian women [7].
Conclusions
We demonstrated that the IL-18 promoter variants −656C/A and −
105G/A are significantly associated with RPL among Tunisian women.
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P b OR (95% CI)
rs1946519 0.58 A 0.46 0.31 <0.001 1.91 (1.48–2.45)
rs187238 0.65 A 0.31 0.28 0.32 1.15 (0.89–1.50)
rs360718 0.45 C 0.27 0.27 0.93 0.98 (0.75–1.28)
rs360717 0.12 A 0.49 0.30 <0.001 2.18 (1.70–2.78)
MAF, minor allele frequency; HWE, Hardy–Weinberg equilibrium
aMinor allele defined based on control frequency
bObserved P value
Table 3 (abstract P3) IL-18 genotype frequencies
SNP Genotype Casesa Controlsa Pb OR (95% CI)
rs1946519 C/C 66 (0.28)c 114 (0.48) <0.001 1.00 (reference)
C/A 120 (0.51) 97 (0.41) 2.11 (1.42–3.15)
A/A 49 (0.21) 24 (0.10) 3.19 (1.82–5.60)
rs187238 G/G 122 (0.52) 126 (0.53) 0.12 1.00 (reference)
G/C 82 (0.35) 92 (0.39) 0.86 (0.59–1.25)
C/C 31 (0.13) 19 (0.08) 1.61 (0.90–2.90)
rs360718 A/A 132 (0.56) 127 (0.54) 0.61 1.00 (reference)
A/C 82 (0.35) 89 (0.38) 0.84 (0.58–1.22)
C/C 21 (0.09) 19 (0.08) 1.05 (0.56–1.96)
rs360717 G/G 82 (0.35)c 120 (0.51) <0.001 1.00 (reference)
G/A 78 (0.33) 89 (0.38) 1.22 (0.83–1.80)
A/A 75 (0.32) 26 (0.11) 4.08 (2.51–6.64)
aA total of 235 RPL cases and 235 control subjects were included
bPearson’s chi squared test
cNumber of subjects (frequency)P4
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Background
Genotype is affected by both the ecological [1, 2] and genetic factors
[3] to some known and conjoint diseases of contrast where the size
of which genes and environment interact. Neglecting the presence
of risk factors, ecological factors will lead to assess the probabilities
of some benefits in a definite population sample. Here, there must
be a general methodology for the analysis of twin data as the gene
interactions (epistasis), the possible weightiness of the gene, and
genetic interactions of the environment, and the conditions which
stop the presumption of “equal environments” for mono monozy-
gotic and dizygotic twins.
Materials and methods
A model to study the genes and gene to gene environment interactions
[1, 2] is presented. The classic twin study assumptions, including Fisher’s
hypothesis which presumes that genes act as hazard points forcombined features in a style needs dominate polygenic added: long way.
Provided there will be no confusion when applying: Environmental-, twin-
and family- data; results show an issue for every trait or common disease
[4]. Every fine-detail that is present through the solution space will match
with a different system of the potential hazard and the action of environ-
ment and genes. Every fine-detail that is present through the solution
space will match with a different system of the potential hazard and the
action of environment- [5] and genes [6].
Conclusions
The present data showed the possibility of limiting the spread of con-
joint diseases when applying environmental-interactions to certain
gene. Our results emphasize the significance of the genetic makeup of
the individual when estimating the possible hazards of complex dis-
eases is overstated [3, 4]. Moreover, when the phenomena are a power-
ful, genetically, because of epistasis, environmental explanation for the
large risk of common brotherhood is reasonable, even when consider-
ing high heritage typical cases. Thus, the results confirm the potential
the previously rejected on the light of the data of the case twin. Thus,
genetic models of family assembly may be incorrect and chase add-
itional genes can be counter-productive to a large extent.
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The gastrointestinal stromal tumor (GIST) is the most common frequent
mesenchymal tumor of the digestive tract. GIST proliferation is driven by
gain-of-function mutations in KIT. These characteristics have facilitated
the targeted therapies development that based on with tyrosine kinase
inhibitors, such as imatinib. Although many clinical studies have demon-
strated revolutionized effects of imatinib, more than 80 % of patients
lastly develop disease progression driven by secondary resistance muta-
tions in KIT kinase domains. However, the full spectrum of genomic and
transcriptomic changes behind the resistance remains unknown.
Results
This study analyzed genomic and transcriptomic changes in drug-
sensitive and -resistant cell lines against imatinib. We also looked at
an “intermediate” cell-line before reaching the full resistance. We
identified SNVs and CNAs from the next-generation sequencing and
also the transcriptome from microarrays. For clinical insights, we con-
ducted exome sequencing for two clinical samples with the resist-
ance. Notably, the cell line briefly exposed to imatinib exhibited
drastic transcriptional changes, but few genomic changes.
Conclusions
We suggest that pre-existing cell death-resistant subpopulations are
the main cause for full resistance via secondary KIT mutations. The
combination of chemotherapy with imatinib and apoptosis pathway-
targeting drugs, could limit the emergence of drug-resistant cancer.
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Background
Mounting burden of HCV infected individuals and soaring cost of treat-
ment is serious source of unease for developing countries. Numbers of
various approaches have been anticipated to develop vaccine against
HCV but majority of them proved ineffective. Development of vaccine by
considering geographical distribution of HCV genotypes and host genetics
shows potential. In this research article, we have tried to predict most pu-
tative HCV epitopes which are efficiently restricted by most common HLA
alleles in Pakistani population through different computational algorithms.
Results
Thirteen selected, experimentally identified epitopes sequences were
used to derived consensus sequences in all genotypes of HCV. Ob-
tained consensus sequences were used to predict their binding affin-
ities with most prevalent HLA alleles in Pakistani population. Three
Class-I from core, NS5B and NS4B region and one class-II epitopes
from NS3 region showed effective binding and proved to be highly
putative to boast immune response. Cocktail of these four have been
checked for population coverage and they gave 81.59 % for Pakistani
Asian and 76.63 % for Pakistani Mixed populations.
Conclusions
Computational algorithems are robust way to shortlist potentail candidate
epitopes for vaccine development but further, in vivo and in vitro studies
are required to confirm their immunogenic properties.
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Background
Alzheimer’s disease (AD) is the neurodegenerative diseases and there
are no perfect treatments. The pathogenesis of AD is directly linked
to the presence of two deposits, senile plaques (SPs), neurofibrillary
tangles (NFTs), and cholinergic abnormalities. Acetylcholine receptors
stimulation is essential for the cure of AD. In this perspective, the role
of AChE inhibitors, which get better cognitive functions, are presently
accepted for its treatment. Cholinesterase inhibitors a compound
that works as a neurotransmitter in the Central Nervous System avert
the metabolism of acetylcholine (a-SEA-til-KOH-lean). Individuals with
dementia generally have lower levels of this compound, which is es-
sential for the processes of remembrance, thinking, and interpret-
ation. Cholinesterase inhibitors slow the breakdown of acetylcholine.
Therefore, in the current study the natural compounds of Bacopa
monerri have been used as an acetyl cholinesterase inhibitor which
could play an important role in the treatment of AD after further
in vitro or in vivo, and other related investigations.
Results
The molecular interaction analysis to explore the binding pattern of
Bacopa monneiri compounds with the 3-D structures of AChE and
BuChE indicates that bacoside X, bacoside A, 3-beta-D-glucosylstigmas-
terol and Daucosterol could be good inhibitors on the basis of the ob-
tained binding energies (i.e. with AChE -15.44, -16.22, and -13.96 Kcal/
mol respectively, and with BuChE -16.23, -15.37 and -15.27 kcal/mol re-
spectively) and inhibition constants (i.e. with AChE 3.32 nM, 11.13 nM
and 24.63 nM and with BuChE 879.51 pM, 2.29 nM and 4.43 nM respec-
tively).These results would be useful for further designing of the AChE
and BuChE inhibitors with high activity in the treatment of the AD.
Conclusions
Therefore, our study indicates that the inhibitory constants of the
aforesaid natural compounds of Bacopa can be utilized for the devel-
opment of inhibitors.
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Background
High levels of Human epidermal growth factor receptor (Her2) have been
associated with cancer development and poor prognosis in many cancer
types. In bladder carcinoma (BC), the clinical significance of her2 status
Table 4 (abstract P9) Association of AGT genotypes with PE









































T/T 2 (0.01) 0 (0.00) NA NA
1 Number (frequency)
2 aOR = adjusted OR, adjusted for BMI, gestation, and baby weight
Fig. 2 (abstract P9) Agarose gel electrophoresis, (a): M235T-AGT
genotypes, Lane C/T: heterozygotes M235/235 T, Lane C/C:
homozygous M235/M235, Lane T/T: homozygous 235 T/235 T,
MT:DNA molecular marker (b): T174M-AGT genotypes, Lane C/T:
heterozygotes T174/174 M, Lane C/C:homozygous T174/T174,
Lane T/T: homozygous 174 M/174 M
BMC Genomics 2016, Volume 17 Suppl 6 Page 11 of 78remains poorly understood. The aim of the current study was to analyze
the status of her2 expression and its clinical value as a prognostic marker
in BC.
Subjects and methods
Bladder cancer samples were collected from patients who underwent
surgical resection at King Abdulaziz University Hospital-KSA. One
hundred and sixty samples were arranged on a tissue microarray
(TMA) and stained using immunohistochemistry (IHC) and bright-
field dual in situ hybridization (BDISH) methods. Correlation between
the levels of her2 protein expression/gene amplification and patients’
clinical parameters were evaluated.
Results
Using Immunohistochemistry, Her2 staining was expressed in the
cytoplasm and cell membrane. Her2 was detected in 85 % of pa-
tients and over-expressed (+3) in 24 % of BC cohort. Overexpression
of her2 protein was significantly associated with tumour staging (p =
0.002), lymph node invasion (p = 0.04) and vascular invasion (p =
0.01). BDISH analysis revealed that her2 gene is amplified (score of 2+)
in 25 % of patients. Significant correlation between her2 gene amplifi-
cation and tumour grade was reported (p = 0.03). Interestingly, amplifi-
cation of her2 gene was significantly associated with poor cancer-
specific survival in bladder cancer (p < 0.04, log-rank test).
Conclusions
High concordance between the IHC and BDISH data was shown. Her2
might serve as a potential marker for cancer metastasis and poor prog-
nosis. This finding also indicates that high proportion of bladder cancer
patient could potentially benefit from anti-her2 targeted therapies.
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Background
Preeclampsia (PE) is a major pregnancy complication, associated with
maternal and fetal morbidity and mortality, and affects about 2-8 % of
pregnancies worldwide (1, 2). PE is characterized by onset of protein-
uria and hypertension after 20th week of gestation. PE is a documented
risk factor for preterm birth and intrauterine growth retardation (IUGR),
and is a multi-factorial disorder involving both modifiable and non-
modifiable factors. The latter include specific mutations in gene impli-
cated in blood pressure control. These include, angiotensinogen (AGT)
gene, which play a key role in blood pressure regulation. This study ex-
amined the association between PE and the AGT polymorphismsM235T
and T174M in (North African) Tunisian population.
Materials and methods
This case-control study included 300 unrelated Tunisian women with
PE, and 300 unrelated age- and ethnically-matched control women.
M235T and T174M genotyping was done by RFLP-PCR (Fig. 2). Haplo-
type analysis was investigated using SNPstats software.
Results
Significant association between PE and M235T [P = 0.0034; OR (95 %) =
2.77(1.35 -5.68)], and T174M [P = 0.01; OR (95 %) = 0.52 (0.32-0.98)] was
seen in the studied population (Tab1e 1). Two-locus haplotype analysis
demonstrated significant association with the 235 T and 174Mhaplo-
types [P = 0.0051; OR (95 %) = 1.56 (1.15-2.13)].
Conclusions
M235T and T174M variants, especially the T235 allele, contribute to
an increased risk of developing PE in (North African) Tunisians.Trial registration
Current Controlled Trials
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Background
Melanoma is among the most prevalent types of cancer worldwide.
Malignant melanoma is aggressive, hard to treat and presents a
significant challenge for early diagnostics. Better understanding of
molecular mechanisms underlying the development and function of
malignant melanoma is essential for improvement of diagnostic
technology.
Results
In this study we used previously published and publicly available
data on microarray patterns of gene expression in normal skin, be-
nign nevi and malignant melanoma samples. We have applied an al-
ternative analysis strategy designed to highlight molecular functions
and regulatory pathways rather than separate biomarkers characteris-
tic of melanoma. As anticipated, we report the three classes of
samples are separated from each other by specific molecular mecha-
nisms. However, the relation between normal skin samples, nevi and
melanoma show striking similarity to previously described relation
between normal, primary tumor and metastatic tumor samples in
other types of cancer. We also present the evidence that in gene
BMC Genomics 2016, Volume 17 Suppl 6 Page 12 of 78expression space some benign nevi samples are located closer to the
cluster of melanoma samples, which may be indicative of their high
metastatic potential detectable on the early stages of development.
Conclusions
Our analysis points at similarity of functional patterns of gene expres-
sion between nevi and malignant melanoma. We hypothesize that
the pathways differentially activated between nevi and melanoma
are responsible for metastatic progression.Fig. 3 (abstract P11) Assessment of apoptotic effect of Thymoquinone
(TQ) by MTT assay using different concentrations (Control, IC50 and 1
μM). a: The IC50 of TQ in Jurkat cells; b: Percentage of Annexin V positive
cells; c: Percentage of caspase 3/7 positive cellsP11
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Background
Leukemia is a cancer of blood cells. This malignant disease is a heavy
burden for patients and the health system worldwide. According to
the American Cancer Society estimates, about 48,610 new cases and
about 23,720 deaths occurred in the United States in 2013 [1, 2]. It is
the most common pediatric cancer, representing approximately 25 %
of cancers diagnosed in children aged <20 years [3]. There have
been dramatic improvements in blood cancer treatment using
chemotherapy, ionizing radiation, radio immunotherapy, immuno-
therapy, gene therapy, and stem cell transplantation [4]. However,
most of these therapies are plagued with side effects, and almost all
cause cytotoxicity in healthy cells [5]. These findings make discovery
of new treatments measures for leukemia very imperative. Natural
compounds have been an important source of drugs since ancient
times. Thymoquinone (TQ) is the major bioactive compound of the
essential oil of Nigella sativa which have many anticancer effects. The
aim of this study is to analyze the potential of TQ to induce apop-
tosis in Jurkat cells. The cytotoxicity was evaluated by MTT assay at
different concentration of TQ to determinate the IC50 (half maximal
inhibitory concentration). Apoptosis effect was analyzed by annexin
V and caspase3/7 assays at both IC50 and 1 μM.
Results
Our results reported an IC50 of 210 nM for TQ. We showed also that
the number of labeled cells by annexin V and caspase 3/7 activity
are proportional to TQ concentration.
Conclusions
TQ has an apoptotic activity which is concentration dependent. It is
an interesting anticancer agent extracted from natural compounds.
However, further in vitro investigations are required to optimize its
effect and assess possible side effects.
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Background
Sonic hedgehog gene (SHH) is a key regulator at an early embryonic
development. Recent findings revealed a constitutive activation of
the SHH pathway in several malignancies including bladder cancer.
The role of SHH in bladder pathogenesis may be related to increased
stemness and EMT. We here investigated the clinical and patho-
logical significance of SHH in bladder cancer.
Materials and methods
The expression pattern of SHH protein was examined in 160 patients
with bladder cancer using immunohistochemistry (IHC). Correlation
analysis of the SHH status with clinicopathological parameters was
performed using SPSS.
Results
SHH protein was overexpressed in 46 % of bladder cancer patients. The
expression of SHH was significantly associated with lymph node invasion
(p = 0.02) and with distant metastasis (p = 0.034). In univariate analysis,
there was no relationship between SHH expression with other parame-
ters including tumor grade, stage, age, gender, cancer type and survival.
Conclusions
Our data support previous findings and revealed that SHH contribute
in bladder tumorigenesis. Further research is needed to investigate
the functional significance of SHH in bladder cancer.
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Inflammation is considered both as a cause and consequence of cancer.
Litterature has shown that the imbalance between pro-inflammatory and
anti-inflammatory cytokines could modulate colorectal carcinogenesis [1].
Interleukin 18 is a pro-inflammatory cytokin, which level was reported to
be increased in cancer disease [2,3] .We hypothesised that it can be gen-
etically controlled by polymorphisms located in the promoter region .
Materials and methods
We had conducted a case-control study of 148 subjects: 74 patients and
74 healthy volunteers of Tunisian origin. DNA isolation was made by
Miller’s method. Genetic profiling was performed of the RFLP-PCR assay
of the -607 A/C and -137 G/C polymorphism of Interleukin 18 gene. Stat-
istical Analysis was conducted by the EPIINFO v.7.1.2.0 statistical software.
Results
Our work has demonstrated a significant association of the A/A geno-
type of the -607 A/C polymorphism under the additive and recessive
models of genetic transmission by the onset colorectal cancer (Table 5).
In contrast, no association has been observed betwwen the -137 G/C
(Table 6) promoter polymorphism and colorectal cancer.
Conclusions
This paperwork has demonstrated that promoter polymorphism -607
A/C seems to play a role in the colorectal cancer development in the
studied Tunisian sample population.
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polymorphism under the three models of genetic transmission
Model Genotype Controls Cases OR [CI 95 % ]* p-value**
Additive A/A 7 (9.4 %) 17(22.9 %) 2.87 [0.94-9.38] 0.038
A/C 35 (47.2 %) 30(40.5 %) 1.01 [0.47 -2.18] 0.891
C/C 32 (43,2 %) 27 (36.4 %) 1 -
Dominant A/A - A/C 42(56.6 %) 47(63.4 %) 1.32 [0.65-2.707] 0.5
C/C 32(43.2 %) 27 (22.9 %) 1 -
Recessive A/A 7(9.4 %) 17(22.9 %) 2.85 [1.02-8.68] 0.02
A/C - C/C 67(90.4 %) 57(76.9 %) 1 -
*Fisher exact Odds Ratio
**Fisher exact p-value
Table 6 (abstract P13) Genotypic distributions of the -137G/C
polymorphism under the three models of genetic transmission
Model Genotype Control Cases OR [CI95%]* p-value**
Additive G/G 20 (27 %) 21 (28.3 %) 1 -
G/C 36 (48.6 %) 30 (40.5 %) 0.79[0.33-1.86] 0.69
C/C 18 (24.3 %) 23 (31 %) 1.21[0.46-3.17] 0.824
Dominant G/G 20 (27 %) 21 (28 %) 1 -
G/C- C/C 54(72.9 %) 53(71.6 %) 0.93[0.42-2.04] 0.85
Recessive G/G- G/C 56(75.6 %) 51(68.9 %) 1 -
C/C 18 (24.3 %) 23 (31 %) 1.40(0.64-3.09) 0.36
*Fisher exact Odds Ratio **Fisher exact p-valueP14
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Background
Little is known about the pathogenic mechanisms underlying cyto-
megalovirus (CMV) induced fallopian tube (FT) damage and ectopic
pregnancy (EP) [1, 2]. This study measured the prevalence of CMV infec-
tion in EP and its impact on the production of interleukin (IL)-6 family
members and their corresponding receptors (IL6R, IL11R & LIFR) in Fal-
lopian tubes (FT) with and without EP.
Materials and methods
Fresh FTs were obtained from 84 women with EP, 20 total abdominal
hysterectomy (TAH) during the midluteal phase and 31 tubal liga-
tions. Tubal infection with CMV was detected by an IVD CE PCR kit.
The participants were then categorised according to their CMV re-
sults and he candidate molecules were measured by realtime RT-PCR
and immunohistochemistry in tubes with EP and were CMV-positive
(n = 15) and the results were compared with those obtained from EP
(n = 15) and TAH (n = 15) and were negative for the virus.
Results
The frequency of viral infection was higher (P = 0.01) in EP (21.4 %)
than controls (5.9 %) and EP samples simultaneously positive for
CMV had higher expression of all candidate cytokines and their re-
ceptor, except for IL11R, at the gene (Fig. 4) and protein (Table 7)
levels compared with negative EP and TAH.
Conclusions
CMV infection of FT appears to be involved in the pathogenesis of
EP by increasing the production of members of IL-6 family in the FT.
Further studies are needed to explorer the function of CMV and can-
didate cytokines in the pathogenesis of tubal pregnancy.
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and immunohistochemistry for IL-6, IL-11, LIF and their receptors in
Fallopian tubes collected from control, CMV negative (CMVN-EP) and
positive (CMVP-EP) ectopic pregnancies
Control CMVN-EP CMVP-EP
Age (years) 37.2 ± 5.1 33.3 ± 6.3 31.5 ± 5.4a
Gestational age (weeks) N/A 7.3 ± 1.5 7.6 ± 1.8
β-hCG (IU/L) ND 2,317 ± 1,964 2,861 ± 2,016
IL-6 188.3 ± 33.1 301.7 ± 34.2a 367 ± 41.2a,b
IL6Rα 104.4 ± 22.7 179.5 ± 35.8a 301.3 ± 67.3a,b
IL-11 182.3 ± 36.4 251.9 ± 36.4 367.5 ± 41.1a,b
IL11Rα 149.7 ± 22.6 230.6 ± 42.8a 241.2 ± 51.4a
LIF 205.5 ± 31.2 277.8 ± 49.8a 344.4 ± 58.6a,b
LIFR 188.1 ± 33.6 264.9 ± 47.2a 327.4 ± 53.1a,b
N/Anot applicable; ND not done; aP < 0.05 compared with control & bP < 0.05
compared with CMVN-EP group)
Fig. 4 (abstract P14) Mean ± SD of messenger RNA relative
expression of a IL-6, b IL6RA, c IL-11, d IL11RA, e LIF and f LIFR, in
Fallopian tube collected from control, EP negative for CMV (CMVN-
EP) and EP positive for CMV (CMVP-EP) groups. (a P < 0.05 compared
with control & b P < 0.05 compared with CMVN-EP group)
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Background
This study was carried out to identify the coexistence of phenotypes,
intestinal virulent genes and phylotypes between human diarrhe-
genic E. coli (DEC) and avian pathogenic E. coli (APEC).
Materials and methods
A total of 36 diseased chickens (3 visceral organs; liver, spleen
and heart per each) were collected from different poultry farms
located in the district of Mansoura, Egypt, during the first quarter
of 2015. Seventy-eight human stool samples (50 diarrheic patients
and 28 healthy persons) were taken from a small charity hospital
laboratory in the district of Mansoura, Egypt during the second
quarter of 2015. Culturing, phenotyping, PCR screening of intes-
tinal virulent markers (intimin and shiga toxin genes) and phylo-
grouping were performed.
Results
From 186 chicken visceral (108) and human stool (78) samples, sixty
five (35.3 %) biochemically identified E.coli isolates were detected from
chicken (29/108; 26.9 %) and human samples (36/78; 46.2 %). Seven-
teen phenotypes were determined from human and chicken isolates
and the most common serotypes distinguished from APEC isolates
were O78, O2 and O1. Importantly, only 2 similar serotypes (O119:H4
and O26:H11) were identified from both APEC and human DEC isolates.Molecularly, the respective percentages of 100 and 35 with intimin
(eae) and Shiga toxin genes were detected from APEC isolates while
50 %, 27.8 % and 19.4 % of human DEC isolates harbored eae, stx1 and
stx2 genes respectively. Phylogrouping revealed the significant (P <
0.05) higher occurrence of pathogenic phylogroups (D and B2) in APEC
(19/29, 65.5 %) than human DEC isolates (8/36, 22.2 %).
Conclusions
Our results verified that APEC isolates shared serotypes, virulent
genes and phylotypes with DEC isolates with a subsequent po-
tential public health concern. Also, the implementation of PCR
based methods along with the conventional cultural methods is
beneficial. To the best of our knowledge, this is the first report in
Egypt that determines virulent genes and phylogroups concomi-
tance between APEC and DEC isolates.P16
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Background
Hepatocellular carcinoma (HCC) is a highly fatal cancer without
effective therapy. Recently, a novel strategy known as cancer-
targeting dual gene virotherapy (CTDGVT), in which an oncolytic
adenoviral vectors (oncolytic Ads) encodes two therapeutic
genes, has shown efficient anticancer therapy, whereby, an excellent
triplex antitumor effect can be achieved by the viral oncolytic effect on
cancer cells and the additive or synergetic interaction between the two
expressed anti-tumor genes. Therefore, the present research work is de-
signed to investigate the therapeutic potential, possible synergy and
safety profile of this CTDGVT strategy in treatment of human HCC.
Materials and methods
Herein, we constructed two oncolytic Ads: one expressing human
TRAIL (Ad-ΔB/TRAIL); an apoptotic ligand induces apoptosis in
tumor cells; and other expressing human ING4 (Ad-ΔB/ING4), a
novel tumour suppressor gene, and then investigated their indi-
vidual and combined therapeutic efficacy and safety against HCC
both in vitro on human HCC cells and in vivo on xenogarfted
model of human HCC in nude mice.
Results
Co-therapy with Ad-ΔB/TRAIL and Ad-ΔB/ING4 elicited significant killing
effect on HCC cells and growth suppression on the xenogarfted tumor,
without overlapping toxicity (Fig. 5). Mechanistically, Ad-ΔB/TRAIL and
Ad-ΔB/ING4 had co-operated together to induce apoptosis; stimulate
anti-tumor immune response reflected by excess interferon gamma
(IFN-γ) production and deep infiltration of natural killer cells (NK1.1 + ve
cells) and antigen presenting cells (Cd11 + ve cells); and to inhibit vas-
cular endothelial growth factor (VEGF) and CD31 expression as well as
microvessel density in xenografted tumors.
Conclusions
Combination therapy with oncolytic Ads expressing human TRAIL
and human ING4 genes additively suppressed human HCC both
in vitro and in vivo, via inhibition of tumor angiogenesis and vascula-
ture as well as induction of anti-tumor immunity and apoptosis.
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Fig. 5 (abstract P16) Treatment of hepatocellular carcinoma by
using cancer gene-viro-therapy strategy.
Fig. 6 (abstract P17) Representative photographs of histological,
immunohistochemical and TUNEL analyses of the tumor tissues.
H&E: hematoxylin and eosin staining for histopathology; TUNEL:
staining of apoptotic cells in tumor tissue; NK1.1: to detect the
infiltrated natural killer (NK) cells, the tumor tissues were treated with
purified anti-mouse NK1.1 monoclonal antibody; CD11b: to detect
the recruited antigen-presenting cells (dendritic cells and
macrophage), the tumor tissues were treated with purified anti-
mouse CD11b monoclonal antibody; and CD31: to detect tumor
microvessels endothelial cells and vascular density, the tumor tissues
were treated with anti-CD31 antibody. Brown staining indicates
positive staining cells.
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Background
Cancer gene therapy-mediated by oncolytic adenoviruses (Ads)
encoding immunostimulatory interleukin-12 (IL-12) gene, or pro-
apoptotic tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL) gene, have been recently emerged as a novel strategy in
cancer therapy. In this study, we generated, and the investigated
the single and combination therapy of two oncolytic Ad encod-
ing human TRAIL gene (Ad-ΔB/TRAIL) and oncolytic Ad encoding
human IL-12 gene (Ad-ΔB/IL-12) on human hepatocellular carcin-
oma (human HCC) cell lines and on orthotopic human HCC
(Hep3B) model in athymic nude mice.
Results
Ad-ΔB/TRAIL and Ad-ΔB/IL-12 combination therapy elicited a
more significant cytopathic effect on HCC cells and additive
growth suppression of the xenogarfted tumor compared with
their single therapy, without overlapping toxicity. Additionally, the
augmented anti-HCC activity of Ad-ΔB/TRAIL and Ad-ΔB/IL-12
combination therapy had also resulted in a more activation of
the apoptotic-caspase-3 and-8 pathway, overproduction of inter-
feron gamma (IFN-γ), high infiltration rate of natural killer cells
and antigen presenting cells. Moreover, Ad-ΔB/TRAIL and Ad-ΔB/
IL-12 combination treatment additively reduced vascular endothe-
lial growth factor (VEGF) and CD31 expression as well as the
microvessel density in the tumor tissues.
Conclusions
Cancer dual gene therapy with Ad-ΔB/TRAIL and Ad-ΔB/IL-12 was
synergistically interacted in suppressing human HCC in vitro and
in vivo with enhanced activation of anti-tumor immunity and
apoptosis, and also enhanced inhibition of tumor angiogenesis
and vasculature.
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Background
The limited efficacy and safety of the current therapies of human
colorectal carcinoma (CRC) represent a major obstacle. Thus, de-
velopment of more effective treatment option is a paramount
medical demand. In this regard, Paricalcitol (PCAL), a new vitamin
D analogue with less calcemic side effects than vitamin D, has
been recently identified as a pluripotent anticancer agent. There-
fore, the current study was designed to investigate the thera-
peutic effect of Pcal against CRC and determine its underlying
mechanism.
Materials and methods
CRC was developed in rats by using azoxymethane (AOM) model.
Five groups of male Wistar rats were assigned as follow: normal con-
trols, AOM alone, AOM-treated with 5–Fluorouracil (5-FU) which is
the standard chemotherapeutic agent in the treatment of human
CRC, AOM-treated with PCAL, and AOM-treated with PCAL + 5-FU. All
groups were examined at week 15 after AOM injection, and their
colons were and assessed at gross, histopathological, immunohisto-
chemical, and molecular levels.
BMC Genomics 2016, Volume 17 Suppl 6 Page 16 of 78Results
Therapy with PCAL not only reduced the growth of CRC but also
augmented the tumoricidal effect of 5-FU, and they were signifi-
cantly co-operated in inhibition of the colonic expression of well-
known pro-oncogenic, angiogenesis- and metastasis inducing genes
and molecules; such as Wnt/β-catenin signalling pathway, CDNK-1A,
NF-kB, iNOS, Smads, HSP90, COX-2, Caspase-3, TGF-β1, and VEGF,
that collectively have crucial roles in CRC development, promo-
tion, invasion and metastasis. As shown in Fig. 7 Pcal and 5-FU
had cooperated together to more repress the expression of pro-
cancerous Wnt (Fig. 7a), β-catenin (Fig. 7b), CDNK-1A (Fig. 7d),
COX-2 (Fig. 7e) NF-Kb (Fig. 7f); and to upregulate the expression
of anti-tumorigenesis DKK-1 (Fig. 7c) compared with their
monotherapies.
Conclusions
This study suggests that therapy with PCAL not only inhibit
CRC development and promotion, but also has beneficial syner-
gistic tumoricidal effect with 5-FU, and thereby could act as a
potent additive anticancer agent for treatment of human colon
cancer.Fig. 7 (abstract P18) Paricalcitol (Pcal) and 5-Flurouracil (5-FU) had
cooperated together to repress the expression of pro-cancerous
genes of Wnt, β-catenin, CDNK-1A, NF-kB, COX-2, and to upregulate
the expression of anti-tumorigenesis gene of DKK-1 compared with
their monotherapies.P19
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Rubus idaeus bioactive consider as cancer prevention according to
Stoner et al [1]. Researches show berry bioactive protect against oxi-
dative DNA damage), also a first line of defense against the multi-
stage process of carcinogenesis. [2]. Active compounds play a major
role in the induction of apoptosis (1). The aim of this study was to
determine the cytotoxic activity of Rubus idaeus extract towards hu-
man lymphocyte and cancerous cell line also employed the pathway
by which extract work and determine the cytokine level and CD
markers in lymphocyte and cancerous cultured cell.
Materials and methods
Determination of Cytotoxicity effect of Rubus idaeus extract according
to selected parameters including MTT assay [3] and In vitro Immuno-
modulation Determination.
Results
Extracted components from Rubus idaeus showed cytotoxic effects on
the primary cell culture of normal hepatic cells (WRL-68), and cancer
hepatic cell lines (HepG-2) at 120 μg/ml concentration. The most
significant reduction (p ≤ 0.05) in cell viable count was at the
concentration of 100 μg/ml which appears to cause induction of
cell death via mitochondrial pathway for HepG-2 cell line after
24 hours’ exposure. The extract suppresses lymphocytes prolifera-
tion and caused increase in IL-2 and IL-4 level estimated by ELISA
at concentrations of 250 and 500 μg/ml, while opposite results
were shown after 4 hours of exposure.
Conclusions
Rubus idaeus extract having cytotoxic effects on HepG-2 and normal
hepatic cells WRL68 line in a dose dependent manner.
References
1. Stoner GD, Wang LS, Casto BC (2008). Laboratory and Clinical Studies of
Cancer Chemoprevention by Antioxidants in Berries. Carcinogenesis.
29, 1665 – 1674.
2. García-Lafuente A, Guillamón E, Villares A, Rostagno M, Martínez J (2009).
Flavonoids as Anti-inflammatory Agents: Implications in Cancer and
Cardiovascular Disease. Inflammatory Research. 58, 537 – 552.
3. Freshney, R.I. (2012). Culture of Animal Cell. Sixth Edition. Wily-Liss, New
York.
P20
Etanercept, a TNF-alpha inhibitor, alleviates mechanical
hypersensitivity and spontaneous pain in a rat model of
chemotherapy-induced neuropathic pain
Djouhri, Laiche1, Chaudhary Adeel 2, Nedjadi, Taoufik3
1Department of Physiology, College of Medicine, King Saud University,
Riyadh, KSA; 2Centre for Excellence in Genomic Medicine Research, King
Abdulaziz University, Jeddah, KSA; 3King Fahd Medical Research Centre,
King Abdulaziz University, Jeddah, KSA.
Correspondence: Nedjadi, Taoufik (tnedjadi@kau.edu.sa) – King Fahd
Medical Research Centre, King Abdulaziz University, Jeddah, KSA.
BMC Genomics 2016, 17(Suppl 6):P20
Background
Cancer is a major health problem and a leading cause of death
worldwide. Many cancer patients receiving chemotherapy are unable
to complete full or optimal treatment schedules because many po-
tentially curative cancer chemotherapeutic agents cause severe toxic
damage to the peripheral nervous system. This neurotoxicity is often
accompanied by chronic peripheral neuropathic pain (NP). This
chemotherapy-induced NP (CINP) is extremely debilitating and se-
verely affects the life quality of 10 % to 100 % of cancer patients
and survivors (depending on the dose and drug type). The
underlying mechanisms of CINP, which is resistant to currently
available drugs, are poorly understood, but pro-inflammatory cy-
tokines may play a role. The aim of the current study was to
examine the hypothesis that the pro-inflammatory TNF-α is in-
volved in the pathophysiology of CINP, and that its blockade
would alleviate pain hypersensitivity in an in vivo rat model of
CINP.
BMC Genomics 2016, Volume 17 Suppl 6 Page 17 of 78Materials and methods
To induce CINP, 18 male Sprague Dawley rats were injected with the
anti-cancer drug, Paclitaxel (2 mg/kg, i.p.) on four alternate days. All
the rats were assessed for behavioral signs of mechanical and heat
hypersensitivity, and spontaneous pain 4 weeks after treatment. To
examine the effects of blocking TNF-α on these pain behaviours, two
groups of CINP rats were used: one group (n = 12) was treated with
the anti-TNF-α, etanercept (6 mg/kg, i.p.) and the other with vehicle
(n = 12).
Results
All paclitaxel treated rats showed significant decreases (P <
0.001) in paw withdrawal threshold to a mechanical stimulus,
but not in paw withdrawal latency to a noxious heat stimulus
4 weeks post treatment indicating development of mechanical
hypersensitivity (allodynia), but not heat hypersensitivity (hyper-
algesia). The rats also exhibited significant spontaneous foot lift-
ing, a behavioural sign of spontaneous pain (see Djouhri et al.,
2006; 2012). Interestingly our data also show that, compared with
vehicle, etanercept significantly reduced mechanical hypersensitiv-
ity and spontaneous pain at both 24 h (P < 0.01) and 48-h (P <
0.01) post-drug treatment.
Conclusions
The findings suggest that TNF-α is involved in the pathophysiology
of CINP, and that strategies that target TNF-α inhibition may be ef-
fective in treating CINP.
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Background
Medulloblastoma (MB) is a paediatric tumour of the cerebellum
which is responsible for 15-20 % of all childhood brain tumours.
Mortality due to this disease is high (~40 %) and successful
treatment is associated with significant neurological and cogni-
tive consequences, making new therapies desirable. Disruption
of the Sonic Hedgehog (SHH) signaling pathway, including
mutations in PTCH1, define a major subset of human MB. Mice
heterozygous for the Ptch1 ortholog develop MBs at low
frequency.
Materials and methods
To identity genes that co-operate with Ptch1 in MB development, we
have performed a Sleeping Beauty insertional mutagenesis screen in
this murine model. To identify the genes responsible for this en-
hanced tumour formation we have used Splinkerette-PCR and 454-
FLX sequencing to define SB insertion sites within 40 tumours. Monte
Carlo and Kernel Convolution statistical methods were applied on
these data to identify statistically significant candidate MB genes
defined by common insertion sites (CISs). Sophisticated bioinfor-
matic analysis were conducted in human gene expression data-
sets to identify a plausible neuronal network. Illumina beadsmicroarray was carried out on mutagenised mice primary tumour
samples.
Results
We find that mutagenesis significantly increases the frequency of
MB formation in Ptch heterozygote mice from ~3 % to ~25 %
after 8 months (p < 0.001). Statistical analysis identified 18 (CISs).
Many of these are gene known to be involved in neuronal devel-
opment and cell fate determination. Subsequent ARACNe network
analysis has established that seven (CISs) lie within a single net-
work (with Myt1l, was highly networked gene), which is enriched
for both neuronal genes and transcription factors, and includes
genes known to interact with the SHH pathway. Furthermore, the
disrupted network genes work synergistically to upregulate Igf2
(involved in MB formation).
Conclusions
Functional analyses of this network should both improve our under-
standing of how this tumour develops, and define potential targets
for therapeutic and diagnostic intervention.P22
Involvement of interleukin-1 in vitiligo pathogenesis
Mala Singh1, Mohmmad Shoab Mansuri1, Shahnawaz D. Jadeja1, Hima
Patel1, Yogesh S. Marfatia2, Rasheedunnisa Begum1
1Department of Biochemistry, Faculty of Science, The M.S. University of
Baroda, Vadodara- 390 002, Gujarat, India; 2Department of Skin andVD,
Sir Sayajirao Gaikwad Medical College, The Maharaja Sayajirao University
of Baroda, Vadodara, Gujarat, India.
Correspondence: Rasheedunnisa Begum (rasheedunnisab@yahoo.co.in) –
Department of Biochemistry, Faculty of Science, The M.S. University of
Baroda, Vadodara- 390 002, Gujarat, India
BMC Genomics 2016, 17(Suppl 6):P22
Background
Vitiligo is a hypomelanotic autoimmune skin disorder. High serum
and transcript levels of IL1 have been reported in vitiligo patients
[1, 2]. IL1RN intron 2 VNTR (rs1794068) has been found to be as-
sociated with autoimmune disorders including vitiligo [3]. We
have explored the role of Interleukin (IL)-1 in vitiligo by monitor-
ing the expression of IL1A, IL1B, IL1Receptor1 (R1) and IL1 Receptor
Antagonist (RN) in skin samples, effect of IL1-α on melanocyte
viability, IL1R1 membrane expression and genotyping of IL1RN
VNTR in Gujarat population.
Materials and methods
Twelve skin biopsies from vitiligo patient’s lesional, non-lesional
skin and controls were obtained. RNA was isolated and relative
gene expression was performed using Real-time-PCR. Genomic
DNA was extracted from whole blood of 226 vitiligo patients and
controls for IL1RN VNTR genotyping. PrimaryNormal Human Mela-
nocytes (NHM) were isolated and cultured from human skin, cell
viability was monitored by MTT assay. Membrane expression of
IL1R1was monitored using Flow-cytometry.
Results
We investigated the expression of IL1A, IL1B, IL1R and IL1RN in
control and vitiliginous human skin, and found unaltered levels
of IL1A, IL1R1 and IL1RN (p = 0.6000, p = 0.8186, p = 0.2147 re-
spectively). Interestingly, significant increase in IL1B levels was
seen in non- lesional compared to lesional vitiliginous skin (p =
0.0021), suggesting its important role in disease progression
(Fig. 8a). In vitro studies were performed on NHM to monitor the
dose dependent effect of IL1-α on melanocyte death. IL1-α
(100 ng/ml) showed ~12 % melanocyte death upon 48 hrs. treat-
ment (Fig. 8b). Further, transcript levels as well as membrane
expression of IL1R1 in NHM upon IL1-α treatment was stud-
ied.1.24-fold increase in IL1R1 and ~22 % increase in membrane
expression of IL1R1 as observed (Fig. 8c). Additionally, genotyping
of IL1RN VNTR in 226 patients and controls was carried out and
no significant difference was found in genotype and allele fre-
quency (Table 8).
Table 8 (abstract P22) Distribution of Genotypes and Alleles for IL1RN
intron 2 VNTR (rs1794068) in vitiligo patients and controls from Gujarat. ‘n’















Genotype n = 226 n = 226
(A 1/1) 85 (37.61) 93
(41.15)
R 1a -
(A 1/2) 89 (39.38) 84
(37.16)
0.4891a 0.8626a 0.5674 to
1.311a
(A 2/2) 40 (17.69) 33 (14.6) 0.3109a 0.7540a 0.4364 to
1.303a
(A 3/2) 3 (1.32) 4 (1.76) 0.7992a 1.219a 0.2650 to
5.605a
(A 3/1) 8 (3.53) 9 (3.98) 0.9564a 1.028a 0.3794 to
2.787a
(A 4/2) 1 (0.44) 00 (0.00) 0.2970a 0.3048a 0.01224
to 7.589a
(A 1/4) 00 (0.00) 1 (0.44) 0.3403a 2.743a 0.1102 to
68.30a
(A 5/2) 00 (0.00) 2 (0.88) 0.1786a 4.572a 0.2163 to
96.66a
Allele
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Significant increase of IL1B in non-lesional skin indicates its im-
portant role in vitiligo progression. IL1-α decreases the NHM
viability via upregulation of IL1R1, suggesting the important role
of IL1 in immune homeostasis and melanocyte biology. Lack of
genetic association of IL1RNVNTR polymorphism suggests dysreg-
ulation of IL-1 signaling may not be due to IL-1RN studied poly-
morphism i.e., rs1794068.
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levels in skin of vitiligo patients (n = 12) and controls (n = 12).
Significant increase of IL1B transcript levels in non lesional skin
compared to lesional skin of vitiligo patients and control skin.
(p = 0.0021 and p = 0.0290 respectively) was observed. However,
no significant difference in the transcript levels of IL1A, IL1R1 and
IL1RN was observed. b MTT cell viability assay: IL1-α (100 ng/ml)
showed significant decrease in cell viability of NHM at 48 hrs
(n = 3, *p < 0.0210). However, at lower concentrations
(0.1-50 ng/ml) IL1-α did not show any significant change in the
% cell viability. c The NHM were treated with 10 ng/ml IL1α and
100 ng/ml IL1α and subsequently IL1R1 levels were measured by
Flow cytometry after 48 hrs of treatment. Results showed
significant increase (~22 %) in the membrane expression of
IL1R1 upon exogenous IL1-α stimulation to NHM
182(55.6)
A1 133(40.6) 187(57.3) Rb 1b -
11(3.36)
A2 123(37.7) 0.5177b 0.9001b 0.6542 to
1.238b
1(0.30)
A3 13(3.98) 0.7404b 1.150b 0.5022 to
2.634b
0(0)
A4 1(0.30) 0.9848b 0.9733b 0.06038
to 15.69b
A5 2(0.61) 0.1641b 4.867b 0.2319 to
102.1b
‘R’ represents reference group
HWE refers to Hardy-Weinberg Equilibrium
CI refers to Confidence Interval
(P) refers to Patients and (C) refers to Controls
aVitiligo Patients vs. Controls (genotype) using chi-squared test with 2 × 2
contingency table
bVitiligo Patients vs. Controls (allele) using chi-squared test with 2 × 2
contingency table
A are different alleles of IL1RN intron 2 VNTR (rs1794068)P23
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BMC Genomics 2016, Volume 17 Suppl 6 Page 19 of 78Background
This study represents the frequency of chromosomal abnormalities in
12,844 patients referred to the Human Cytogenetics Department
from the outpatient’s clinics of Clinical Genetics Department, National
Research Centre. The aim of this study is to assess the frequency and
types of chromosome abnormalities and identify the role of FISH in
refine the clinical diagnosis and compare our findings to results re-
ported in similar studies.
Results
According to the cause of referrals the patients were categorized into
six groups, intellectual disability/multiple congenital abnormalities
represented 31.4 % of all patients, disorders of sex development rep-
resent 24 %, genetic counseling for previous history of affected child
10 %, repeated abortions 10 %, premarital counseling 9.2 %, miscel-
laneous group like obesity, Congenital heart defects, limb anomalies,
chromosome breakage syndrome, etc 15.4 %. Males represent
46.2 %, females represented 52.8 % and unidentified sex 1 %. The
total rate of chromosomal abnormalities was 19.3 %. The highest
anomaly rate was among Down syndrome. Autosomal anomalies
represent 78.5 %, numerical anomalies were 50.5 %, and structure
anomalies were 28 %. Sex chromosome anomalies were 21.5 %, nu-
merical 15.7 %, and structural 5.8 %. FISH analysis was performed on
12 % of patients referred for cytogenetic analysis, it diagnosed pa-
tients with microdeletion syndromes, confirmed the sex chromosome
anomalies in DSD and identified the break sites in chromosomal
translocation and the nature of add chromosomal materials. Through
the detection of microdeletion syndromes FISH raised the chromo-
somal abnormalities in this referred population by 1 %.
Conclusions
Cytogenetics and FISH could diagnose 20.3 % of referred population
for cytogenetics, still a large number of these patients needs genetic
diagnosis especially patients with ID. We recommend the application
of multiple ligation probe amplification (MLPA) and array CGH which
will help for more accurate genetic testing.
Acknowledgements
Authors would like to thank the National Research Centre, Egypt for
supporting this work.
References
1. Wellesley D, Dolk H, Boyed PA, Greenlees R, Haeuusler M, Nelen V, Garne
E, khoshnood B, Doray B, Rissmann A, Mullaney C, Calzolari E, Bakker M,
Salvador J, Addor M, Draper E, Rankin J, Tucker D: Rare chromosomal
abnormalities, prevalence and prenatal diagnosis rates from
population-based congenital anomaly registers in Europe. European
Journal of Human Genetics 2012, 20:521-526.
2. Ghazaey S, Mirzaei F, Ahadian M, keifi F, Tootian S, Abbasadegan R.
Pattern of chromosomal aberrations in patients from north east Iran.
CELL Journal 2013, 3: 258-265.
P24
Analysis of binding properties of angiotensin-converting enzyme 2
through in silico method
S. M. A. Shahid1, Qazi Mohammad Sajid Jamal2, J. M. Arif1, Mohtashim
Lohani3
1Department of Biochemistry, College of Medicine, University of Hail,
Hail, Saudi Arabia; 2Department of Health Information Management,
College of Applied Medical Sciences, Buraydah Colleges, Al Qassim,
Saudi Arabia; 3Department of Biosciences, Faculty of Applied Science,
Integral University, Lucknow, India.
Correspondence: S. M. A. Shahid (2007.sma@gmail.com) – Department
of Biochemistry, College of Medicine, University of Hail, Hail, Saudi
Arabia
BMC Genomics 2016, 17(Suppl 6):P24
Background
Angiotensin-converting enzyme 2 (ACE 2) belongs to the rennin-
angiotensin system (RAS) and is a potential therapeutic target for the
control of cardiovascular diseases and hypertension. Inhibitors of
ACE2 are effective drugs for the treatment of cardiovascular diseases
and associated pathophysiology. In this study, we have taken thehuman Angiotensin-Converting Enzyme 2 and their known inhibitors,
to identify the catalytic site residues of ACE2. The predicted catalytic
traid of ACE2 is ALA 354 - GLN 281 - LYS 511 – GLU 376 – THR 282.
Our results would be more useful in designing and development
new inhibitors of human ACE2 to control cardiovascular diseases and
hypertension.
Results
We used a novel, rapid, and economical structure-based approach to
predict the catalytic site of human Angiotensin-Converting Enzyme 2
(ACE2). We docked all 7 known inhibitors with ACE2 using AutoDock
program and evaluated the binding compatibility with receptor
based on docked energy (in kcal/mol). The docking tool generated
30 conformations for each docked inhibitor in approximately 25 mi-
nutes of CPU time. Based on docking energy it was predicted that
the inhibitors Candesartan (-7.55 kcal/mol), losartan (-12.07 kcal/mol),
Quinapril (-11.7 kcal/mol), Ramipril (-11.57 kcal/mol), Valsartan
(-6.75 kcal/mol), Perindopril (-10.04 kcal/mol) and Enalapril (-10.36 kcal/
mol) have good binding affinities towards the ACE2 and their Root
mean square deviation from a reference.
Conclusions
The protein-ligand interaction plays a significant role in structure
based drug designing and is extensively used to reduce cost and
time in drug discovery. In this present work, we have taken 7 known
inhibitors of ACE2 namely Candesartan, Losartan, Quinapril, Ramipril,
Valsartan, Perindopril and Enalapril were taken for in silico prediction
of catalytic site (ALA 354 - GLN 281 - LYS 511 – GLU 376 – THR 282)
residues of the human Angiotensin-converting enzyme 2 (ACE2). Our
reports can be used to design and develop new inhibitors with bet-
ter binding affinities towards the ACE2 to recuperate cardiovascular
disease.
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Background
Sickle cell anemia is the first monogenic disease described in human,
and it became the paradigm for a disease traceable to a single muta-
tion in a single gene. Spectacular results are certainly being obtained
useful for understanding the phenotypic variability of the disease.
However, Fetal hemoglobin (HbF) plays a dominant role in ameliorat-
ing morbidity and mortality of hemoglobinopathies. The aim of this
study is to evaluate the effect of polymorphic markers located in cis
and trans of βS-globin gene on the variation of HbF expression
among Tunisian sickle cell patients. After formal consent, we per-
formed the Haplotype analysis of the β-globin gene cluster by (PCR-
RFLP), the framework polymorphism was established by PCR-
sequencing, four independent regions of interest were investigated:
the 5′ region of β-LCR-HS2 site, the intervening sequence II (IVSII) re-
gion of the two fetal genes (Gγ and Aγ) and the 5′ region of β-Globin
gene. In trans of the βS-globin gene we studied two polymorphisms
rs1005589 and rs11095629 on neuronal membrane glycoprotein
gene (GPM6B) in chromosome X by SSP-PCR.
Results
The Correlation of these various Haplotypes and SNPs with HbF ex-
pression was studied. Our data showed that among the various
BMC Genomics 2016, Volume 17 Suppl 6 Page 20 of 78polymorphic markers analyzed in cis of βS-globin gene, only the se-
quence (AT)xN12(AT)y in LCR HS2 region was significantly associated
(p < 0.05) with increased HbF levels, suggesting that the β-globin
gene cluster exerts a significant effect on HbF in sickle cell patients.
In GPM6B gene, our results indicate that the rs11095629 and
rs1005589 are associated with HbF level variation.
Conclusions
This study suggests that different genes might modulate the rate of
HbF in sickle cell anemia, which can improve understanding of the
physiopathology of the disease and aid to increase our ability to pre-
dict clinical severity.
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Background
Breast cancer (BC) is the most frequently diagnosed cancer and
the leading cause of cancer death among women worldwide [1].
The incidence rates are increasing alarmingly among Sudanese
women. Estrogen receptor alpha, encoded by ESR1 gene, is a
ligand-activated transcription factor that mediates estrogen action
in target tissues. Estrogen is essential in breast tissue proliferation
and differentiation. Estrogen exposure is a central risk factor in
the development of BC [2]; therefore, genetic variants in ESR1 are
likely to affect BC susceptibility. Most genetic associations on BC
have arisen from studies investigating European and American
patients. However, possibility of specific changes among cancer
patients of different ethnic groups remains unexplored. The aim
of this study was to evaluate the association of two single nu-
cleotide polymorphisms (SNPs) in ESR1 with BC among Sudanese
women.
Subjects and methods
This case-control study included 71 BC women diagnosed at Na-
tional Cancer Institute (NCI-UG), University of Gezira, Sudan from
2012 to 2014 (patient group); and 73 women having no evidence
of personal or family history of BC were recruited as a control
group. DNA was extracted from peripheral blood. Genotyping of
the ESR1 polymorphisms were performed using polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP).
Amplification products were digested by BsmAI and Hpy188III
endonucleases for rs3020314 and rs1643821 respectively, the
DNA fragments were electrophoresed and the resulting bands
were visualized using automated gel documentation system.
Information on demographic data, personal and family medical
history, in addition to reproductive history was obtained.
Anthropometric measurements and clinicopathological characteris-
tics were assessed.
Results
The findings showed significant differences in genotype frequen-
cies between cases and controls. For rs3020314, women carrying
the heterozygous genotype CT had a significantly increased risk
of BC compared to controls (OR: 2.67; 95 % CI: 1.19-6.01; p =0.014). Conversely, for rs1514348 women with the heterozygous
genotype CT showed a significantly decreased BC risk (OR: 0.41,
95 % CI: 0.19-0.89; p = 0.046). There were no differences in allele
frequencies between the two groups. For rs3020314, cases with
BMI > = 25 kg/m2 carrying CT genotype had 7 times BC risk than
controls, likewise postmenopausal BC patients with CT genotype
had 6 times BC risk than controls. No association was found be-
tween genotype frequencies of either SNP with clinicopathologic
features.
Conclusions
Our data suggest that the ESR1polymorphism rs3020314 might
contribute to increased BC risk, and rs1643821 to decreased risk in
Sudanese women. However, these findings need to be further tested
in a larger number of Sudanese women in a population-based
approach.
References
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M,
Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence
and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon,
France: International Agency for Research on Cancer; 2013. Available
from: http://globocan.iarc.fr, accessed 14 Oct 2015.
2. Dumitrescu RG, Cotarla I. Understanding breast cancer risk - where do
we stand in 2005? J Cell Mol Med 2005; 9(1): 208-221.P27
KCNQI gene polymorphism and its association with CVD and T2DM
in the Saudi population
Maha S AlShammari, Rhaya Al-Ali, Nader Al-Balawi , Mansour Al-Enazi, Ali
Al-Muraikhi, Fadi Busaleh, Ali Al-Sahwan, Francis Borgio, Abdulazeez
Sayyed, Amein Al-Ali, Sadananda Acharya
College of Medicine, Institute for Research and Medical Consultations,
University of Dammam, Dammam, Saudi Arabia
Correspondence: Maha S AlShammari (Alshammari.maha.s@gmail.com) –
College of Medicine, Institute for Research and Medical Consultations,
University of Dammam, Dammam, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):P27
Background
Genome Wide Association studies have identified several loci as-
sociated with an increased risk of developing CVD and T2DM, this
was confirmed by replication studies. Polymorphisms within
KCNQ1gene are consistently associated with T2DM in a number
of populations. Recent reports indicated that both T2DM and
CVD are increasing in the Saudi population, with T2DM reaching
alarming levels in the Eastern Province. This study was under-
taken to shed light on the possible association of three polymor-
phisms (rs2237892, rs151290 and rs2237895) with T2DM and/or
CVD in this population.
Subjects and methods
Patients clinically diagnosed with either T2DM (320 patients), CVD
(250 patients) or both (60 patients) and 516 healthy controls were in-
cluded in the study. Genotyping was performed by TaqMan assay
run on a real time PCR thermocycler.
Results
A statistically significant association was found for SNPs rs151290 (OR =
1.63; p = <0.00001) and rs2237895 (OR = 1.70; p = <0.00001) with CVD.
Moreover, SNPs rs151290 (OR = 2.20; p = 0.0029) and rs2237895 (OR =
1.56; p = 0.031514) showed a strong association in patients with both
T2DM and CVD. However, none of the SDNPs tested showed any signifi-
cant association with T2DM. Haploview analysis showed that CCC
(rs151290 “C”; rs2237892 “C”; rs2237895 “C”) and ACC (rs151290 “A”;
rs2237892 “C”; rs2237895 “C”) haplotypes are the most significant risk (p
< 0.00001) allele combinations for CVD, while CCA (rs151290 “C”;
rs2237892 “C”; rs2237895 “A”) and ACA (rs151290 “A”; rs2237892 “C”;
rs2237895 “A”) are co-morbidity risk haplotypes for T2DM and CVD.
Conclusions
KCNQ1 polymorphism at SNPs rs151290 and rs2237895 is strongly
associated with CVD in this population, but reflected no association
with T2DM.
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Background
\Microcephaly-capillary malformation syndrome (MICCAP syndrome)
is a newly recognized congenital neurocutaneous central nervous
system disorder. To date the diagnosis has been confirmed in 14 af-
fected individuals.
Materials and methods
Meticulous clinical examination, brain MRI, echocardiogram, abdominal
ultrasound, ophthalmological examination, electroencephalogram (EEG),
thyroid profile, intelligent quotient, karyotyping and array-CGH were done.
Results
We report a 5 years old girl of a non-consanguineous marriage with
microcephaly, early onset seizures that started at 7 months of age,
craniofacial dysmorphism, recurrent infection and profound intellec-
tual disability. Delayed mile stones, craniofacial dysmorphism in-
cluded narrow forehead, anterior recession of hair line, scanty eye
brows, depressed nasal bridge, squint, tented upper lip, and pro-
truded tongue. Limited extension of right wrist, brittle dystrophic
nails, soft tissue syndactly of fingers and areas of cutaneous vascular
malformation. Neurologically, she had hypertonia and hyperreflexia.
The anthropometric measurements were weight 9 Kg (-3.5 SD), head
circumference 39.5 cm (-8.8 SD) and height 90.5 cm (-3.7 SD). Thyroid
profile showed hypothyroidism and Echo heart displayed patent for-
amen oval, right ventricular dysplasia. DEXA revealed osteopenia at
the spine and femur. The Intelligent Quotient (IQ) at the age of
5 years based on the Wechsler Intelligence Scale was 56 (profound
intellectual disability). The MRI brain showed severe microcephaly
with marked cerebral atrophic changes, incomplete demyelination,
vascular malformation and hemorrhage of the brain. Dental examin-
ation revealed high arched palate, delayed teeth eruption, abnormal
small teeth, premature shedding of upper incisors and high caries
index. Karyotype revealed normal female karyotype 46,XX and array-
comparative genomic hybridization analysis (array CGH) was normal.
Conclusions
To our knowledge this work presents the first patient of Microcephaly
capillary malformation syndrome reported in Egypt. Our study displays
previously unreported findings of dental abnormalities and osteopenia.
Consent to publish
Written informed consent for publication of the clinical details
was obtained from the parents of the patient. A copy of the
consent form is available for review by the Editor of BMC
Genomics.
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Inflammatory bowel diseases (IBD) are chronic disease that are
thought to occur due to loss of tolerance toward commensal flora
and food antigens in the gut. The CD200 receptor (CD200R) cell
surface protein is an inhibitory receptor mainly expressed on
myeloid cells, whose known functions are immunosuppression
and modulation of inflammation [2]. We aimed to analyze the
structural deviation of clinically significant mutant forms of
CD200R by computational modeling and to investigate the ex-
pression of CD200R1 by dendritic cells (DCs) using flow cytometry
to determine whether there are any abnormalities in their expres-
sion at the cellular level.
Materials and methods
The In-silico analysis of clinically potential missense mutations
of human CD200R1 gene was performed by algorithms based
on sequence and structure homology (SIFT, PolyPhen and Con-
Surf). Molecular modeling and secondary structural analysis was
done to confirm their impact on the stability and secondary
properties of wild-type and mutated CD200R1 protein. For
in vivo validation, 37 IBD patients (14 UC and 23 CD) were in-
cluded. Fourteen age-matched healthy volunteers (5 males and
9 females) served as a healthy control group (HC). Peripheral
blood mononuclear cells were collected and analyzed for ex-
pression of CD200R1 on DCs multi-parametric flow cytometry as
described elsewhere [4]. The study protocol was approved by
the Ethics Committee of the KAUH.
Results
By using in-silico algorithms, we were able to identify that the dele-
terious mutations corresponding to p.Y291N, p.G223V, p.A176V,
p.V149A and p.S39L have potential role in structural and functional
deviations of CD200R1 activity (RMSD ≥ 2 Å) (Fig. 9). Multi-parametric
flow-cytometry results revealed significant decrease (P < 0.001) in
CD200R expressing DCs of IBD patients when compared with that of
HC (Fig. 10).
Conclusions
In-silico finding suggests that mutations in CD200R1 influence
IBD rate, which we confirmed this hypothesis by demonstrating
that CD200R1 expressing DCs are significantly lower in IBD pa-
tients compared with healthy controls. Collectively, these data
present evidence for dysregulated expression of the inhibitory
molecule CD200R1 on DCs that may contribute to the immuno-
logic abnormalities occurring in this disease and provide insight
into the pathophysiology of IBD. Further functional studies are
mandatory to explore the molecular mechanism underlying the
down-regulation of CD200R in IBD.
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Fig. 9 (abstract P29) The central figure demonstrates the ab initio
3D model of CD200R1 developed from 1 Tasser server. Surrounding
figures show the structural deviation between wild-type model (green
coloures) and mutant type model (non-green coloured) of selected
mutations of CD200R1 protein which is related to IBD. (Visualized by
PyMol-Molecular graphic system)
Fig. 10 (abstract 29) Boxplot shows the frequency of CD200R+ on
DCs of patients with Ulcerative colitis (UC), Crohn’s Disease (CD)
as compared with (healthy Controls) HC: NS: not significant;
*P < 0.05; **P < 0.001
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Background
Periodically, complete novel antigenic subtypes of influenza vi-
ruses have been introduced in human population, causing large-scale global outbreaks with high death tolls. As a consequence of
all this, pandemic preparedness has become an important issue
worldwide and specially for Kingdom of Saudi Arabia. Theses
Pandemic plans should include proper approaches that allow
early recognition of novel influenza viruses infecting humans in
the future.
Results
In silico PCr analysis of the designed oligonucleotide primers showed
a strong matching with the corresponding nucleotide sequences of
the KSA H1N1 viral strains. Moreover, real time PCR data generated
from this study produced a variable range of Cycle threshold (C.t.)
values of 16.61 – 31.7. Furthermore, sensitivity test of the optimized
real time PCR protocol showed that recommended protocol is effi-
cient and specific to the H1N1 KSA strains, especially the oligo-
nucleotide primers H1N1 KSA F2R2 which produced an earlier C.t.
value of 16.61.
Conclusions
Results of this study confirm the importance of design specific
diagnostic protocols against local infectious agents in order to
increase the accuracy and efficiency of the detection process
and, hence, increases the chances to control the epidemic
spread of H1N1 viruses. Finally, this scientific article represents
the first research to design and test specific oligonucleotide
primers for the detection of local H1N1 viral strains in Kingdom
of Saudi Arabia.
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Background
Osteoarthritis (OA) is a progressive joint disease characterized by
gradual degradation of extracellular matrix (ECM) components in the
cartilage and bone. The ECM of cartilage is highly specified structure
that is mainly composed of type II collagen that provides tensile
strength to the tissue, aggrecan and proteoglycans. However,
changes in the ECM composition and structure can lead to collagen
type II loss, and network integrity. Several risk factors have been cor-
related with OA including age, genetic predisposition, hereditary fac-
tors, obesity, mechanical injuries, and joint trauma. Certain genetic
association studies have been identified several genes associated
with OA using genome-wide association studies (GWASs).
Materials and methods
To understand the pathology of OA and changes in the ECM that
could be caused by genetic mutation, we performed a pilot whole-
exome sequencing study on blood samples obtained from five end-
stage OA patients with an age range of 46 –70 years old.
Results
Although no common genetic factors have been found, we identified
several novel genetic variants affecting genes that function in several
candidate causative pathways including immune response, inflamma-
tory and cartilage degradation such as SELP, SPN, COL6A6 and
COL7A1.
Table 9 (abstract P32) New statistical and evolutionary information
included in E-GRASP
SNP ID Statistical Replication Evolutionary Information
rs4719450 RepInPMID 3 Evalue 7.06E-12
RepInPhenotype 3 Rate(x1000) 7558
RepInEachPMID 1 FetchTime 265
RepInEachPMIDinPhentotype 1 Prank 93828
UniqueStudyInSNP 3 Erank 103468
NumofSNPsinPMID 546944 E-P 9640
RepPhenotypeinPMID 546944
UniqueSNPinPMID 355701
BMC Genomics 2016, Volume 17 Suppl 6 Page 23 of 78Conclusions
The approach of exome sequencing can be a promising method to
identify gene mutations that influence the OA disease.
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Background
Genome-wide repository of associations between SNPs and pheno-
types (GRASP) is a centralized repository of publically available
genome-wide association study (GWAS) results. GRASP v2.0 contains ∼
8.87 million SNP associations reported in 2044 studies and ~178
thousand phenotypes [1]. However, this database does not contain
evolutionary information about individual SNVs, particularly the
prioritization of SNVs by using evolutionary conservation of SNVs.
Materials and methods
We built a new relational database that contains information from
GRASP v.2.0 as well as evolutionary information. The resulting SQL data-
base was subjected to MATLAB analysis in order to compute secondary
fields, including the statistical replication of SNVs over studies and evo-
lutionary information for each SNV. All SNVs were mapped to genome
position of human genome build 38 (hg38) using the LiftOver resource.
Results
We developed an integrated E-GRASP-DB that provides detailed informa-
tion of SNPs, an efficient examination of past GWAS results for diverse sets
of researchers to complete various qualitative and quantitative analyses.
Statistical SNV replication category provides information about replication
of SNVs in studies, replication of SNVs in phenotype, SNVs replication in
each study of each phenotype, and number of unique studies for each
SNV. Another replications based on studies include number of SNVs in
each study, studies replication in phenotype, and number of unique SNVs
in each study (Table 9). Further, evolutionary information includes E-value
for SNP phenotype association, rank of the evolutionary rate of the pos-
ition, and rank of the evolutionary time span of the position that have
been retrieved from the E-rank web server for each SNP [2].
Conclusions
Our E-GRASP database has additional information related to SNPs
replication and evolutionary scores, facilitating better data interpret-
ation and new hypotheses to be generated.
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Background
The story of Familial Hypercholesterolemia (FH) in the Middle East
started fifty years ago with the first description of Essential Familial
Hypercholesterolemia in Lebanese families by Khachadurian in 1962.
Later the field of FH and atherosclerosis expanded exponentially with
the discovery of the LDL-receptor (LDLR) defect in fibroblast of
homozygote FH individuals leading the way for Goldstein and Brown
to receive the Nobel prize. Later numerous mutations in the LDLR
gene where reported.
Results
Through record keeping of FH individuals we exposed the global
under reporting, poor management and premature death in undiag-
nosed FH cases in Saudi Arabia. In addition, mapping private muta-
tions and the emergence of the third culprit (PCSK9 gene) associated
with FH has flourished the concept of the heterogeneity in FH
and the gene-gene interaction. Furthermore, the advance imaging
of atherosclerosis in FH had aided in the understanding of the
phenomena of aortic calcification and the essential role of inflam-
mation as a neglected marker and target for intensive therapy in
these individuals.
Conclusions
Efforts to maintain a registry and a cascade screening program for
FH are undergoing to improve the recognition of FH in Saudi Arabia.
Increase awareness of the number one genetic risk for CVD, which is
FH, and the preventive strategies to reduce premature atheroscler-
osis are expected to improve FH life expectancy.
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Table 10 (abstract P35) Software/databases used for design a TALENs
plasmid knockout system for the ABCB1 gene
Software/
Database
Description URL (Uniform Resource Locator)

























ApE software Plasmid editor. http://biologylabs.utah.edu/
jorgensen/wayned/ape/
Fig. 11 (abstract P35) The model of the final forward and reverse
plasmids for the ABCB1 TALEN
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Hepatocellular carcinoma (HCC) is the fourth most common cancer
type, and has one of the highest mortality rates among cancer pa-
tients. The disease is more common in Eastern Mediterranean na-
tions, probably due to a significant contribution of hepatitis C virus
(HCV) and hepatitis B infection. The disease is mostly diagnosed at
advanced stages, and therefore has poor prognosis. Previously, we
have developed a rat model of liver cancer for the identification dis-
tinct molecular mechanisms for early HCC. In this study, we gathered
recent human HCC genomic data sets and performed cross-species
comparative genomic analyses and identified a gene list that may be
most relevant to early HCC. Moreover, we validated our gene-list on
the gene expression profiling of peripheral blood mononuclear cells
(PBMC) from patients with HCC. Furthermore, using our gene list we
performed functional annotation, gene networks and pathway
analyses.
Results
We identified potential gene signature that is conserved across rat
and human HCCs, and validated its diagnostic value on the PBMC
from patients with HCC dataset as well as independently performed
HCC datasets. Our results indicate alterations in a number of cancer
related pathways and critical for early HCC transformation.
Conclusions
The results suggest that network analysis coupled with cross-species
genomic analysis may provide a robust method to identify key bio-
logical programs associated with early HCC and may lead to im-
proved diagnosis and therapeutic options.
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Background
Finding a treatment for various types of cancer is a key challenge
with very poor clinical outcomes. Chemoresistance induced by can-
cer stem cells (CSCs) and subsequent tumour relapses are major ob-
stacles in cancer chemotherapy [4,5]. ABCB1 is a gene which is
highly expressed in CSCs that encodes for the P-glycoprotein (P-pg)/
multidrug resistance protein (MDR), protecting the cancer cell from
anticancer drugs [2]. To overcome the chemoresistance ability in can-
cer cells and/or CSCs, we designed a TALEN-based oncolytic viral vec-
tor approach as a genome editing tool to knockout the ABCB1 gene
and inhibit over expression of P-gp in CSCs [1,3].
Materials and methods
Several bioinformatics tools (Table 10) were utilized to determine
structure/function relationships of ABCB1 gene and to design
TALENs.
Results
E-TALEN/De-novo software shows 12 designs depicting nucleotide
sequence, transcript and exon, RVD sequence score and percent of
total transcripts hit. TALEN designs with highest scores were selected
based on i.e. length of binding site / (DNA composition Variation +
RVD Composition). ABCB1_14_59842 had the higher score of the suc-
cessful designs and no off-target theoretical crossmatches with a
score of 1.379 whereas RVD recognized the nucleotide sequence of
ABCB1 gene in ENST00000265724 at exon 5. The RVD sequence of
the TALEN design ABCB1_14_59842 was evaluated by using E-
TALEN/Evaluation software. In order to obtain functional TALENs, re-
peats were generated into the Sangamo plasmid model and forward
and reverse TALEN plasmids map were constructed by using ApE
plasmid editing tool.
Conclusions
Genetically engineered TALENs with repeat variable diresidues (RVD)
which specifically target and cleave the ABCB1 gene via DSB/NHEJ
mechanisms at exon 5, were designed. These can be delivered byrecombinant oncolytic viral vectors that specifically target CSCs.
ABCB1 knockouts and reversion of chemoresistance in CSCs could
potentially improve the outcome of chemotherapy in cancer
patients.
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Fig. 12 (abstract P36) a Phase contrast microscopic image of
synovial fluid-MSC (SF-MSC) showing the spindle-shape morphology
(magnification 10x); b -Flow cytometry analysis of surface-marker
expression on SF-MSC showing positive expression for CD73,
CD90, CD105, CD29 and negative expression for CD34 and CD 45;
c - Cell proliferation (MTT assay) of SF-MSCs at 24 h, 48 h and 72 h
showing increase in cell proliferation with time; d - Real time gene
expression analysis (qRT-PCR) showing increased expression of SOX9
and COL2A1
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Background
Osteoarthritis (OA), a progressive disease of synovial joints represents
failed repair of joint damage that results from stresses that may be
initiated by an abnormality in any of the synovial joint tissues [1].
Synovial fluid contains mesenchymal stem cells (MSCs) that contrib-
ute to cartilage regeneration [2]. The aim of this study is to derive
the MSCs from the synovial fluid (SF-MSCs), characterize them for
stemness and evaluate their differentiation potential into chondro-
cytes and related gene expression.
Materials and methods
Synovial fluid samples were collected from patients following
institutional ethical approval and informed patient consent. Deriv-
ation SF-MSCs were done using earlier established protocol and were
assessed for their morphology (Phase contrast microscopy), cell
viability and proliferation (MTT assay), CD marker expression (flow cy-
tometry) and cartilage related gene expression (qRT-PCR).
Results
SF-MSCs were derived with greater efficiency and propagated to pro-
duce primary cell lines. Initial passages showed short fibroblastic
morphology and increased proliferation (Fig. 12a) and were positive
for MSCs related CD markers namely, CD73, CD105, CD90, CD29 and
negative for CD34, CD45 (Fig. 12b). Cell proliferation by 229.42 %
and 264.71 % at 48 h and 72 h compared to the 24 h respectively
and these increases in values were statistically significant (Fig. 12c).
qRT-PCR analysis showed increased expression of collagen II and
SOX9 in the differentiated samples compared to the controls
(Fig. 12d).
Conclusions
SF-MSCs were derived, expanded in culture and were also differenti-
ated into chondrocytes that highly expressed cartilage related genes.
Presence of MSCs from within the joint indicate the self healing
mechanisms. Thus these cells might be a right choice of cell type for
cartilage regeneration. In addition they may be able to provide closer
insight into actual disease status enabling development of targeted
therapies.
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Background
Genome-Wide Repository of Associations between SNPs and Pheno-
types (GRASP) is an extensive database of publicly available genome-
wide association study (GWAS) results, which are the genetic variants
(single nucleotide variants, SNVs) associated with complex traits and
diseases [1]. This resource is primarily a population genetics resource,
which currently ignores the evolutionary information available for
the positions harboring SNVs. We have developed a web application
to make the information available in the GRASP2 resource along with
the evolutionary information.
Materials and methods
In building the web application, we used JavaScript, Ajax and ASP.net
to develop the client-side web interface which is served on the back-
end by a SQL server, Matlab, D3.js, D3Plus.js and jQuery datatable.
Popular dbSNP, dbSNP-Q and hgLiftOver resources were used for
synchronizing and populating the database, in addition to the con-
tect available at GRASP2.
Results
We developed a new web application and database named “E-
GRASP” to enable easy and fast data retrieval of SNVs in GRASP and
associated evolutionary information. E-GRASP presents three different
views. (a) SNV View that contains information about each SNV such
as SNPid, PMID, P value, chromosome number, position, number of
studies reporting the SNV, and number of phenotypes associated
BMC Genomics 2016, Volume 17 Suppl 6 Page 26 of 78with each SNV. (b) Study View that presents information on individ-
ual studies and basic information, including PMID, list of SNVs, their
replication, phenotypes. (c) Evolutionary View that contains evolu-
tionary conservation information as well as the E-rank [2] of SNVs in
individual studies (plus P value, E value, P-rank, E-rank, and MAF)
(Fig. 13).
Conclusions
E-GRASP will enable users to examine the GWAS data along with
evolutionary information. In future, we plan to add more features
and filters to improve it further.
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Background
Glycogen storage disease (GSD) type III is autosomal recessive dis-
ease affects several organs as liver, heart and skeletal muscles. It is
due to glycogen debranching enzyme deficiency that is responsible
for glycogenolysis and is encoded by amylo-1, 6-glucosidase, 4-α-
glucanotransferase (AGL) gene. We aim in this study to screen AGL
gene mutation in a Saudi family with GSD type III from Al-Madinah
Al-Munawwarah.Materials and methods
Blood samples from 6 members of a family were collected including
two affected with GSD III. DNA was extracted using QIAGEN Mini Kit.
Quality of DNA was tested using gel electrophoresis and UV
visualization. Polymerase chain reaction (PCR) was done to amplify all
exons of AGL gene. PCR products were purified by QIAquick Purifica-
tion Kit. The products of cycle sequencing were purified using X-
terminator PCR Purification kit. The targeted exons were sequenced
by ABI 3500 genetic analyzer. The data were analyzed using BioEdit
Sequence Alignment Editor.
Results
Clinical manifestations of hepatomegaly was observed in two af-
fected individuals. Laboratory investigations revealed an increase in
creatinine kinase and transaminases. No potential sequence variants
were found when patients DNA sequence was compared with refer-
ence sequence of exons and splice junctions of AGL gene.
Conclusions
Sequence analysis revealed no mutation in the patients DNA, while
the possibility of presence of mutation in the regulatory region
(promoter, enhancer) of this gene cannot be excluded.
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Background
Varicocele is diagnosed in about 15 % of the adult male population
and ~40 % of infertile males. The prevalence of varicocele is 35 % in
men with primary infertility, but increases to 81 % in men with sec-
ondary infertility, implicating varicocele as a cause of progressive de-
cline in fertility. Approximately 90 % of varicoceles occur unilaterally
on the left side, while 10 % occur bilaterally. Despite extensive re-
search, the exact cause of infertility in men having varicocele remains
unknown. We utilized proteomic analyses to identify proteins and
pathways that may be affected and responsible for infertility in men
with varicocele.
Materials and methods
An in-silico analysis of proteomics data targeting proteins in sperm-
atozoa from infertile men with varicocele (n = 5) both unilateral and
bilateral and men of proven fertility (n = 5) were separated on 1-D
gel electrophoresis. Proteins were digested with trypsin in gel and
identified on a LTQ-Orbitrap Elite hybrid mass spectrometer system.
The differentially expressed proteins identified were subjected to bio-
informatics pathway analysis using STRING, IPA and Metacore soft-
ware to find out the putative pathways involved in development of
infertility in these patients.
Results
Ninety nine proteins were differentially expressed in the varicocele
groups, of which nine were uniquely expressed in the fertile group
and 2 proteins in the varicocele groups. Integrins (ITGM and ITGB2)
are uniquely expressed in varicocele group. The underexpressed pro-
teins in varicocele group include proteins involved in stress response
and energy metabolism, molecular chaperones, vesicular transport,
proteins necessary for chromatin compaction and epigenetic regula-
tion and sperm function (Acrosin, AK7, SPA17, CACNA2D). The regula-
tory subunit of protein kinase A (PKA) was underexpressed in the
varicocele group.
BMC Genomics 2016, Volume 17 Suppl 6 Page 27 of 78Conclusions
The in silico proteomic profiling reveals that mitochondrial dysfunc-
tion may lead to oxidative stress mediated anomalies in sperm func-
tion. Underexpression of PRKAR1A may lead to activation of Protein
kinase A, a tissue specific extinguisher leading to dismantling of sig-
naling in the spermatozoa of varicocele patients resulting in reduced
fertilizing ability.
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Background
Both primary and secondary infertility are due to an impairment of
sperm function which is associated to some proteomic profile alter-
ations. The objective of the present study is to compare the prote-
ome profile of spermatozoa of fertile and infertile men irrespective of
primary or secondary causes. The specific aim was to determine the
differentially expressed proteins (DEPs) in infertile group involved in
sperm function linked to failure of successful pregnancy in their
partners.
Materials and methods
This prospective proteomic study analyzed proteins in spermatozoa
from proven fertile (n = 5) and infertile men (n = 5). Proteins were ex-
tracted and separated by 1-D gel. Bands were digested with trypsin
and analyzed on a LTQ-Orbitrap Elite hybrid mass spectrometer system.
Protein identification was done using Mascot (Matrix Science, London,
UK; version 2.3.02), SEQUEST (Thermo Fisher Scientific, San Jose, CA,
USA; version 1.4.0.288) and X! Tandem (TheGPM, thegpm.org; version
CYCLONE (2010.12.01.1). Mascot, Sequest and X! Tandem were set up
to search the human reference with database assuming trypsin as the
digestion enzyme. Functional annotations of proteins were obtained
using bioinformatics tools and pathway databases.
Results
Proteins associated with functional annotations related to one or
more of the search terms, namely, sperm function, motility,
fertilization, stress response, acrosome reaction, and reproduction
revealed 40 DEPs in infertility group, when compared with fertile
group. The 35 underexpressed DEPs in the infertile men revealed
dysregulation of post-translational modification, protein folding,
heat-stress response, cell motility, DNA damage mediated apoptosis
and mitochondrial inner membrane assembly. On the other hand,
HIST1H2BA, a variant histone specifically required to direct the trans-
formation of dissociating nucleosomes to protamine in male germ
cells was overexpressed in infertile group.
Conclusions
Pathway analysis in our current study suggests that the dysregulated
post-translational modification, protein synthesis, ubiquitination and
proteosomal break down may lead to accumulation of defective pro-
teins in the spermatozoa, which consequently could lead to compro-
mised sperm function. This may result in unsuccessful pregnancy.Acknowledgements
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Background
Reduced expression of heat shock proteins particularly, HSPA2 is as-
sociated with oligozoospermia, increased frequency of chromosomal
aneuploidies, DNA fragmentation, apoptosis, abnormal morphology,
cytoplasmic retention, reduced fertility potential, and even preg-
nancy failure following in vitro fertilization (IVF). Despite the import-
ance of HSPA2 in spermatogenesis and fertility, there is a lack of
reports on the role of HSPA2 in human sperm maturation. The
present study was designed to identify the pathways involved in pro-
tein turn-over, particularly heat shock proteins in spermatozoal func-
tion from infertile patients; and subsequently validate the role of
testis-specific HSPs in sperm function.
Materials and methods
This prospective proteomic study analyzed proteins in spermatozoa
from infertile men. Briefly, spermatozoa from infertile patients (n = 5)
were fractionated on density gradient (80, 60 and 40 %) layers. Frac-
tion 1 (F1) refers to the least mature stage having lowest density
whereas the fraction 4 (F4) comprises of the most dense and mor-
phologically mature motile spermatozoa. Fraction 2 (F2) and fraction
3 (F3) are the intermediate stages. Proteins were extracted and sepa-
rated by 1-D gel. Bands were digested with trypsin and analyzed on
a LTQ-Orbitrap Elite hybrid mass spectrometer system. Protein identi-
fication was done using Mascot, SEQUEST and X! Tandem which
were set up to search the human reference with database assuming
trypsin as the digestion enzyme. Functional analyses of proteins were
performed using gene ontology analyses. Selected candidate pro-
teins were validated by Western blot.
Results
A significant decreasing trend in spectral counts of molecular chaper-
ones was observed from F1 to F4 fractions. Among the chaperones,
HSPA2 was selected as it is testis specific and its average spectral
count decreased from 707.7 in F1 to 276 in F4. This was validated by
western blot. Another important HSP 70 family member HSPA1L was
also validated and correlated with the pathway analysis data. Beta-
Actin was taken as internal control. The results showed similar trend
as per the proteomic analysis.
Conclusions
HSPA2 expression correlates significantly with sperm maturation
process. Aberrant HSPA2 expression and downregulation of protein
modification and folding may play an important role in sperm func-
tion and fertilization processes.
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Fig. 14 (abstract P42) CGH array detected alteration in
Chromosome 8 (8p23.1, 8p22, 8p11.23) of recurrent abortion patient
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Background
Continuously increasing world population is major concern today,
however many couples are praying for a child as their desire to
have baby results in combination of frustration, inadequacy and
hopelessness, because of recurrent pregnancy loss or spontan-
eous recurrent abortion (SRA) [1]. Chromosome abnormalities has
been reported as major reason for SRA and cytogenetics tech-
niques are routinely used to detect chromosomal techniques,
however, it has many limitations [2].
Materials and methods
In the present study, we applied high-density whole genome
array- comparative genomic hybridization technique to identify all
chromosome abnormalities in forty one SRA patients where clas-
sical cytogenetics G-band analysis technique fails to detect such
abnormalities [3]. The array-CGH analysis was performed by Agilent
sure print G3 Hmn CGH 2x 400 K arrays (Agilent Technologies, USA) fol-
lowing manufacturer’s protocol.
Results
Array-CGH results showed ~800 losses and gains in different genomic
regions of 41 SRA patients with cut off values of -1.0 for microdeletion
and 0.8 for microduplication. We reported 35 frequent alterations that
were present in >10 % of patients, including three macro-alteration
(8p23.1, 10q11.21-q11.22, 15q11.2) and multiple micro-deletions/ampli-
fications: 1p21.1 (AMY2A, AMY2B, AMY1A/B/C), 1q21.3 (LCE3C), 1q24.2
(NME7), 3p22.2 (CTDSPL), 4q13.2 (UGT2B17), 6p21.32 (HLA-DRB5,HLA-
DRB6), 7p15.2 (SKAP2), 7p14.1(TARP), 7q34 (MGAM, PRSS1, PRSS2,
MTRNR2L6, TRY6), 8p23.2(CSMD1), 8p22 (MSR1), 8p11.23 - p11.22
(ADAM5P,ADAM3A), 10q11.22(PPYR1, GPRIN2), 11q11 (OR4C11, OR4P4,
OR4S2, OR4C6), 12p13.2 (PRH1, TAS2R46, TAS2R43, PRR4), 14q11.1-
q11.2 (OR11H12, POTEG, POTEM, OR4Q3, OR4M1, OR4N2, OR4K2,
OR4K5, OR4K1), 14q32.33 (KIAA0125,ADAM6,NCRNA00226), 20p13
(SIRPB1), 22q11.22 (MIR650, IGLL5), 22q11.23 (LOC391322,GSTT1,
GSTTP2) (Fig. 14).
Conclusions
The study shows that whole genome array-CGH can be used in the
identification of potential genes and chromosomal abnormalities
underlying RSA problem. We have reported some of the novel CNVs/
genes involved in the Saudi RSA patients. A more comprehensive pro-
cedure is required to validation the possible causative CNVs and genes
in these regions to improve the diagnoses and treatment of RSA.
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Background
Kidney cancer (KC) is the sixth-leading cause of cancer death worldwide
[1]. KC in its metastatic stage is least responsive to treatment, however,
early detection opens survival window by surgical resection. Therefore we
need to investigate the exact molecular events leading to disease onset
and progression of KC.
BMC Genomics 2016, Volume 17 Suppl 6 Page 29 of 78Materials and methods
We performed whole gene expression profiling of seven KC against five
control using Affymetrix HuGene 1.0 ST arrays and Partek genomic suite v
6.6. IPA, a genome-wide biological pathway analysis package, was used to
find significantly molecular networks and pathways associated with KC.
Results
We identified 1596 differentially expressed significant genes, 542 up and
1054 down regulated, with cutoff P value≤ 0.05 and a fold change> 2;
comparing KC with normal kidney tissues. The most significantly upregu-
lated genes were small nucleolar RNA, C/D box 29 (SNORD29), hypoxia
inducible lipid droplet-associated (HILPDA), caveolin 1 (CAV1), early B-cell
factor 2 (EBF2), transforming growth factor, beta-induced (TGFBI), mito-
chondrially encoded tRNA cysteine (MT-TC), enolase 2 (ENO2), neuropilin
(NRP) and tolloid (TLL)-like 2 (NETO2), anoctamin 4 (ANO4), versican
(VCAN) and matrix metallopeptidase 16 (MMP-16) whereas downregu-
lated genes were aldolase B, fructose-bisphosphate (ALDOB), solute car-
rier family12 (SLC12A3), calbindin1 (CALB1), uromodulin (UMOD),
plasminogen (PLG), kininogen 1 (KNG1), nephrosis2 idiopathic, steroid-
resistant (NPHS2), and potassium inwardly-rectifying channel subfamilyJ1
(KCNJ1). IPA based canonical pathway analysis shown LPS/IL-1 Mediated
Inhibition of RXR Function, Valine Degradation I, Tryptophan Degradation
X (Mammalian, via Tryptamine), Noradrenaline and Adrenaline Degrad-
ation, Serotonin Degradation and FXR/RXR Activation Signaling pathway
to be significantly associated with our kidney cancer cases and this find-
ing is in accordance with other finding [2, 3, 4].
Conclusions
Present study identified differentially expressed genes in kidney cancer
of Saudi Arabian patients using whole transcript, high-density expres-
sion arrays. Our dataset is small but has a potential source for novel
biomarker and may offer unique biological insights for kidney cancer.
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Background
Calcium is important for male fertility in vasodilation, sperm develop-
ment and several enzymatic reactions. It also serves as a second mes-
senger to control acrosome reaction and sperm motility. Calciumchannel-blockers (CCB) as nifedipine and ethosuximide are used in
hypertension and epilepsy treatment can affect the male reproductive
system. However, little is known about their side effects on
chromosomes, StAR-gene, histology of testis and the underlying mech-
anism of the male reproductive dysfunction. The present study utilized
various analyses including genotoxicity, histology and sperm analysis to
address the involvement. of CCB in inducing male infertility.
Materials and methods
Thirty-six albino male mice were orally treated by 50 or 100 mg/kg
body weight nifedipine and ethosuximide respectively for 20 days
followed by another 10 days without treatment for drug withdrawal
and assayed for chromosome aberrations; epididymal sperm count,
motility, abnormal shape; and the testicular expressions of biomarkers
gene including steroidogenic acute regulatory protein (StAR) gene were
measured. In addition, the histologic structure of the testis was investi-
gated to the process of spermatogenesis which indicating partly absent
and atrophy and malformation.
Results
Mice administrated CCB showed a significant increase in the percent-
age of chromosome aberration and sperm shape change. In addition,
expressions of StAR-mRNA was significantly down regulated. Sperm
count and motility were significantly decreased. However, a slight
improvement was observed in all tested parameters after drug with-
drawal. All seminiferous tubules displayed total atrophy, more disrup-
tion, severe damage and more elongation of the tubules with
disorganization of germinal epithelium that detached from the base-
ment membrane. In addition, the lumen of seminiferous tubules
showed the completely absence of sperm cells.
Conclusions
There is evidence that both nifedipine and ethosuximide cause a sig-
nificant increase in chromosome abnormalities, decrease in sperm
structure and function, and downregulation of StAR-mRNA expres-
sion. All these side effects may lead to irreversible male sterility.
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Background
The native nature of high dimension low sample size of gene expres-
sion data make the classification task more challenging. Therefore, fea-
ture (gene) selection become an apparent need. Selecting a
meaningful and relevant genes for classifier not only decrease the com-
putational time and cost, but also improve the classification perform-
ance. Among different approaches of feature selection methods,
however most of them suffer from several problems such as lack of ro-
bustness, validation issues etc. Here, we present a new feature selection
technique that takes advantage of clustering both samples and genes.
Materials and methods
We used leukemia gene expression dataset [1]. The effectiveness of
the selected features were evaluated by four different classification
methods; support vector machines, k-nearest neighbor, random for-
est, and linear discriminate analysis. The method evaluate the import-
ance and relevance of each gene cluster by summing the expression
level for each gene belongs to this cluster. The gene cluster consider
important, if it satisfies conditions depend on thresholds and per-
centage otherwise eliminated.
Results
Initial analysis identified 7120 differentially expressed genes of
leukemia (Fig. 15a), after applying our feature selection methodology
BMC Genomics 2016, Volume 17 Suppl 6 Page 30 of 78we end up with specific 1117 genes discriminating two classes of
leukemia (Fig. 15b). Further applying the same method with more
stringent higher positive and lower negative threshold condition,
number reduced to 58 genes have be tested to evaluate the effect-
iveness of the method (Fig. 15c). The results of the four classification
methods are summarized in Table 11.
Conclusions
The feature selection method gave good results with minimum clas-
sification error. Our heat-map result shows distinct pattern of refines
genes discriminating between two classes of leukemia.
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Table 11 (abstract P45) Results of different classification methods on the
test set
Leukimia Dataset
Method Accurecy Sensitivity Specificity
SVM
linear 97.14% 100% 92.85%
polynomial 88.57% 100% 71.24%
radial 97.14% 100% 92.85%
sigmoid 97.14% 100% 92.85%
k-NN
K = 1 94.28% 100% 85.71%
K = 3 97.14% 100% 92.85%
K = 5 94.28% 100% 85.71%
K = 7 91.42% 100% 78.85%
K = 9 85.71% 100% 64.29%
K = 11 77.14% 100% 42.86%
Random Forest 93.42% 99.52% 84.28%
LDA 91.42% 100% 78.57%P46
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Background
Osteopontin (OPN) is an extracellular matrix protein possess central
role in many physiological and pathological processes including,
tumorigenesis. It is over-expressed in a variety of solid tumors, in-
cluding lung, breast, colorectal, stomach and ovarian cancers. It is be-
lieved that manipulation of OPN levels may be useful in the
treatment of cancer metastasis. The purpose of this work is to study
the association of OPN expression profile with several clinic-
pathological variables and patient outcome in colorectal carcinoma
(CRC).
Patients and methods
Hundred and Thirty-Four archival FFPE samples of CRC were
collected from King Abdulaziz University Hospital, Saudi Arabia. Tis-
sue microarrays were constructed and automated immunohisto-
chemistry was done to evaluate the impact of expression patterns of
OPN protein in CRC.
Results
OPN is expressed in both cytoplasm and nuclei. About 20 % and
23 % of the tumor samples showed high cytoplasmic and nuclear
OPN expression patterns, respectively. There was no association
between OPN expression patterns and gender, age, tumor size and
location. However, borderline significant correlation was observed
with lymph nodes status (p < 0.06) while significant correlations were
observed with tumor grade (0.008), tumor invasion (0.01) and distant
metastasis (0.04). Interestingly, the disease free survival (DFS)
outcome of CRC patients, by using Kaplan-Meier analysis, showed
that there was a significant (p < 0.05) variation in DFS between pa-
tients with high expression tumors as compared to those with low
expression tumors in that patients with tumors of high expression
stay alive longer.
Conclusions
The data imply that OPN expression might have an essential function
in tumor invasion and distant metastasis and provides additional in-
formation in predicting patient outcome in CRC.
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Background
Glypicans (GPC) are engaged in developmental morphogenesis,
and have been involved in regulatory processes of several cell
signaling pathways. Abnormal expression of glypicans has been
observed in different cancer types, including ovarian, pancreatic,
and breast cancers. The present work was designed to investigate
the expression profiling of Glypican-3 (GPC-3) and its association
BMC Genomics 2016, Volume 17 Suppl 6 Page 31 of 78with clinico-pathological features as well as prognostic signifi-
cance in colorectal carcinoma (CRC).
Patients and methods
Hundred and Forty-Two archival FFPE samples of CRC were collected
from King Abdulaziz University Hospital, Saudi Arabia. Tissue microarrays
were constructed and automated immunohistochemistry was done in
order to detect and evaluate the impact of expression patterns of GPC-3
protein in CRC.
Results
About 70 % of the tumor samples showed high cytoplasmic
GPC-3expression, whereas 30 % of cases showed low expression
patterns. There was no correlation between GPC-3 expression
and age, gender, tumor grade, and lymph node status. How-
ever, borderline significant correlation was observed with tumor
invasion (p < 0.06). Interestingly, in Kaplan-Meier survival ana-
lysis, there was a significant (p < 0.015) difference in disease-
specific survival (DSS) between patients with high expression
tumors (living significantly longer) and those with low expres-
sion patterns tumors.
Conclusions
GPC-3 is significantly associated to disease survival outcome,
holding some prognostic significance. However, large cohort
study is recommended in order to explore the molecular value of
GPC-3 in CRC.Fig. 16 (abstract P48) The average P-rank vs. E-rank of the top highly
replicated SNPs. a top 1000 SNPs. b a zoom view of the top 100 SNPs
Table 12 (abstract P48) Example of SNPs with high replication and
better E-rank than P-rank
SNP P-value P-rank E-rank In Gene NoStudy dbSNPfxn





rs2266788 2.14E-07 52 40 Apolipoprotein A-V
(APOA5)
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Background
A number of loci associated with total cholesterol concentration
and cardiovascular diseases are identified by genome-wide associ-
ation studies (GWAS). The Genome-Wide Repository of association
between SNPs and phenotype (GRASP v2.0) database has most of
the publically available data for diverse phenotypes including
total cholesterol [1]. These direct association results do not ac-
count for difference in evolutionary conservation of positions and
the power of the test, which may not identify all SNPs with sig-
nificant associations [2]. We applied the E-ranking approach,
based on P value, allele frequency, and evolutionary conservation
score, on total cholesterol data in GRASP to reassess the signifi-
cant and reproducible genetic disease associations [2].
Materials and methods
We retrieved 232,051 single nucleotide variants (SNVs) for a total chol-
esterol GWAS. We generated ranks of all SNVs using the E-value pro-
duced by the E-rank web server [2]. We assessed the quality of the
highest ranking SNVs based on the number of times they were re-
ported in 79 other cholesterol studies available in the GRASP database.
Results
We found 3,173 of the top-5000 E-rank SNPs shared with the top
5000 P-rank SNPs. Overall, we indicated an improved average replica-
tion for top E-rank SNPs (average = 4) after removing bad P-rank
SNPs (average = 3.5). Of the missense mutation causing SNPs, 15 out
of 21 SNPs were identified by using combined E-rank/P-rank ap-
proach were underestimated using p-value alone. Two SNPs
(rs1919127-C2orf16 and rs2266788-APOA5) of coding region were
identified as highly associated with total cholesterol (Table 12). In
contrast, we also found few top replicated SNPs in total cholesterol
category with lower E-rank than Prank (Fig. 16).Conclusions
Evolutionary ranking of genomic positions to filter disease associ-
ated SNPs can improve the reproducibility of SNPs at faster
evolving sites and can enhance SNP discovery in published
GWAS. These results are based on replication in studies with a
limited number of significant SNPs, therefore, using full dataset
can contribute significantly for improvement of the discovery of
genetic variants in future work.
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Fig. 17 (abstract P49) a Phase contrast micrograph of human
umbilical cord Wharton’s Jelly stem cells (hWJSCs, 4x magnification); b
Cell proliferation (MTT assay) of hWJSCs; c Flow cytometry analysis of
surface-marker expression on hWJSCs showing positive staining for CD73
(top panel, left) , CD90 (top panel, middle), CD105 (top panel, right),
CD29 (bottom panel, left), CD44 (bottom panel, middle), and negative
staining CD 45 (bottom panel, right); d Toludine Blue histology of
hWJSCs showing both control (left) and chondrocyte differentiation
(right) following 21 days of culture in chondrocytic differentiation
medium; e Gene expression analysis (qRT-PCR) showing increased
expression of three markers SOX9 (left), COL2A1 (middle) and Aggrecan
(right) respectively following chondrocytic differentiation of hWJSCs
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Background
Adult cartilage has limited intrinsic self-repair capacity and poor
regeneration. New hope come from using stem cells for cartilage
tissue engineering [1]. Mesenchymal stem cells especially those
from the Wharton’s Jelly of the human umbilical cord (hWJSCs)
represent an attractive source for chondrogenic differentiation,
given their capacity for self-renewal, ease of access and lack of
immunogenic or tumorigenic activities [2]. In the present study
we aim to derive hWJSCs from the umbilical cords, characterize
them for the mesenchymal stem cell markers, evaluate their
morphology, proliferation and differentiate them into chondro-
cytes in vitro. Differentiation efficiency was evaluated using hist-
ology as well as cartilage related gene expression.
Materials and methods
Human umbilical cords were collected following ethical approval
from the King Abdulaziz University (KAU) and informed patient
consent. hWJSCs were derived using earlier established protocol
and were assessed for their morphology (Phase contrast micros-
copy), cell proliferation (MTT assay), surface markers analysis
(FACS), chondrogenic differentiation capacity (Toluidine Blue hist-
ology) and related gene expression (qRT-PCR).
Results
hWJSCs were derived and propagated to produce primary cell
lines. Early passages showed short fibroblastic morphology
(Fig. 17a) and increased proliferation by 38.22 % and 263.80 % at
48 h and 72 h compared to the 24 h respectively (Fig. 17b).
MSCs related surface markers namely CD73 (99.6 %), CD105
(98.9 %), CD90 (95.1 %), CD44 (97.8 %) and CD29 (99.9 %) were
highly expressed (Fig. 17c). hWJSCs were successfully differenti-
ated into chondrocytes (Fig. 17d) which showed increased ex-
pression of collagen II (COL2A1), aggrecan (ACAN) and SOX9
compared to the control (Fig. 17e).
Conclusions
hWJSCs was successfully derived with greater efficiency and ex-
panded in culture. They were also differentiated into chondro-
cytes in vitro, that highly expressed cartilage related genes.
Unlike BM-MSCs, hWJSCs can be harvested in abundance with no
risk of donor site morbidity, are relatively young in nature, rich in
proteoglycans, hypoimmunogeneic and non-tumorigeneic [2].
hWJSCs therefore can be used either alone or with biological
nanoscaffolds for cartilage regeneration.
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Background
Over the past decade, the field of genomics has witnessed important
advances in terms of scope and used technologies [1]. The integra-
tion of genomics into biomedical research and clinical care has tre-
mendous impacts on research, health and society [2]. Understanding
the attitudes of healthcare students is a prerequisite to design appro-
priate research programs integrated into their educational curriculum
(Double Helix Curriculum) in order to ensure perpetual development
and innovation in biomedical technologies and applications[3, 4]. In
Saudi Arabia, previous studies have focused only on medical stu-
dents and used questionnaires that were not validated. The objec-
tives of this study were (1) to assess the attitudes of healthcare
students towards biomedical research; and (2) to investigate the fac-
tors affecting their attitudes.
Fig. 18 (abstract P51) a Phase contrast microscopic image of Bone
Marrow-MSCs showing the spindle-shaped morphology (Magnification 4x);
b FACS image showing positive expression for CD29, CD73, CD90, CD105
and negative expression for CD 34, CD45; c Effect of Thymoquinone on
BM-MSCs showing decrease in proliferation with increase in concentration
of TQ; d, e Gene expression analysis of IL-6, TNF-α, COX2,BAX and BCL2
by real-time PCR following treatment of BM-MSCs ith (1 μM and 3 μM
of TQ. GAPDH was the internal control. Data analysis and relative
quantitation was done using comparative Ct method (ΔΔCt)
BMC Genomics 2016, Volume 17 Suppl 6 Page 33 of 78Materials and methods
This cross-sectional study was conducted among all senior healthcare stu-
dents (Faculties of Medicine, Dentistry, Pharmacology and Applied Med-
ical Sciences), at King Abdulaziz University, Jeddah, Saudi Arabia using a
validated Research Attitudes Questionnaire [5]. The questionnaire con-
tained 11 items covering different aspects of biomedical research. Each
item was rated on a 5-point Likert scale. A higher score indicates more
positive attitudes towards biomedical research. Data were described
using means and standard deviations. The t-test and one-way ANOVA
were used to test the association between predictors and attitude scores.
Results
Out of 512 consent students, the general percentage attitude score was
69 %. The majority of students showed positive attitudes towards bio-
medical research although some showed negative attitudes towards cer-
tain aspects such as participant safety. The relationship between
students’ attitudes and type of faculty and previous involvement in med-
ical research was significant (p-value = 0.04 and 0.01, respectively.) In
addition, higher knowledge of biobanking was correlated with positive
attitudes towards biomedical research (Pearson’s r = 0.30, p-value < 0.001).
Conclusions
In general, health care students showed favorable attitude towards
biomedical research. A noticeable effect of the students’ faculty and
previous involvement in research on their attitudes towards biomed-
ical research was observed. These findings suggest that healthcare
schools should consider including teaching of advanced research
methodology and OMICs-based approaches in their curricula as well
as motivate students to participate in biomedical research activities.
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Background
Inflammatory events lead to altered immunological profile and acceler-
ation of the disease pathology in osteoarthritis (OA). Thymoquinone (TQ)
which is a major active chemical component of Nigella sativa is reported
to have immunomodulatory properties which impart beneficial effects on
bone and joint diseases [1]. We in the present study aim to evaluate the
effect TQ on inflammatory and cell death related gene expression.Materials and methods
Bone marrow aspirate from OA patients were obtained following in-
stitutional ethical approval (11-557). Primary cultures of BM-MSCs
were established and basic characterization including cell morph-
ology (phase contrast microscopy), MSC related CD marker expres-
sion (FACS) were done. BM-MSCs were treated with TQ and their
effects on cell proliferation (MTT assay) and gene expression for IL-6,
TNF-α, COX 2, BAX and BCL-2 were done using real-time PCR.
Results
Derived BM-MSCs demonstrated characteristic fibroblastic morphology
(Fig. 18a) and were highly positive for CD105, CD73, CD29, CD44 and
CD90 and negative for CD34 & CD45 (Fig. 18b). BM-MSCs treated TQ
showed mean maximal decrease in cell proliferation by 61.08 %,
66.84 % and 65.67 % for 24 h, 48 h and 72 h respectively compared to
the control (Fig. 18c). Inflammation related genes namely IL-6, TNF-α
and COX2 were decreased by 14.41, 10.92 and 12.55 fold respectively
compared to the control (Fig. 18d). BAX was increased by 29.48 (1 μM)
and 8.18 fold (3 μM) respectively, while BCl2 decreased by3.23 fold
(1 μM) and were not detectable at 3 μM (Fig. 18e).
Conclusions
BM-MSCs were isolated with greater efficiency and expanded in culture.
Treatment with TQ showed dose dependent decrease in inflammation
related genes. TQ has been shown to have immunoregualtory effects
on pancreatic ductal adenocarcinoma cells earlier [2]. Inhibitory effect
on cell proliferation at higher concentrations indicate that TQ have also
a cytotoxic effect. Hence, an optimal dose of TQ ranging between 1 μm
and 3 μm may be useful in decreasing the inflammatory events without
compromising required stem cell numbers for cartilage regeneration.
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Background
Hepatitis C virus the main reason of chronic liver ailment and
liver cancer globally and is distributed into six discrete geno-
types through the world with numerous subtypes in each geno-
type (1-6). The response and extent of interferon treatment is
genotype specific and host restriction. Number of cellular genes
are involved in this process including TBXA2R (G-protein
coupled receptor), TRAF2 (adapter protein), LTbeta which is a
membrane protein, NFkappaB2 and RelA (transcriptional factors),
SNARK and MKK7 (protein kinases) and two diligently associated
TNF/lymphotoxin pathway. A reported polymorphisms (SNPs) in
these and other genetic factor are involved in viral clearance
and chronicity. Genetic studies have also identified several SNPs
round the interferon λ3 interleukin-28B, which are sturdily re-
lated with SVR to PEG-IFN and RBV cure for chronicity. In this
study we examined SNP in IL10 and IL28B in HCV-GT3 infected
individuals.
Materials and methods
A total of 349 patients of chronic hepatitis have been included in
this genetic susceptibility study. The infected individuals were di-
agnosed anti-HCV positive and then confirmed by HCV Polymer-
ized Chain Reaction (PCR) qualitative test. All these selected
patients had been diagnosed for HCV and taken the standard
treatment of interferon and ribavirin from 20 weeks to 36 weeks.
The end product of PCR was confirmed by gel electrophoresis.
The following restriction enzymes Ear I/, Rsa 1 and Mae III were
used to digest the PCR product. This study focused only on pa-
tients who were non-responsive and had relapsed from conven-
tional therapy.
Results
Our study proposes that both the interleukin genes interleukin
28B and IL-10 are found mutual in 2 foremost castes of the prov-
ince Punjab. We determined that HCV GT-3a is precisely commu-
nal (84.0 %) amongst group of responders whereas GT-1a is more
acquainted in relapser (66.2 %) as well as resistant (54.0 %).
Genotype 4was excluded, the remaining 5 major genotypes,
known as 1a (61.40 %), 2a (0.50 %), 2b (20.00 %), 3a (13.70 %)
and an unidentified (4.40 %) were reported amongst the twelve
various groups of Pakistan. Our findings designate that IL-10 and
IL-28 genes may be intricate in the clearance of HCV GT3 in
Asian population.
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Background
Fat mass and obesity associated (FTO) is gene involved in obesity
which affects more than 1/6 of the population worldwide [1].
FTO is located in the ‘p’ arm of the human chromosome 16 [2].
Certain variants of this gene are associated with obesity [3]. Re-
search studies in humans and mice showed a role in cardiovascu-
lar and nervous systems and a robust association with obesity
risk [4]. Natural products may play a effective role to prevent
obesity especially those containing fibers, polyphenols, sterols,
and alkaloids [5]. The aim of this study is to assess the use of se-
lected flavonoids as potential obesity preventing agents targeting
the three dimensional structure of FTO protein followed by an
in vitro validation.
Materials and methods
An in silico approach based on well-established computational
methods in quantitative structure-activity relationship, pharmaco-
phore identification and computational docking software named
CLC drug discovery Workbench were used [6]. Protein Data Bank
was used to download the protein structure of FTO (3LFM). Se-
lected natural compounds known to suppress the FTO action
involved in obesity and lipid metabolism such as (a)Luteolin (Res-
eda luteola),(b)Quercetin(Emblica officinalis),(c) Capsaicin(Capsi-
cum),(d)Abscisic acid(Abscisin II), (e)Ajoene(Allium sativum), and(f)
Diosgenin(Dioscorea villosa) were subjected to comparative dock-
ing analysis. Subsequent in vitro validation of the selected com-
pounds using cell culture will be envisioned.
Results
Flavonoid luteolin showed maximum affinity with a highest dock-
ing score of -25.632Kcal/mol, while Ajoene, Diosgenin and Quer-
cetin showed less affinity towards FTO. The empathy of the
selected natural compounds was in the order of Luteolin >
Abscisic acid > Capsaicin > Ajoene > Quercetin > Diosgenin. Luteolin
formed five H-Bonds in the active site of FTO protein at GLU161,
ASP299, and ASP189 (3). Abscisic acid formed three H-Bonds at
specific active sites such as ASP189, ARG196 and ASP299 with
docking score of -28.636 Kcal/mol.
Conclusions
Flavonoids (particularly Luteolin) may act as an effective drug against
FTO protein and could be therapeutically used for prevention of
obesity. Further in vitro and in vivo validation will be necessary to
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Fig. 20 (abstract P54) Shows components with high affinities to
5-HT1A a Vitamin B, b Tryptophan c hypericin
Fig. 19 (abstract P53) Interaction of a Luteolin forming five HBonds
with active site of FTO protein and b Abscisic acid which formed
three HBonds with docking score of -28.636 Kcal/mol
BMC Genomics 2016, Volume 17 Suppl 6 Page 35 of 78P54
Computational selection and in vitro validation of flavonoids as
new antidepressant agents
Shilu Mathew1, Manal Shaabad1, Lobna Mira1, Shireen Hussain1, Mourad
Assidi1,2, Muhammad Abu-Elmagd1, Mohammed Al-Qahtani1
1Center of Excellence in Genomic Medicine Research, King Abdulaziz
University, Jeddah, Saudi Arabia; 2Center of Innovation in Personalized
Medicine at King Abdulaziz University, Jeddah, Saudi Arabia
Correspondence: Mourad Assidi (mourad.assidi@gmail.com) – Center
of Excellence in Genomic Medicine Research, King Abdulaziz University,
Jeddah, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):P54
Background
HTR1A (5-Hydroxytryptamine Receptor 1A) is a protein associated
with some diseases mainly depression [1], which is considered as a
serious healthcare concern worldwide [2]. HTR1A gene encodes a
GPCR for serotonin, which is implicated in several physiologic and
pathologic conditions [3]. 5-HT1A receptor is the dominant receptor
of HTR1A and found to be responsible for depression and plays a
role in the mechanism of action of several antidepressant drugs [4].
Studies indicate that with inactivation of HTR1A in mice resulted in
increased stress and anxiety [5].Flavonoids are considered as one of
the promising safer alternatives to treat depression [6]. The objective
of this study is to screen various flavonoids which could potentially
target the 5-HT1AR protein using in silico docking study. These
flavonoids with potential antidepressant effect will be subjected to
subsequent in vitro validation.
Materials and methods
Selected natural anti-depressant compounds known for anti-
depressive effects such as (a) hypericin (Hypericum perforatum), (b)
Saffron (Crocus sativus), (c) Omega-3 fatty acid (α-Linolenic acid ), (d)
Inositol (Vitamin B8),(e) Kave kave (Piper methysticum), (f) Tryptophan
(Tryptophan synthase), (g) Vitamin B, and (h) Ginkgo (Ginkgo biloba)
were screened against the active domain sites of residues in 5HT1AR
using computational structural biology tools CLC drug discovery
workbench. To evaluate the inhibitory activity of selected medicinal
flavonoids, a quantitative structure-activity relationship (QSAR) was
conducted.
Results
These studies confirm an inhibitory activity of the recruited medicinal
drugs on 5-HT1AR. The docking scores were highest for vitamin B
with -15.632Kcal/mol and showed a interactions at active site
ALA349 (2), ASP352, and PHE353. Furthermore, selected medicinal
drugs such as ginkgo, hypericin and omega-3 fatty acid also formed
two H-bond interactions whereas hypericin interacted with active site
region at SER45 and SER43 with high affinity.
Conclusions
Docking studies of the vitamin B showed that this compound is
good molecule which docks well with 5-HT1AR. These results in-
dicated that vitamin B could be one of the potential compound
to treat depression, which need further validation, and assess-
ment of their pharmacological activities using in vitro and in vivo
models.References
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Background
Very recently a new mechanism of gene regulation, called telomere
position effect over long distances (TPE-OLD) has been discovered.
As telomeres shorten during normal aging, certain genes nearby
telomeres showed altered expression with increased age. It is
thought that this off/on phenomenon could explain certain aging-
associated diseases. However, only few TPE-OLD regulated genes
have been functionally validated. Here we perform a preliminary in
silico screening for these genes.
Materials and methods
Two different in silico approaches were used; the first (forward)
started from a list of genes which expression is changed during
aging, that are available in the GenAge database (http://genomics.se-
nescence.info/genes/) or described in the literature as having their
expression affected by telomere shortening. These genes were then
filtered based on their proximity to telomere, their involvement in
age-related diseases, and other attributes (gene size, signaling and
regulation pathways, expression profile, etc.) using a weighted score.
A set of 24 genes (with a standardized cut-off score of 0.5) was
Table 13 (abstract P56) RT-PCR analysis of the mRNA from normal
human tissues for SSX2, UBL4B and GAGE1 genes identified from the
Microarray analysis
Table 14 (abstract P56) RT-PCR analysis of the mRNA from cancer
tissues for SSX2, UBL4B and GAGE1 genes identified from the Microarray
analysis
BMC Genomics 2016, Volume 17 Suppl 6 Page 36 of 78identified as genes of high interest for further experimental valid-
ation. The second (backward) approach consisted of a genome scan
of all the genes located within 10 Mb from telomere using a
machine-learning based procedure (Bayesian networks).
Results
Preliminary results showed modest sensitivity of the approach, which is
expected given the reduced size of the training dataset and the non-
availability of well characterized distinctive features of this class of
genes and a deep understanding of TPE-OLD mechanisms. In fact, the
main challenge in the backward approach is to define a training set
with ‘positive’ and ‘negative’ genes, that is large enough to ensure high
precision of the model learning process. The second challenge in this
approach is choosing the gene features that are relevant and highly
predictive of the TPE-OLD regulation status.
Conclusions
This study is an initial attempt to identify comprehensive and bi-
directional approaches to identify aging-associated genes that are
affected telomere length changes for subsequent analysis and func-
tional validation. Once validated using larger gene sets, the overlap
between these two approaches will help clarify the genes and mech-
anisms underlying aging-related human diseases.
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Background
Humans possess a class of genes that are normally expressed in the tes-
tes of adult males, and are also characteristic of several types of cancer
cells [1]. These genes are known as cancer-testis (CT) antigen genes and
they might be helpful for both diagnosis and immunotherapy drug tar-
geting [2]. For this reason, identifying new CTA genes has significant clin-
ical importance. We postulated that meiosis-specific genes may provide a
good source for identifying potential novel CTA genes. The overall pur-
pose of this investigation was to identify new CTA candidate genes via
RT-PCR analysis. A bioinformatic screening program, which included
microarray analysis [3] and an expressed sequence tag (EST) analysis pipe-
line [4], indicated potential meiotic genes which could serve this purpose.
Materials and methods
16 and 11 genes were chosen at random from the candidate genes
identified via the EST and the Microarray analyses, respectively. The RT-
PCR validation employed RNA from 21 normal tissues, including adult
testis. The genes that were expressed only in the testis were further ex-
amined by RT-PCR using 33 different cancer tissues.
Results
CCNA1, C2orf69, C11orf70, C20orf195, HORMAD1, NOL4, ZNF558, SSX2,
UBL4B, GAGE1 and FSCN3 were identified from the gene expression
Microarray data analysis pipeline, which predicted they are testis-specific.
The expression of these genes was investigated in 21 human normal tis-
sues using RT-PCR technique. SSX2, UBL4B and GAGE1 were expressed
only in the testis (Table 13), while the remaining 8 genes were expressed
in different normal tissues. Therefore, SSX2, UBL4B and GAGE1 were fur-
ther validated in 33 human cancer cell lines and tissues. SSX2 and GAGE1
genes were expressed in different types of cancer cells (Table 14).
Conclusions
The validation of the 27 genes using RT-PCR analysis determined that
four genes showed a cancer testis-restricted expression patterns and
four genes displayed meiosis-specific expression patterns. Therefore,
these CT genes represent promising candidates due to their expression
patterns in distinct types of cancer. However, further investigation is
needed to establish the protein products of these excellent CT candi-
date genes in a range of normal and cancer tissues.
References:
1. Whitehurst A. Cause and Consequence of Cancer/Testis Antigen
Activation in Cancer: Annual Review of Pharmacology and Toxicology
2014, 54:251-272.2. Caballero O, Chen Y: Cancer/testis (CT) antigens: potential targets for
immunotherapy. Cancer Science 2009, 100(11):2014-2021.
3. FEICHTINGER J, MCFARLANE R, LARCOMBE L: CancerMA: a web-based
tool for automatic meta-analysis of public cancer microarray data.
Database: The Journal of Biological Databases and Curation 2012, 2012:
bas055.
4. Meta‐analysis of expression of l (3) mbt tumor‐associated germline
genes supports the model that a soma‐to‐germline transition is a
hallmark of human cancers. International Journal of Cancer 2014, 134:
2359-2365.P57
More comprehensive forensic genetic marker analyses for accurate
human remains identification using massively parallel sequencing
(MPS)
Angie Ambers1, Jennifer Churchill1, Jonathan King1, Monika Stoljarova1,2,
Harrell Gill-King3, Mourad Assidi4, Muhammad Abu-Elmagd4, Abdelbaset
Buhmeida4, Muhammad Al-Qatani4, Bruce Budowle1,4
1Institute of Applied Genetics, Department of Molecular and Medical
Genetics, University of North Texas Health Science Center, Fort Worth,
TX 76107, USA; 2Institute of Gene Technology, Department of Molecular
Diagnostics, Tallinn University of Technology, Akadeemia tee 15A-604,
Tallinn 12618, Estonia; 3Laboratory of Forensic Anthropology, Center for
Human Identification, Department of Biological Sciences, University of
North Texas, 1511 West Sycamore, Denton, Texas USA; 4Center of
Excellence in Genomic Medicine Research, King Abdulaziz University,
Jeddah, Saudi Arabia
Correspondence: Bruce Budowle (bruce.budowle@unthsc.edu) –
Center of Excellence in Genomic Medicine Research, King Abdulaziz
University, Jeddah, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):P57
Background
Although the primary objective of forensic DNA analyses of unidentified
human remains is positive identification, cases involving historical or
Fig. 21 (abstract P58) Flow cytometry analysis of patient #3
diagnosis with oligospermia. Sperms were stained with Promidium
Iodide and the stain discriminates between two populations of
sperms, one as viabe (right peak) and non-viable (left peak)
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son [1]. Massively parallel sequencing (MPS) offers an opportunity to pro-
vide biometric data in such cases, and these cases provide valuable data
on the feasibility of applying MPS for characterization of modern forensic
casework [2, 3]. In this study, MPS was used to characterize 140-year-old
human skeletal remains discovered in a historical site in Deadwood,
South Dakota, United States. The remains were discovered in an un-
marked grave and there were no records or other meta data to identity
of the individual. Due to the high throughput of MPS a variety of biomet-
ric markers could be typed using a single sample.
Results
Using MPS and suitable forensic genetic markers, more relevant informa-
tion could be obtained from a limited quantity and quality sample.
Results were obtained for 25/26 Y-STRs, 34/34 Y SNPs, 165/165 ancestry-
informative SNPs, 28/28 phenotype-informative SNPs, 102/102 human
identity SNPs, 27/29 autosomal STRs (plus amelogenin), and 4/8 X-STRs
(as well as nine regions of the mitochondrial genome). The Y-
chromosome (Y-STR, Y-SNP) and mtDNA profiles of the unidentified
skeletal remains are consistent with the R1b and H1 haplogroups, re-
spectively. Both of these haplogroups are the most common hap-
logroups in Western Europe. Ancestry-informative SNP analysis also
supported a European background. The genetic results are consistent
with anthropological findings that the remains belong to a male of Euro-
pean ancestry (Caucasian). Phenotype-informative SNP data provided
strong support that the individual had light red hair and brown eyes.
Conclusions
This study is one of the first to genetically characterize historical hu-
man remains with forensic genetic marker kits specifically designed
for MPS. The outcome demonstrates that substantially more genetic
information can be obtained from the same initial quantities of DNA
as that of current-based analyses.
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Background
Infertility has becoming an increasing social problem that reached to an
alarming level of up to 12 %. In the Middle East countries, a newly married
couple usually become very eager to get their first child as soon as they
start their marriage life. This is due historic and cultural traditions that the
father should get a child who will carry the family’s name and continue
the heritage of the family’s tribe. If for some reasons that the pregnancy
delayed or did not happen then the newly married couple, especially in
the Gulf countries including Saudi Arabia, starts to get pressurized and
stressed from other members of their families. Serious social impacts of in-
fertility on the married couple has been recently reviewed. Among these
are economic difficulties, improper integration with the rest of the societyand family violence. These serious impacts highlight the real need for hav-
ing real measurements and screening for the causes of the infertility which
will directly and positively reflect on the families and the whole society in
general. The aim of the current study is to establish a robust molecular
assay to assess the quality of the sperms in both fertile and infertile men.
Subjects and methods
Ethical approval was granted from the centre of innovation and per-
sonalized medicine (CIPM) by the ethical committee. Consent forms
were signed by the patients. Four assays are being established in-
cluding measuring DNA fragmentation using TUNEL assay, mitochon-
drial membrane potential, sperm vitality using Promidium Iodide and
sperm reactive oxygen stress (ROS).
Results
We have just started assessing the sperm viability of an infertile patient
and the flow cytometry analysis showed that the sperms can be cate-
gorized to two separate population (viable and noviable) (Fig. 21).
Conclusions
Preliminary results showed that using flow cytometry approach shows that
this approach could be a used as a robust quick analysis to discriminate
between viable and non-viable sperms. Also, the technology could help in
perfect selection of quality sperms that could be used in IVF clinics.
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Tissue microarrays (TMAs) is a new high-throughput tool for the study of
protein expression patterns in tissues and are increasingly used to evalu-
ate the diagnostic and prognostic importance of biomarkers. Renal cell
carcinoma (RCC) is a seventh ranked malignancy with a poor prognosis
(1). The aim of this study was to identify protein signatures that would
predict clinical outcomes in a large cohort of patients with RCC based on
data from previous gene expression microarray studies (2).
Materials and methods
We conducted microarray to identify differentially expressed genes as-
sociated with RCC and TMA based immunohistochemical analysis of
CyclinD1 (CCND1) to validate our microarray finding over 139 cases of
RCC patients. Statistical analysis was used to determine the association
of CCND1 expression with RCC and cases were evaluated based on the
absence or presence of staining intensity in the tumor cells.
Results
The result showed the positive percentage of CCND1 expression in
53 % (73/139) of RCC cases. CCND1 was one of the important upreg-
ulated gene identified in microarray and validated by TMA. Studies
revealed that it is frequently deregulated in cancer and is a bio-
marker of cancer phenotype and disease progression (3, 4).
Conclusions
Our microarray and TMA based finding confirm the high expression
of CCND1 in RCC. It is hoped that CCND1 may be potential thera-
peutic targets and its inhibition could target the migratory, invasive,
and metastatic potential of RCC.
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Background
Since the inception of nanotechnology, noble metal nanoparticles
(NPs) have shown greater impact in genomic medicine, cancer
studies and targeted drug delivery. They are used in diagnostics
and prognostic, DNA and RNA detection, SNP screening forvarious carcinomas and cardiovascular disorders [1,2]. Several re-
searchers have employed these NPs in describing human se-
quence variations, multiplex SNP, genetic polymorphism of base
excision repair, polymorphism at the level of single gene such as
ERGG2 gene (for thyroid cancer risk), CLTA-4 gene (for suscepti-
bility to type 1 diabetes) etc.
Material and methods
Gold NPs were synthesized and characterized by transmission elec-
tron microscopy (TEM), followed by their toxicity analysis was per-
formed by comet assay. The surface was modified with
glutaraldehyde as biocompatible coating for enhancing their poten-
tial application in drug delivery for concurrent therapy and other
diagnostic based applications.
Results:
TEM results showed that the synthesized NPs were of 30 nm. Comet
result showed that as a result of surface functionalization of gold NPs
by glutaraldehyde, reduction in DNA damage was reduced from
7 μm to 2 μm.
Conclusions
These NPs can be used in numerous techniques involving NPs based
enhancement in electrochemical DNA hybridization signals, electro-
nucleation and ultra-sensitive electrical detection of nucleic acids
with increased specificity and sensitivity apart from multiplexing cap-
ability and short turnaround times.
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Background
In the post-genomic Era, biobanks are the main core facility where high
quality biospecimens with their fully annotated clinico-pathological
data are processed according to best Standard Operating Procedures
(SOPs) [1, 2][3]. Since biospecimen is the main driver towards precision
medicine, its management and processing along with their biodata re-
main therefore the crucial step that will significantly impact their subse-
quent use in research and/or diagnostics. In this context, the objective
of this study is to underline the biospecimen management and pro-
cessing at the CEGMR Biobank Unit (CBU), CEGMR, King Abdulaziz Uni-
versity, Jeddah, Saudi Arabia; and to suggest future guidelines to
upgrade this facility.
Materials and methods
A summary of biospecimen transition steps within the CBU (col-
lection, transport, reception, labelling, extraction, storage and re-
lease) with a special focus on the main improvement milestones
since its establishment in 2008, current challenges and future
plans are presented. Additionally, the main achievements of the
CBU in terms of the biospecimens’ collection and its role in
bridging the gap between clinicians and scientists are discussed.
Results
Biospecimen management at the CBU started in 2008 with basic freez-
ing infrastructure and manual recording. A home-made Laboratory In-
formation Management System (LIMS) “Biosearch” was implemented as
user-friendly platform for biospecimen biodata entry, follow-up and
BMC Genomics 2016, Volume 17 Suppl 6 Page 39 of 78retrieve [4]. Progressive introduction of SOPs and biospecimen quality
control at different steps were implemented. A particular effort was
given to staff training and public awareness mainly in healthcare pro-
viders explaining significant increase of CBU biospecimen providers
over the past few years. Therefore, around 15000 high quality and fully
annotated biospecimens (50 % genetic disorders; 40 % of mainly solid
cancers) have been collected and part of them supplied to healthcare
scientists. More than 150 studies published in ISI journals were carried
out using CBU biospecimens.
Conclusions
The continual improvement of biospecimen management and process-
ing is vital to keep CBU updated with the rapid evolution in biobanking
concept, rules and applications worldwide. Additional efforts are
needed to improve the CBU governance and biospecimen manage-
ment including the introduction of robotic-based cryopreservation, the
increase of awareness, and the implementation of the latest inter-
national SOPs and rules toward international accreditation.
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Autism Spectrum Disorder (ASD) is a neurological disorder that is
characterized by an impaired social interaction, communication,
restricted, and repetitive behaviors. It starts at the time of birth
or within the first three years of life, and is a big challenge not
only for the affected child but also for the whole family. About
67-million individuals are suffering with autism worldwide
whereas its prevalence ranges from 1.4 to 29 per 10,000 persons
in Saudi Arabia [1, 2, 3]. Here, we study the general knowledge,
awareness, and attitude of public towards autism patients in
Jeddah, KSA.
Materials and methods
A survey comprises of thirty questions regarding ASD has been used
to collect the data from 300 residents of Jeddah, KSA. Questionnaires
were distributed hand-to-hand and through the creation of an online
survey.
Results
In this study, 300 people, both males and females, have success-
fully completed the questionnaire. The results have shown that
89 % people were aware of autism, 83 % believed that the autis-
tic child has difficulty in social interaction, and 53 % has linked
autism with an emotional or psychological disorder. 30 % pre-
dicted that the autism patients do not want friends, 72 % were
with a point of view that a person with autism may exhibit ritual-
istic or repetitive behavior, 67 % were convinced that autism can
be cured or children with autism will eventually grow out of it,
70 % were with a thought that autistic patients may have very
limited interests (i.e. preoccupation with one toy, movie, game
etc). Furthermore, 25 % answered that autism is associated with
mental retardation, 59 % think that autism affect the intelligence
level, 52 % believed that the child with autism get married in
the future. 58 % favored that autism child should attend special
school, and 45 % accepted that there is a discrimination in soci-
ety against the autistic child.
Conclusions
In conclusion, there is a need to increase the public awareness
about ASD. Several educational awareness programs, seminars,
and campaigns are required to build an autism friendly society. It
is expected that the society will be more sympathetic and re-
sponsible towards ASD patients as a result of this informative
study.References
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Background
Thrombophilia is a condition where the blood has an increased
tendency to clot. It can be acquired or inherited. Inherited throm-
bophilia is a result of DNA mutation in genes responsible for the
production of blood clotting proteins. While inherited thrombo-
philia can be caused by a number of mutations, the most
BMC Genomics 2016, Volume 17 Suppl 6 Page 40 of 78common ones are factor V Leiden (FVL) and prothrombin (factor
II). Factor V Leiden mutation is a single nucleotide point mutation
(SNP) located at position number 506 and alters amino acid ar-
ginine to glutamine in FV gene. Prothrombin (factor II) is the pre-
cursor to thrombin and located on chromosome 11p11-q12.
Prothrombin G20210A mutation (factor II mutation) is a SNP lo-
cated at position 20210 and changes amino acid guanine to ad-
enine in the prothrombin gene. This mutation is associated with
high levels of prothrombin and was reported to increase the risk
of thrombosis almost three fold. Patients with high levels of
other procoagulants such as factors VIII, IX, XI, VII, fibrinogen, and
Von Willebrand factor (VWF) are also at high risk of thrombosis.
Materials and methods
Next Generation Sequencing allows high throughput DNA sequen-
cing and mutation detection at a low cost and high turnover. This in
turns has a major influence in both clinical care and understanding
susceptibility to thrombophilia. Therefore, we have designed the
Thromboscan panel which will allow the simultaneous screening of
23 coagulation genes using the Ampliseq™ technology.
Results
In this study, a screening panel of 23 coagulation genes has been de-
veloped, optimized and tested for the early diagnosis of thrombophi-
lia using the cutting edge technology of next generation sequencing.
The results confirmed 99.26 % coverage of the targeted genes with
430 amplicons with sizes ranges between 125-275 bp generating
81.56 kb of DNA sequence. We have demonstrated that this panel
can be used on DNA extracted from peripheral blood or saliva.
Conclusions
The availability of this panel will help increase our understanding of
genetic susceptibility to thrombophilia and other aberrant throm-
botic events.
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Background
Congenital heart defects (CHDs) are the most common birth de-
fects leading to increased morbidity and mortality in neonatal
life. CHDs are usually presented associated with developmental
delay (DD) dysmorphic features and/or other congenital malfor-
mations. Genetic causes such as chromosome anomalies and syn-
dromic CHDs contribute to a small proportion of CHDs, however,
a large proportion of cases no genetic diagnosis could be
achieved by clinical examination and conventional cytogenetic
analysis [1].The development of genome wide array-Comparative
Genomic Hybridization technique (array-CGH) allowed for the de-
tection of cryptic chromosomal imbalances and pathogenic CNVs
not detected by conventional techniques [2]. We investigated 94
patients having CHDs associated with other malformations and/or
DD. Clinical examination and Echocardiography was done to all
patients to evaluate the type of CHD and any associated malfor-
mations. To investigate for genome defects we applied high
density array-CGH 2X400K (33 patients) and CGH/ SNP microarray
2X400K (Agilent) for 25 patients. Confirmation of results was
done using Fluorescent in situ Hybridization (FISH) and qPCR
techniques.Results
Chromosomal abnormalities such as trisomy 18, 13, 21, 9p and
microdeletions: del22q11.2, del7q11.23, del18 (p11.32; p11.21), tetras-
omy 18p, and der 9, 15 (q34.2; q11.2) were detected in 15/94 pa-
tients (16 %) using conventional cytogenetics methods and array-
CGH. Pathogenic variants were detected in 12/58 (20.7 %) samples,
CNVs were observed in a large proportion of the studied samples.
CGH/SNP array could detect loss of heterozygosity (LOH) in different
chromosomal loci in 10/25 patients.
Conclusions
Array-CGH technique allowed for detection of cryptic chromo-
somal imbalances that could not be detected by conventional
cytogenetic methods. Clustering of CNVs in certain genome loci
needs further analysis to identify causal variants from those of
unknown significance, and to identify candidate genes that may
provide clues for understanding the molecular pathway of cardiac
development. Detection of loci of LOH might reflect regions of
homozygosity that can aid in diagnosis of autosomal recessive
diseases through selection of candidate genes for sequence
analysis.
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Background
Organochlorine pesticides induce extensive genotoxicity but dichlo-
roethane is still being used in industry. The genotoxic profile of this
compound has not been clearly identified. Current study evaluated
genotoxic potential of dichloroethane using a battery of mutagenic-
ity and genotoxicity assays.
Materials and methods
Adult Wistar rats (8 week old, both sexes, 5 rats/dose) were intraperito-
neally injected with three doses [10 %, 20 %, 30 % of dichloroethane
LD50 (807 mg/kg)].The cyclophosphamide was used as positive control.
Bone marrow flushes and other cell types were harvested after comple-
tion of specified duration. The samples were tested in standard assays
for genotoxicity (CA, MNT and MI), DNA damage (comet assay), mito-
chondrial membrane potential [MMP] estimation and cell cycle alter-
ation analysis by flowcytometry.
Results
Dichloroethane treated rats showed a significant increase in
micronucleated polychromatic erythrocytes and extensive
chromosomal aberrations (CA value of 6.34 ± 1.69 at highest
dose of 242.1 mg/kg). The treated rats also displayed high level
DNA damage compared to the untreated control group (p <
0.05) as indicated by the value of olive tail moment (19.87 ± 1.4
at dose 242.1 mg/kg after 24 hour) in the comet assay. The
BMC Genomics 2016, Volume 17 Suppl 6 Page 41 of 78flowcytometric analysis following PI staining of dichloroethane
exposed cells after 24, 48 and 72 hour showed enhanced apop-
tosis which increased with the dose and exposure duration. The
appearance of SubG1 apoptotic peak in cell cycle was also no-
ticed. The cyclophosphamide treated group (positive control)
showed 100 % cell population in the apoptotic phase. The MMP
analysis (flowcytometry examination following rhodamine 123
staining) demonstrated a significant decrease in MMP of all
WBCs (neutrophils, eosinophils, lymphocytes and monocytes) in
the treated groups.
Conclusions
The dichloroethane exposure in Wistar rats induced excessive apoptosis
in normal cells by direct DNA damage. The DNA damage resulted in
decreased mitochondrial membrane potential which in turn altered
membrane permeability leading to the release of pro-apoptotic signals
and activation of caspase pathway. Thus, driving cells to undergo apop-
tosis. Therefore, dichloroethane has a potential for inducing severe cell
injury and genotoxicity.
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Background
A considerable number of phenotypes relating to disorders of sexual
development (DSD) were reported and characterized mainly by atypical
development of the external genitalia. This ambiguous genitalia is one
of the mixed gonadal dysgenesis that affects 1 in 4,500 of newborns
worldwide [1, 2]. The main karyotype associated with this DSD is 45,X/
46,XY mosaicism with normal or abnormal Y [3]. The phenotype is af-
fected by the distribution of 45,X cell among the body cells and the Y
chromosome aberration. Neonatal diagnosis is critical due to the high
risk of developing dysgerminomas and gonadoblastomas. We report
here both chromosomal and molecular cytogenetic analysis of a case
diagnosed with an ambiguous genitalia in Jeddah, Saudi Arabia. The
case has been admitted at King Abdulaziz University Hospital (KAUH)
and has been referred to the Diagnostic Genomic Medicine Unit
(DGMU) at the Centre of Excellence in Genomic Medicine Research for
subsequent molecular and cytogenetic analyses.
Subjects and methods
Blood sample was taken from a 21-day newborn diagnosed with
clinical indication of ambiguous genitalia and suspect of phenotypic
female gender. The case was referred from the Pediatrics Unit at
KAUH to the DGMU for molecular and cytogenetic investigations to
determine the newborn sex.
Results
Based on 50 metaphase stages examined, The karyotype was
46,XY,del(y)(q11.2)[32]/45,X[18]. This male karyotype was marked by
the presence of two different cell lines: 64 % of the examined cells
showed deletion in the long arm of the chromosome Y at breakpoint
q11.2; and 36 % of the cells showed monosomy of chromosome X.
Fluorescent in situ hybridization using centromeric probes for
chromosomes X and Y and whole chromosome confirmed sex chro-
mosomes and the deleted part of Y chromosome didn’t inserted in
another chromosome.
Conclusions
The gender of our current case of ambiguous genitalia was male
with Y chromosome long arm deletion. This case of DSD shows the
importance of the chromosomal and molecular cytognetic analysis
for early and accurate determination the genetic gender in order toensure that patients with similar conditions will receive proper diag-
nosis, management and both medical and psychological follow up in
adolescence and adulthood.
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Background
Hepatocellular carcinoma is third most common cause of death and
one of the most common cancers worldwide [1, 2]. HCC ascends in cir-
rhotic livers secondary to numerous environmental condition [3, 4].
However, HCC may also progress in both normal liver, and abnormal
non-cirrhotic liver. HCV and HBV infections are one of the major cause
resulting in cirrhosis and finally HCC [5]. Each of above conditions com-
prises altered epigenetic and genetic alterations, differential activation/
inhibition of molecular pathways, gene mutations and chromosomal
aberrations [3]. This study was done to achieve a comprehensive ana-
lysis of gene expression profiling using in silico methodologies to iden-
tify novel pathways and disease specific gene clusters in HCC.
Materials and methods
We have obtained Affymetrix Microarray CEL files from Gene
Expression Omnibus (GEO) (GSE49515). The CEL files were then ana-
lyzed using Genespring™ GX 13.1 software (Agilent, USA). Statistical
analysis was done using unpaired Student’s t-test to obtain differen-
tially expressed genes (P < 0.05) with 2-fold cut-off between normal
liver tissue and HCC samples. The differentially expressed genes were
then subjected to Hierarchical Clustering to obtain HCC specific gene
clusters. Furthermore, we have used Ingenuity Pathway Analysis (IPA)
software (Ingenuity Systems, USA) to obtain differentially expressed ca-
nonical pathways and novel gene networks in HCC.
Results
Gene expression profiling between non-tumor tissues and HCC resulted
in the identification of deregulated pathways and potential genetic net-
works in the context of HCC (Fig. 23). Pathway analysis defined evi-
dence that various biological pathways, such as TREM1 Signaling,
pathogenesis of multiple sclerosis, communication between innate and
adaptive immune cells, toll-like receptor signaling and HER-2 signaling
in breast cancer. Few differentially expressed classes of genes in HCC
are related to cellular assembly, organization, cell cycle, DNA replica-
tion, cellular development, recombination and repair, cell morphology
and RNA post-transcriptional modification, post-translational modifica-
tion, RNA damage and repair, and liver toxicity.
Conclusions
Our gene expression profile analysis unraveled a complete cluster of
genes and several dysregulated signaling pathways that are different
in HCC. These observations may deliver the root for developing novel
diagnostic, and prognostic biomarkers of HCC to design effective
therapeutics in clinics.
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Background:
Most cases of ovarian cancer are only detected at advanced stages
which carries poor prognosis and have approximately 30 % 5 year sur-
vival rate [1]. Mesenchymal stem cells (MSCs) are identified to exert
anti-cancer properties [2,3]. The anticancer properties human Wharton’s
jelly stem cells conditioned medium (hWJSCs-CM) on primary ovarian
carcinoma cells in vitro and also identification of possible novel targets
using systems biological approaches was evaluated.Materials and methods:
Primary cultures of epithelial ovarian cancer cells (EOCs) and hWJSCs
were derived following Ethical Committee approval [33-15/KAU] and
cultured using their recommended media. EOCs were exposed to
hWJSC-CM (100 %) for 24 h, 48 h and 72 h. Mophological changes
(Phase-contrast imaging) and cell proliferation assay (MTT) were eval-
uated. Ingenuity Pathway Analysis (IPA, Igenuity Systems, USA) was
used to identify targets and mechanisms in ovarian cancer.
Results:
EOCs showed growth as small clusters of epithelial cells with cobble-
stone appearance (Fig. 24a) while hWJSCs showed a monolayer of short
fibroblasts (Fig. 24b). Treatment with hWJSC-CM led to varied morpho-
logical changes that resulted in death of EOCs (Fig. 24c-f). Time
dependent inhibition in EOCs proliferation (MTT assay) were observed.
Mean decreases in proliferations were 12.23 %, 19.71 % and 37.07 % at
24 h, 48 h and 72 h respectively compared to untreated control
(Fig. 24g). IPA of EOC genes implicated in canonical pathways led to
the identification of important molecular pathways and signaling net-
works associated with cancer cell death (Fig. 24h). Earlier transcriptome
analysis of hWJSCs showed high expression of tumour suppressors and
apoptosis inducing genes, which significantly overlap with IPA predict-
ive results. Additional targets and mechanisms of EOCs death/inhibition
identified using IPA needs validation by further in vitro/in vivo studies.
Conclusions:
hWJSC-CM induce primary EOCs inhibition in vitro and cause cell death
probably via apoptosis. Our findings are in line with earlier reports of
cancer inhibition by various other MSCs [2,3]. IPA predictive results indi-
cating the genes/targets invovled in EOCs that overlap with hWJSCs
tumour suppressors further support our findings. Additional in vitro and
in vivo studies are necessary to ascertain EOCs inhibition with hWJSC-
extracts and identify its possible mechaisms.
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Background
Autosomal recessive primary microcephaly (MCPH) is a neurodeve-
lopmental disorder that is characterized by smaller head circumfer-
ence present at birth with mental retardation [1]. Abnormal Spindle-
like, Microcephaly-associated (ASPM) gene is responsible for majority
of the primary microcephaly patients. Here, we aim to establish mu-
tational spectrum of ASPM gene in Saudi population.
Materials and methods
We have ascertained 50 patient samples with microcephaly. De-
tailed clinical information was taken from each patient. Fluores-
cent labeled Microsatellite markers are used to link the ASPM
gene using Gene Scan method. Massive sequencing using Sanger
sequencing method was carried out to identify the mutations in-
volved in the ASPM gene.
Results
The sequencing of ASPM gene from patient samples has revealed
number of known and novel mutations associated with primary
microcephaly and mental retardation.
Conclusions
Once the genetic basis of primary microcephaly is known in
Saudi population, it will help in the provision of molecular diag-
nosis and genetic counseling that may help to decrease the fre-
quency of this disorder.
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Background
Primary microcephaly is a genetic disorder characterized by reduced
head circumference that is at least 4 standard deviation (SD), accom-
panied with non-progress mental retardation. The brain is architec-
turally normal but the size of cerebral cortex is significantly reducedcausing the microcephaly. In this research project we aim to identify
the mutated genes behind the primary microcephaly patients in the
Saudi population.
Materials and methods
We have ascertained 10 consanguineous families with primary micro-
cephaly from Jeddah, Makkah and Taif cities of Saudi Arabia. Detail
clinical information and Pedigree (family tree) of the families were
analyzed. DNA was extracted from peripheral blood of affected and
normal individuals of the families. Fluorescent labeled microsatellite
markers were used to link the known genes previously identified
with the disease. Sanger sequencing method was used to identify
the known and novel genes.
Results
Our linkage analysis results showed that four out of ten families were
linked with the ASPM gene and three families were linked with
MCPH1 gene. Three families were excluded from the previously
known genes associated with primary microcephaly. Furthermore we
have done the sequencing of ASPM and MCPH1 gene that has re-
vealed novel and known mutations.
Conclusions
Identification of exact genotype phenotype correlation would help in
genetic counseling and prenatal diagnosis for primary microcephaly
and would enable us to reduce the incidence of microcephaly in a
highly consanguineous population of Saudi Arabia.
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Background
Hereditary non-polyposis colorectal cancer (HNPCC), also referred to
as Lynch syndrome, represents 1-7 % of all cases of colorectal cancer
and is characterized by autosomal dominant inheritance caused by
germline mutations in many DNA mismatch repair genes [1,2]. The
aim of current research involves the molecular characterization of
Lynch syndrome to provide predictive information of greater accur-
acy regarding the risks of colon and extracolonic cancer in Saudi
population.
Materials and methods
Detailed clinical information was taken from patients suffering from
lynch syndrome. Amsterdam criteria and Bethesda guidelines were
used to confirm the lynch syndrome. Immunohistochemistry, micro-
satellite instablitity and testing of mismatch repair (MMR) genes per-
formed to diagnose the disease.
BMC Genomics 2016, Volume 17 Suppl 6 Page 44 of 78Results
On first stage we have established state of art facility for the ef-
ficient diagnosis of HNPCC in families of Saudi Arabian origin at
risk and to find the novel genetic factors associated with it by
using cutting edge technology. So far 20 samples of hereditary
colorectal cancer involving two or more patients in a family
have been collected. The sequencing of mismatch repair genes
carried out to find the mutation spectrum in the population
and exclude the families for possible novel genes involving
lynch syndrome.
Conclusions
Once the full spectrum of MMR gene mutations is known in
Saudi population, it will help in screening and intensive sur-
veillance or some other measures such as hysterectomy and
colectomy that will reduce the risk for colorectal cancer de-
velopment. This will result in better quality medical facility
for counselling and diagnosis as well as reduce the health ex-
penditures to the Saudi families affected with lynch
syndrome.
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Abstract
Background
Chlamydia trachomatis strain D/UW-3/Cx is a Gram-negative intracel-
lular bacterium which belongs to bacterial family Chlamydiaceae [1].
C. trachomatis causes sexually transmitted disease Chlamydia as well
as blinding trachoma [2].
Materials and methods
In our study, we used a number of bioinformatics tools to predict the
functions of HPs of C. trachomatis. A combination of latest protein
family databases, pathway and genome databases are available to
assign an appropriate function to HPs whose sequence is available.
We also performed sub-cellular localization and signal peptide
prediction.
Results
After analysis of the proteome data of C. trachomatis strain D/
UW-3/Cx, it was found that ~30 % (272) proteome is listed as
conserved hypothetical protein (HP). Extensive analysis of all 272
HPs resulted in the putative function prediction of 60 HPs withhigh precision. We further categorized HPs on the basis of pre-
dicted functions as enzymes, transporters, binding proteins, bio-
synthesis proteins, type III secretion system effectors, and
proteins with miscellaneous functions.
Conclusions
The outcome of this study will be helpful in studying the mechanism
of pathogenesis of C. trachomatis to identify the potential drug tar-
gets, thus helping in the discovery of effective drug against the
pathogen.References
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Background
Melanoma is often considered one of the most aggressive and
treatment-resistant human cancers. Presence of melanin pig-
ment makes it easier to detect than other malignancies, and so
it has been subjected to countless therapies. Approximately
one in each three patient with cutaneous melanoma develops
metastatic stage with poor rate of survival. Current conven-
tional methods used for melanoma detection are Breslow thick-
ness, Clark level invasion and ulceration, but they cannot
perfectly predict the melanoma at individual level [1]. Break-
through in fundamental understanding of molecular basis of
disease by new techniques has increased survival rate of mel-
anoma patients.
Materials and methods
PubMed database was searched for research articles, reviews and
case reports related to skin cancer or melanoma. Other resources
used for getting proper information are MEDLINE, EMBASE,
Cochrane, Database of Systematic Reviews, Cochrane Central
Register of Controlled Trials, ISI Web of Science Proceedings, ISI
Web of Science Citation Index, CINAHL, TOXLINE, PUBMED, and
Scopus. Pre-specified search terms and keywords like melanoma,
skin cancer, transcription factors in melanoma, signaling pathways
involved in melanoma and therapeutic options in melanoma etc,
were used to identify information regarding randomized clinical
trials, nonrandomized intervention studies, and observational
studies. A list of transcription factors were prepared and ex-
plained accordingly. Citations from 1990 to 2015 were used to
generate data and assemble the article.
Results
A number of transcription factors are found to be overactive in
most of human cancers which are ideal target for anticancer
drug development [2]. Several transcription factors like GATA-1,
NF-kB, AP1, Nrf2, STAT, Cox, C-Jun and Src and pathways like
MAPK play significant role in melanoma development and prog-
nosis [3, 4]. Discoveries of frequent mutations involving several
transcription factors can make the pathway easier to under-
stand, and can help in making therapies for their effective
treatment.
BMC Genomics 2016, Volume 17 Suppl 6 Page 45 of 78Conclusions
These transcription factors are immediate and potential targets for
treating cancers. This study elaborates the role of current list of tran-
scription factors and signaling molecules in melanoma prognosis and
treatment.
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Background
Plumbagin (PL) is derived from the root of Plumbago indica, has various
medicinal properties and reported to induce the apoptosis by activat-
ing caspases [1]. Caspase-3 and Caspase-7 has been driving force be-
hind execution of apoptosis. In vitro and In vivo studies has shown PL
activating effect on caspases for inducing apoptosis [2] but the struc-
tural insight into the binding mechanism of PL mediated caspases
actiation is not defined yet. Here, for the first time we have used In
Silico studies using docking approach to reveal the molecular insight
into the binding of PL with Caspase-3 and Caspase-7.
Materials and methods
Docking calculations were carried out on Plumbagin from Plumbago
indica protein model using AutoDock and Autogrid programs. Each
docking experiment was derived from 100 different runs that were set
to terminate after a maximum of 250000 energy evaluations. The popu-
lation size was set to 150.
Results
The study demonstrate binding mode of Plumbagin to caspase-3 and
caspase-7 using docking and simulations analysis. Our results affirm the
role of various important residues 251-SER, 252-PHE, 253-ASP, 256-PHE
of caspase-3 and 159-ILE, 211-TYR, 213-ILE, 214-PRO, 221-PHE, 223-TYR,
292-VAL of caspase-7. We found very negative value for dock score and
binding energy was also very close to well known inhibitors.
Conclusions
For the very first time we have shown the binding mechanism of Plu-
mabgin to apoptosis executioner using In Silico approach. In this re-
port we found that total number of four and seven critical residues
of Caspase-3 and Caspase-7 respectively play very important role in
binding to Plumbagin.
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Background
The emerging of single cell genomics (SCGs) has revolutionized
the OMICs scale approaches to target extremely small amounts
of biomolecules at the single cell level. Such powerful screening
advanced approach has permitted comprehensive analysis of
molecular heterogeneity within tissues, and the development of
pioneering applications in experimental, clinical and forensic ap-
plications [1]. Preimplantation Genetic Screening (PGS) for aneu-
ploidy is one of the main SCGs clinical applications used as an
adjunct in IVF clinics to select embryos prior their transfer. PGS
is offered to patients with advanced maternal age, repeated im-
plantation failure, recurrent pregnancy loss, and infertility [2, 3].
Given the limitation of starting material, single cell whole gen-
ome amplification (scWGA) is a crucial step in PGS that needs
to be carefully optimized in order to get an amplified DNA with
high affinity and reproducibility [4]. The aim of this study is to
optimize PGS efficiency through the selection of the best
scWGA among three commercial kits allowing thus an efficient
detection of copy-number variations (CNVs) and translocations
with high reproducibility.
Materials and methods
Two scWGA kits based on multiple displacement amplification
(MDA): REPLI-g® Single Cell (Qiagen) and Single Cell GenomiPhi
DNA Amplification (GE Healthcare) were compared to the PCR-
based SurePlex DNA Amplification System (Blue Genome) using a
single white blood cell (WBC) from the same patient as a template
and unamplified genomic DNA as a control (Fig. 25). All three
methods were compared using array comparative genomic
hybridization (aCGH) to detect potential differences in amplifica-
tion uniformity and/or errors, CNVs, and detection of structural
aberrations larger than 10 Mbs.
Results
All three scWGA methods provided satisfactory DNA yields when
starting from single cell (≥3 μg). Following aCGH data analysis,
selected scWGA methods had similar genome coverage and rep-
resentativity compared to the unamplified reference (P > 0.05).
Preliminary evidence showed better CNVs detection with SurePlex
kit.
Conclusions
This study showed that SurePlex DNA Amplification System is more
suitable for PGS to ensure a pregnancy-free disease but further valid-
ation using massively parallel sequencing (MPS) is needed. Since
most scWGA have some imperfections, a better selection of the
scWGA that fits best with both the clinical application and the target
genomic variation is recommended.
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In our previous report we tried to understand the mechanism of G1 cell
cycle arrest upon stimulation of immature B-lymphocytes through B
cell receptors in which gene expression and Ingenuity Pathway Analysis
drew our attention that ZFP36 is an important hub among the various
genes identified. Because it recruits various kinds of miRNAs (miRs) by
binding itself at the 3′ AU-rich regions of various mRNA it is called as
RNA Binding protein and miRNA recruiter [1]. In this study we decipher
the ZFP36 recruited miRs regulating anti-IgM triggered Immature B cell
G1 cell cycle arrest.
Materials and methods
CH1 cell were used for study. Literature survey was carried out; we
found the list of miRs involved in regulation of immature B cell cycle
arrest [2]. So we employed the ZFP36 siRNA system from Santa cruz
in anti-IgM triggered immature B cells followed by real-time analysis
against listed miRs.
Results
Our real-time analysis suggests that upon ZFP36 silencing in immature
CH1 cells triggered with anti-IgM miR-34a which was down-regulated in
normal BCR triggered CH-1 Cells, shows slight increase in expression at
RNA level.
Conclusions
Our results suggest that in normal triggered CH1 cells ZFP36 leads to
down regulation of miRs-34a may be downregulating some protein at
RNA level which might be directly indirectly involved in regulation of
miRs.
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Background
Microcephaly-capillary malformation syndrome (MIC-CAP syndrome;
OMIM#614261) is an extremely rare disorder of the central nervous sys-
tem disorder that is characterized by microcephaly, developmental
delay, generalized cutaneous capillary malformation, and seizures. This
syndrome has been reported in patients, both male and female, born to
unrelated or consanguineous parents of various ethnicities, including
Arabs. Exonic and intronic mutations (including missense mutations) in
the STAM-binding protein (STAMBP) gene are well-established causes of
this syndrome in dozens of patients. This gene encodes deubiquitinating
isopeptidase, which has a key role in cell surface receptor-mediated
endocytosis and sorting.
Materials and methods
We present two affected male children from a consanguineous fam-
ily having developmental delay and seizures. We performed exome
BMC Genomics 2016, Volume 17 Suppl 6 Page 47 of 78sequencing on one of the siblings and both parents on the Illumina
HiSeq 2500. Base calling was performed using CASAVA v1.8.2 and reads
were mapped to the hg19 reference sequence using the BWA-
backtrack algorithm from BWA v0.5.9. Variant calling was performed
using GATK 1.1-28. Variants were classified into loss of functions and
missense. The rare variants were defined as those at < 5 % frequency in
1000 Genomes, NHBLI Exome Sequencing Project, Exome Aggregation
Consortium and one in-house databases.
Results
In the proband, we found a homozygous missense single-nucleotide vari-
ant in exon 7 of the STAMBP gene. With Sanger sequencing, we found
the same homozygous mutation in the affected sibling. Both parents are
heterozygous at this position. The A >G substitution (c.A908G) results in
an amino acid change of lysine to arginine (p.K303R). This exonic muta-
tion (chr2:74077543:A:G) has not previously been reported in the
STAMBP gene, therefore it constitutes a novel mutation, presumed to be
disease-causing. We further interrogated the genome of one of siblings
for copy number variation, using the Affymetrix CytoScan HD platform,
and did not find any potentially pathogenic CNVs.
Conclusions
Our results showed a homozygous missense single-nucleotide variant in
exon 7 of the STAMBP gene and no other phenotype-relevant mutations
were found, we attribute the cause of the syndrome to the recessive
mutations in STAMBP.
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Background
Epilepsy is genetically complex disorder affecting 1 % population of
people of the world irrespective of their age, groups and fluctuating in
its type and severity. Now a day’s high throughput sequencing such as
DNA array-based studies have reported relevant copy number variations
(CNVs) in 5-30 % of patients with epilepsy. These CNVs in epileptic pa-
tients is always remaining a challenge to find the causative genes for
epilepsy in the population.
Results
In this study to observe novel CNVs deletion and duplication in the pa-
tients with epilepsy we investigated 40 patients with numerous pat-
terns of seizures with epilepsy, minor dysmorphism and intellectual
disability (ID). We used the high density whole genome Agilent sure
print G3 Hmn CGH 2x 400 K array-CGH chips to find these variations.
Our outcomes showed many novel CNVs including the deletions and
duplications along with deletion plus duplication in the patients on
different chromosomal regions. Duplications were detected in the
chromosomal regions 2q13, 5p14.3, 6q23.2, 7p15.2, 19p12.13 respect-
ively and deletions were observed in the chromosomal regions 1q29,5p14.3, 6p25.3, 7q32.3, 14q11.2 and 19p13.13 respectively. Further-
more, duplication plus deletions were observed in 3q12.3, 5p14.3,
19p13.13. We found several genes related to ion channel and genes
involved in neuron differentiation, so that the frequently occurring
seizures may be due to loss or haploinsufficiency of one or more of
these genes. Moreover, the array CGH results were also validated by
using primer design of deleted regions utilizing the flanked SNPs using
simple PCR and also by using real time PCR.
Conclusions
In our study we found some of the novel deletions and duplication for
the first time in Saudi population. A large proportion of our patients
showed at least one rare copy number variant. Our results suggest un-
less there is a strong indication for a specific monogenic syndrome
otherwise the array-CGH should be considered as a first line of genetic
test for epilepsy. The use of advanced technologies to identify novel
mechanisms for fundamental epileptic disorder may help to recover
the clinical management of the patients in lowering the load of epi-
lepsy in the Saudi population.
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Background
Antibodies naturally exist as part of the specific immune system and their
main function is to detect foreign substances and target them for elimi-
nation.CD44 (HCAM) (homing cell adhesion molecule) antibody is a multi-
functional class I transmembrane glycoprotein (80 kDa) present on T
lymphocytes, granulocytes, red blood cells, brain, and epithelial cells.
CD44 is expressed on malignant cells, as well as on cancer stem cells.
Therefore, CD44 plays an essential role in tumour progression by helping
in cancer invasion and metastasis (Jaggupilli and Elkord, 2012).The aim of
this study was to elucidate the prognostic impact of the cancer marker
CD44 by immunohistochemistry (IHC) in colorectal cancer (CRC) and de-
termine its value as potential biomarker of clinical outcome.
Patients and methods
The expression of CD44 was evaluated by automated immunohisto-
chemistry in 149 Formalin-fixed and paraffin-embedded tissues of
CRC. The expression profile of immunostaining was evaluated by ob-
jective method (index score) that considered both intensity and frac-
tion/extension of expression pattern.
Results
The expression of CD44 was predominantly membranous and /or cyto-
plasmic (Fig. 26). Immunostaining results showed that there was no
association between CD44 immunoexpression and age, gender and
grade of the tumour, however it was found to have a significant associ-
ation with tumour location (p = 0.039) and tumour stage (p = 0.007). In
univariate analysis, there was no correlation between CD44 expression
patterns and disease-free survival (DFS). However, there was a signifi-
cant correlation, with disease-specific survival (DSS), in that patients
BMC Genomics 2016, Volume 17 Suppl 6 Page 48 of 78with CD44 low expression patterns tumours have longer survival out-
come (p <0.03).
Conclusions
Our study primarily showed that CD44 expression profile has a poten-
tial prognostic value in CRC; however, larger cohort with complete fol-
low up data, in addition to deep functional molecular work is highly
recommended in order to assess the correlation between CD44 and
CRC carcinogenesis and progression.
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Fig. 26 (abstract P79) Immunohistochemical staining of CD44.
a Normal tissue (no expression); b colorectal cancer tissue
(B1-moderate and B2-strong expression)
Table 15 (abstract 79) Correlation of CD44 expression patterns with
selected clinic-pathological features of CRC





≤60 years 112 (50%)
>60 years 112 (50%)
Pathological stage: 0.007
Stage I 3 (2.1%)
Stage II 20 (14%)
Stage III 106 (74.1%)
Stage VI 14 (9.8%)
Localization: 0.03
Rt colon 61(28%)
Lt colon and rectum 157 (72%)
Status of patient: 0.03
Alive (106) 77.4%
Dead (31) 22.6%
Fig. 27 (abstract P80) Amplification plot (Rn vs. cycle )- assay
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Hypertension is a complex, multifactorial disease, influenced by a
large number of genetic and environmental factors and their
interaction. Objective: Our study aims to assess the association of
eNOS (G894T) single neuclotide gene polymorphism (SNP) hyper-
tension risk and its relation with variable hypertension predispos-
ing conventional risk factors. Methodology: eNOS (G894T) SNP by
real-time PCR was performed in 70 hypertensive patients (25
have CAD proven by coronary angiography& 20 are diabetic) and
30 age and sex matched apparently healthy individuals. Lipid
profile (TG, TC, LDL and HDL) glucose profile were assessed by
colorimetry.
Results
Hypertensive patients had significantly increased systolic and
diastolic blood pressure (P < 0.001), lipid profile (P < 0.001), fast-
ing blood glucose, 2 h-PPG (P < 0.001) and smoking status (P =
0.01) as compared to control. No significant difference between
the 2 participants groups regarding genotypic distribution of
(G894T) SNP (P > 0.05). However, the combination of (GT + TT)
eNOS genotype and T allele significantly increase the risk of
hypertension (OR = 3.86& 4.33) respectively. Subgroup analysis
based on associated complications showed significant associ-
ation between CAD and eNOS (G894T) in mutant genotype (P =
0.002) and allele frequency (P < 0.001). Moreover, the combined
mutant homozygous and heterozygous eNOS genotype are
significantly associated with higher TC, LDLc, (P < 0.001) and TG
(P = 0.001). Thus dyslipidemia (not shown), CAD (P = 0.002 & OR =
5.01) and hypercholesterolemia (P < 0.001(&12.48) increase the risk
of hypertension among T carrier CI (1.68-14.98) & (3.679-42.33)
respectively.
Conclusions
These results indicated that the T carriers which are weakly asso-
ciated with hypertension, could increase the hypertension risk
with hypercholestolemia (increased both TC and LDLc) and com-
plications (CAD).
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Table 16 (abstract P80) eNOS gene polymorphism data of the studied
patients and controls





No % No %
Genotype Z
GG 49 70.0 27 90.0 1.89 0.058 -
GT 16 22.9 3 10.0 1.23 0.219 TT + GT
TT 5 7.1 0 0.0 1.0 0.319 3.86(1.05-14.12)
G 114 81.4 57 95.0 χ2
T 26 18.6 3 5.0 6.24 0.012(S) 4.33(1.26-14.92)
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Background
The accurate determination of single nucleotide polymorphisms
(SNPs) has received immense attention, particularly in genome-
wide association studies (GWAS). Although enormous SNPs were
identified, only the ones that are known to cause diseases are
considered to investigate the genetic predisposition to complex
diseases such as diabetes. However, it is conceptually known that
allele with low frequency might have genetic effects influencing
diabetic phenotypic traits. Therefore, we address the importance
of detecting the allele and genotype frequency and eventually
examine the common genetic variants that are significantly asso-
ciated with diabetic traits. The study aimed to screen a spectrum
of SNPs in a one single run taking advantage of the large-scale
genotyping technology.
Materials and methods
Selected genetic loci that are located on chromosome 16, and previously
known to be associated with diabetes and obesity were screened utiliz-
ing the availability of Taqman Genotyping Open Array plate. The fre-
quency was estimated for each individual allele and genotype in the
total sample population.
Results
Data have shown the presence of uncommon and rare SNPs variants
in VKORC1 gene.
Conclusions
Identifying SNPs- related diabetes is a very challenging approach
creating a clinical debate whether these variants have a meaningful value
in predicting diabetes risk. Further study has to be conducted to assess
the implication extent of the genetic variations in the development of
the disease.P82
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Background
Gastric cancer (GC) is frequent and second cause of cancer related
deaths. The pathogenesis of gastric cancer includes a sequence of
events that begins with Helicobacter pylori (H. pylori) induced chronic
superficial gastritis, progressing towards atrophic gastritis, intestinal
metaplasia, dysplasia and eventually GC. In this study we aim to
determine the presence and identification of H. pylori from different
gastric biopsies. Further H. pylori virulence factors cagA and vacA
genotypes will be determined by PCR.
Materials and methods
This study includes 30 paraffin embedded gastric specimens from nor-
mal and gastric cancer patients, pathologically diagnosed for gastric
cancer from King Abdulaziz University Jeddah Saudi Arabia. Detection
of H. pylori strain was performed by using specific primers targeting
16S rRNA and ureA genes. The cagA, vacA, GlmM, IceA1, IceA2 and HPU1
presence was determined from H. pylori positive samples by PCR using
their respective primers.
Results
Molecular identification of H. pylori using specific genes (ureA and
16S rRNA) revealed that (26) 86 % of samples were H. pylori positive.
We found that prevalence of cagA, vacA and GlmM were more as
compared to other genotypes such as IceA1, IceA2 and HPU1 in gas-
tric cancer patients. All samples negative for 16S rRNA were also
negative for cagA, vacA and GlmM.
Conclusions
Our results show high prevalence of cagA and vacA in gastric
cancer patients. This study might be of clinical significance in
precise and early diagnoses of gastric cancer and treat gastric pa-
tients by understanding the trend of H. pylori infection in Saudi
Population.
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Table 17 (abstract P84) The table depicts the results for the
transformation efficiency, expression and toxicity studies of pRESTA-
MAP1138c and pET28a-MAP1138c expression vector constructs in




(transformants/μg DNA) of strains
Toxicity Antibiotics + 1mM IPTG over
night
Expression in liquid media
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Low High Low
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Non-Typhoid Salmonellosis (NTS) is one of the leading zoonotic
food-borne illnesses. Infections caused by NTS ranges from 250
to 3200 per 100,000 population across the globe. High number
of cases (ranges between 44-132) have been reported from
Makkah, Saudi Arabia (KSA) during Hajj season. Increased anti-
microbial resistance in NTS from across the world has further
compounded the problem. Fluoroquinolones (FQs) are the drugs
of choice for the treatment of drug-resistant NTS infections. How-
ever, over use of FQs in human and misuse in animal feeds has
led to increase in FQ resistance as well throughout the world. No
data is available about NTS infections and FQ resistance in NTS
from Jeddah, KSA, therefore this study primarily explored the
phenotypic FQs susceptibility among NTS isolates from Jeddah.
Secondly, phenotypic FQ resistance was also correlated with mu-
tations in FQ resistance detection gyrase (gyrA) and topoisomer-
ase (parC) genes.
Materials and methods
A total of 48 NTS isolates were collected during 2014 in one of the
public sector hospital from patients in Jeddah, KSA. Antimicrobial
susceptibility was determined using Clinical and Laboratory Stan-
dards Institute methodology. The presence of mutations for FQs re-
sistance was detected in gyrA and parC genes by PCR- based gene-
sequencing method.
Results
Thirty-eight percent of (18/48) patients’ NTS isolates were resist-
ant to ciprofloxacin phenotypically. Gene sequencing revealed
mutations in two codons of gyrA and parC genes each among 13
out of 18 FQ resistant isolates. Whereas one FQ resistant isolate
showed mutation only in parC gene. Mutations were observed at
codons 83 and 87 (S83F, S83Y, D87G, D87Y,D87W and D87N) in
gyrA and on codons 57 and 80 (S57T, S80I and S80W) in pyrC
gene. None of the FQ susceptible isolates showed mutations in
gyrA and parC.
Conclusions
This study exhibits prevalence of FQ resistant NTS infections in Jed-
dah. Prevalent mutations in gyrA and parC genes among FQ resistant
isolates may assist in development of rapid FQ resistance detection
method. However, wild type gyrA and parC genes among 4/18
phenotypic FQ resistant NTS isolates also indicates presence of an al-
ternate mechanism, such as drug resistance pump, for FQ resistance
which needs further investigation.
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Background
The complete genome of the reference Mycobacterium avium
subspecies paratuberculosis (MAP) strain K-10 has beensequenced [1]. This has provided us with many opportunities to
study the interaction of many putative virulence genes with its
hosts and the environment. Recently, through an in silico ana-
lysis of a putative virulence factor (MAP1138c), it was postu-
lated that since MAP1138c share a sequential, structural and
functional homology with Rv1141c (LprG) of Mycobacterium
tuberculosis it can possibly play a role in the escaping the cell-
mediated immune response within host macrophages in paratu-
berculosis infection [2]. Therefore, considering this fact the
in vitro characterization of the putative ORF MAP1138c is useful
in understanding nature of the protein and its role in the viru-
lence of MAP in ruminants.
Materials and methods
In this study, we have cloned, purified MAP1138c and have per-
formed protein toxicity assays and ELISA to detect the presence of
MAP1138c in MAP infected sheep serum. Data were analyzed using
GraphPad Prism 5 software. ELISA data were compared using a non-
parametric Mann–Whitney U test on O.D values at 490 nm. The level
of significance was set at p < 0.05.
Results
MAP1138c was cloned, purified and confirmed using western
blot. The purified MAP1138c protein was used to perform im-
munoassay and toxicity assay to work out a possible functional
role for the putative MAP1138c protein. From our analyses, it ap-
pears that MAP1138c plays a role in infection of MAP in sheep.
Despite the conserved nature of this protein, a significant differ-
ence (p < 0.05) was observed in serum antibody levels between
control animals (N = 10) and infected sheep’s (N = 20) serum for
MAP1138c (Fig. 28). The toxic nature of MAP1138c was also
established as the presence and expression of protein were negli-
gible in pRSETA-MAP1138c expression vector while contrary re-
sults were obtained using pET28a-MAP1138c expression vector
system (Table 17).
Conclusions
These studies reveal the possible role of MAP1138c protein in
virulence and pathogenesis of MAP. Further, biochemical and func-
tional studies of MAP1138c protein will surely enhance our under-
standing of the role of MAP1138c protein in the pathogenesis of
MAP in ruminants and humans.
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Fig. 29 (abstract P85) a Morphological changes in miR137 treated
MCF-7 cells (arrows indicate cell death); b MTT assay showing decrease
in cell proliferation; c AnnexinV-FITC and PI staining showing apoptotic
cells; d Cell cycle and e IPA analysis of miR137 targets
Fig. 28 (abstract P84) Serum antibody response for a MAP1138c protein
expressed as optical density for infected animals (N= 20) and control
animals (Neg) (N= 10). The horizontal line marks the group average value
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Background
Cancer is one of the leading cause of deaths worldwide, and there has
been an increase in the development of multidrug resistance to cancer
[1]. Micro RNAs (miRs) are small 21-25 nucleotides long single stranded
molecules that interact with their complementary sequences and regu-
late the different genes [2]. MiR-137 is overexpressed in mammogen-
esis during embryonic development and significant overexpression of
miR137 in MDA-MB231 breast cancer cell line inhibited breast cancer
formation in nude mice [3]. We aim to identify the pathways and mech-
anisms influenced by miR137 in breast cancer using in vitro and in silico
studies.
Materials and methods
Human breast adenocarcinoma cells (MCF-7) were seeded in a 24 well
plate (2 × 104/well) and allowed to attach overnight. The cells were
transfected with miR137 at 30nM and 100nM concentrations using lipo-
fectamine 2000© according to the manufacturer’s protocol. Following
culture of transfected MCF-7 cells for 48 h, any changes in their morph-
ology (Phase microscopy), cell proliferation (MTT assay), cell cycle and
apoptosis (AnnexinV-FITC and PI staining using FACS) were studied.
Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Qiagen, USA) was
utilized to determine miR137 targets and pathways in human breast
cancer.Results
MCF-7 cells treated with 100nM miR137 revealed cell shrinkage and cell
death (Fig. 29a). MTT results showed inhibition of cell proliferation by
20.70 % compared to control and this decrease was statistically signifi-
cant (Fig. 29b). AnnexinV-FITC and PI staining showed high percentage
(72.8 %) of cells in the pre-apoptotic phase and low percentage
(12.4 %) in late-apoptotic stage (Fig. 29c). Cell cycle analysis also
showed ‘S’ phase arrest and increase in sub G1-phase (15.20 %) indica-
tive of apoptosis compared to control (Fig. 29d). The IPA analysis for
miR137 in breast cancer revealed several target proteins and pathways
that are implicated in breast cancer pathogenesis (Fig. 29e).
Conclusions
miR137 demonstrated inhibition of MCF-7 cells in vitro and in-
duced mophological changes leading to cell death via an apop-
totic mechanism. In silico analysis identified several key proteins
which are involved in breast cancer pathogenesis in addition to
the most commonly involved HER-2 signaling and stathmin regu-
lated pathways. IPA analysis thus provides additional insights to
explore novel therapeutics.
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Prognosis of breast cancer (BC) is mainly based on the tumor sta-
ging system and other traditional/conventional clinico-pathological
features; however, staging system alone is in adequate in predict-
ing the outcome of patients within same stage. Moreover, early
stage BC patients, who subjected to surgery, have a tendency of re-
currence within upcoming 10 years of follow up time. Therefore,
searching for molecular markers that could help in prognosticating
patients within same stage is of high priority in BC research. In this
study, we evaluated the expression patterns of AURKA gene, a cell
cycle regulator, which has tumorigenic activity, and verify its prog-
nostic value. ,
Patients and methods
The retrospective study cohort consists of 137 female breast primary
invasive ductal carcinoma samples and 2 non-cancerous tissues
representing normal. The patients were diagnosed at the Depart-
ment of Pathology, King Abdulaziz University and Bakhash Hospital,
Jeddah, Saudi Arabia during years from 2000 to 2008. RNA extraction
was carried out using an RNeasy FFPE Kit and was transcripted by
using Sensiscript reverse transcription kit from Qiagen.
Results
In our study, 70 % of the breast cancer patients had shown over ex-
pression in AURKA genes for tumor samples versus benign samples.
We found also the significant correlation between AURKA and recur-
rence rate (p < 0.009). AURKA gene is also over expressed in patients
with high reoccurrence score (RS).
Conclusions
Our study showed that AURKA gene is highly expressed in tumors vs.
benign cases and significantly associated with disease recurrence.
These preliminary data confirmed that high AURKA gene expression
patterns might be helpful in selecting a group of patients of early
stage BC who have high recurrence rate in order to be subjected to
adjuvant therapy.
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Background
Immunogenomics is an expanding field which will allow expand-
ing basic knowledge about the contribution of the genomic im-
munology and its interaction with the environment including the
microbiome of both human health and disease [1]. It helps us to
understand the immune mechanisms in both health and disease
and provides critical clues to foster the medical transition to-
wards precision medicine through the provision of individualized
diagnostics and therapeutics [2, 3]. In this study, we provide an
overview of the recent developments in Immunogenomics and
their potent role to develop novel preventive and therapeutic
strategies for the wellbeing of humans.
Materials and methods
High throughput data, obtained from individual patients, using ad-
vanced technological platforms such as microarrays, next generation
sequencing (NGS) methodologies were examined using freewares like
R and commercial platforms like Genespring GX13.1 (Agilent, USA), Par-
tek Genomics Suite (Partek Inc., USA), JMP Genomics Software (SAS,
USA) etc., The differential expression patterns of immune genes has
been analysed using the Database for Annotation and Visualization and
Integrated Discovery (DAVID), and commercial knowledge bases like
Pathway Analysis (IPA) (Ingenuity Systems, Qiagen USA), Pathway
Studio (Elsevier, Netherlands) etc., to decipher biomarkers and novel
immune-regulatory pathways.Results
The screening of available high throughput data and further analysis
of molecular using computational and comparative genomics tools
provide us key biomarkers and/or pathways driving human immuno-
genomic behaviour at both physiological and pathological contexts.
Conclusions
Immunogenomics is, thus, an expanding field that offers unprece-
dented opportunities for better understanding of the intricate mecha-
nisms of disease regulation and progression using genomics of the
immune system. Therefore, precise prediction of susceptibility, early
and accurate diagnosis using immunogenomic methodologies can be
done frequently to improve personalized healthcare in the near future.
References
1. Mavrommatis B, Young GR, Kassiotis G: Counterpoise between the
microbiome, host immune activation and pathology. Curr Opin
Immunol 2013, 25(4):456-462.
2. Green ED, Guyer MS: Charting a course for genomic medicine from
base pairs to bedside. Nature 2011, 470(7333):204-213.
3. Buonaguro L, Pulendran B: Immunogenomics and systems biology of
vaccines. Immunological reviews 2011, 239(1):197-208.
P88
In Silico physiochemical and structural characterization of a
putative ORF MAP0591 and its implication in the pathogenesis of
Mycobacterium paratuberculosis in ruminants and humans
Syed A Hassan1, Iftikhar A Tayubi1, Hani MA Aljahdali2
1Deaprtment of Computer Science, Faculty of computing and
Information Technology Rabigh, King Abdulaziz University, Rabigh,
21911, Saudi Arabia; 2Department of Information Systems, Faculty of
computing and Information Technology Rabigh, King Abdulaziz
University, Rabigh, 21911, Saudi Arabia
Correspondence: Syed A Hassan (asif_srmcbt@yahoo.com) –
Department of Computer Science, Faculty of computing and Information
Technology Rabigh, King Abdulaziz University, Rabigh, 21911, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):P88
Background
Mycobacterium avium subsp. paratuberculosis (MAP) is an intracellular
pathogen of ruminants and humans [1-2]. However, the identification
of virulence factors of these diseases and their mode of action in caus-
ing pathogenesis in human and ruminant are still partly understood. In
this regard, identifying the role of the “two-component systems” in the
pathogenesis and survival of MAP within host cells; considering the fact
that it plays a role in the establishment and propagation of tuberculosis
infection in humans [3].
Materials and methods
Therefore, a comprehensive sequential, structural and functional com-
parative study between phoP a response regulatory component of the
“two-component regulatory system” of Mtb and its ortholog in MAP
genome was conducted using computational tools namely EggNOG,
ProtScan, ProtPram, Hydropathy plot, and PSIPRED. Swiss-model server
was used to build the three-dimensional structure of an MAP0591 pro-
tein using the crystal structure of the Rv0757 protein as a template. The
quality and reliability of generated model were evaluated using QMEAN
and GMQE structure assessment tools of SWISS-MODEL server.
Results
EggNOG analysis showed that the MAP0591 protein of MAP is an
ortholog of PhoP (Rv0757) protein of Mtb and shares sequential hom-
ology of 97.12 %. Further sequential analysis displayed that MAP0591
protein has a signal receiver domain and winged helix-turn-helix DNA
binding domain suggesting its role in signal transduction and gene
regulation. The ProtPram analysis shows similarity in various physical
and chemical parameters between MAP0591 and Rv0757 proteins
(Table 18). The hydropathy plot of MAP0591 and Rv0757 proteins
showed strong negative peaks indicating the presence of high anti-
genic region along the protein sequence. Comparative PSIPRED analysis
of MAP0591 with Rv0757 protein reveals a similarity of secondary struc-
ture between the two proteins. The predicted three-dimensional model
of MAP0591 protein (Fig. 30) was found to be reliable using QMEAN
and GMQE global structural evaluation tools of Swiss-model server.
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This study highlights the physiochemical, sequential and structural
similarity between the MAP0591 and Rv0757 proteins and opens the
prospects that MAP0591 protein might play a role in the survival of
MAP in host macrophages leading to latency and subsequent infec-
tion in human and ruminants.
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MAP0591 26476.2 239 39.70 98.70 -0.159
Rv0757
(PhoP)
27513.5 247 36.18 98.99 -0.191
*GRAVY (-ve) = hydrophilic nature and (+ve) = hydrophobic nature
Fig. 30 (abstract P88) 3D model of MAP0591 protein generated by
SWISSMODEL server
Fig. 31 (abstract P89) Effect of heat shock on hBM-MSCs. a - Cell
morphology; b - Cell proliferation (MTT assay); c - Apoptosis
(AnnexinV-FITC&PI) assayP89
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Background
Autologus stem cell transplantation for articular cartilage repair appears
promising. However, increase or decrease in temperatures as associated
with the use of arthroscope or laser drilling during stem cell based car-
tilage repair procedures may have detrimental effects on the trans-
planted stem cells [1]. In the present study, we attempt to evaluate theeffect of heat shock on human bone marrow mesenchymal stem cells
(hBM-MSCs) in relation to its proliferation and survival.
Materials and methods
Primary cultures of hBM-MSCs were established and characterized. Early
passages of hBM-MSCs (1x105cells) were exposed to different tempaera-
tures (37°C, 40°C, 50°C, 55°C) and duration (30s, 60s, 90s, 120 s) either as
cell pellet or as cell suspensions. Following heat shock the hBM-MSCs
were cultured under standard culture conditions for 24 hrs and changes
in morphology (Phase-contrast imaging), cell proliferation (MTT assay), cell
cycle (PI staining) and appoptosis (AnnexinV-FITC and PI) were studied.
Results
Exposure to heat shock affected the cellular functions which was more
pronounced in the suspension cells than pelleted cells. Cell death were
observed in both groups at eleveated temperatures (50°C, 55°C) and lon-
ger durations (90s, 120 s) (Fig. 31a). There was an overall inhibition of cell
proliferation in both cell suspension and cell pellet groups at 24 h
(Fig. 31b). However, there was nearly 50 % decrease in inhbition in the
cell suspension group compared to the cell pellet group at higher tem-
peratures and duration studied (Fig. 31b). There were no changes in ei-
ther the cell cycle or apoptosis (Fig. 31c) between the two groups.
Conclusions
Cell pellet have better proliferation and survival compared to cell
suspension in response to heat shock. The observed cell death may
be due to predominantly necrosis although current results wre nega-
tive for apoptois this cannot be ruled out. Further studies on differ-
ential expression of genes related to cell death, heat shock proteins
are currently being pursued to ascertain the underlying mechanisms.
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Table 19 (abstract P90) RSV docking results obtained with proteins






GRB2 -4.236 -8.365 4 O-SER96(A)(2)
O-ARG112(A)(2)
GAB -10.313 -4.236 1 N-LYS1(B)
PI3K -5.462 -6.616 3 O-ASN57(A)(2)
O-GLU61(A)
PTPN 11 -16.357 -9.362 1 O-GLY182(A)
PKC -10.369 -7.161 1 O-LYS654(A)
JNK -5.655 -6.656 2 O-GLU138(A)
O-ILE139(A)
p38 MAPK -6.366 -11.366 1 O-LYS36(A)
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Background
Resveratrol (RSV) is a phytoalexin produced by plants in environmental
stress or pathogenic bout [1]. Phytoalexins offer resistance against an
array of infectious agents in plants [1, 2]. RSV has earlier been shown to
possess anti-inflammatory effects using in vitro and in vivo model sys-
tems [3, 4]. Mast cells are innate immune cells that play a pivotal role in
the regulation of allergy, allergic rhinitis, anaphylaxis, atopic dermatitis,
asthma and other related disorders [5]. In our present study, we specif-
ically dissect the effect of RSV in mast cell mediated signaling process
using in silico approaches.
Materials and methods
The list of target molecules for RSV was obtained using the Ingenuity
Pathway Analysis (IPA) software (Ingenuity Systems, Qiagen, USA). The
RSV target genes were further clarified using Fisher’s Exact Test and
Benjamini Hochberg Multiple Testing Correction (P < 0.05) and sub-
jected to core analysis using IPA to decipher proteins implicated in
mast cell signaling. In order to understand the binding efficiencies of
RSV with proteins implicated in mast cell signaling, computational
docking software named CLC Drug Discovery Workbench version 2.5
(CLC Bio, Qiagen, USA) was used.
Results
Ingenuity knowledge base showed that RSV potently regulates pro-
teins involved in the mast cell signaling pathway such as GRB2, GAB,
PI3K, PTPN 11, PKC, JNK, and p38 MAPK (Fig. 32a). These intracellular
proteins specifically control the Fc epsilon mediated mast cell signal-
ing in allergic responses. Furthermore, the in silico docking approach
(Fig. 32b) showed that RSV significantly interacts and binds strongly
(Docking Score Range: - 4 to -16 Kcal/mol) with GRB2, GAB, PTPN 11,
PKC, PI3K, JNK and p38 MAPK (Table 19).
Conclusions
Our in silico study reiterates the importance of mast cell mediated signal-
ing in innate immune responses. The inhibition of proteins involved in Fc
epsilon signalling by RSV is essential for the attenuation of transcription
of proinflammatory cytokines and chemokines in mast cells and could
lead to the reduction of allergic responses. However, further in vitro stud-
ies in human cord blood derived mast cells (hCBMCs) are required to pre-
cisely translate the anti-inflammatory mechanisms of RSV.Fig. 32 (abstract P90) a. IPA core analysis of the molecules
regulated by RSV showed that the Fc epsilon RI mediated
signaling molecules in mast cells were significantly inhibited
(Red). b. Molecular docking studies of PTPN, PKC, GAB and JNK
(top panel), and p38 MAPK, PI3K and GRB2 (bottom panel)
showing significant interactions with RSVAcknowledgements
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Fig. 33 (abstract P91) Primary cultures of BM-MSCs (a); Morphological
changes following treatment with PM [2.5μm (b) and 10μm(c)]
at varying concentrations (15, 25, 50, 150 and 300 μg/mL); cell
proliferation following treatment with PM [2.5μm (d) and
10μm (e)]
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Background
Airborne particulate matter (PM) less than 2.5 μm are classified as ‘fine
particles’ while those above are classified as ‘coarse particles’. Fine and
coarse PM comprise organic and inorganic substances and both carry in-
halational hazard. Suspended PM include but not limited to dust, smoke,
and liquid droplets which can cause adverse health effects in humans es-
pecially those related to the respiratory and circulatory systems [1]. PM
collected from Jeddah increased expression of genes associated with the
pathogenesis of metabolic syndrome and atherosclerosis both in vitro [1]
and in vivo [2]. The objective of this study is to assess the in vitro effects
of PM on bone-marrow mesenchymal stem cells (BM-MSCs) proliferation,
death and gene expression profiling.
Materials and methods
Dust were collected on Polypropylene filters and immersed in an
aqueous/ alcohol extraction followed by sonication. Particles were
then lyophilized, weighed and stored at -80 °C. Human BM-MSCs
were derived from bone marrow aspirates obtained following
Institutional Ethical Committee approval [11-557/KAU]. BM-MSCs
cells were plated at a seeding density of 2 × 104 cells/well in a
24 well plate and exposed to two different sizes of PM (2.5 μm
and 10 μm) at five different concentrations (15, 25, 20, 150 and
300 μg/mL). Cell morphology and cell proliferation (MTT assay)
were carried out.
Results
Primary cultures of BM-MSCs demonstrated their characteristic spin-
dle shaped morphology (Fig. 33a). Treatment with PM (2.5 μm and
10 μm) at varying concentrations (15, 25, 50, 150 and 300 μg/mL) led
to morphological changes which resulted in death of BM-MSCs at
higher concentrations (50, 150 and 300 μg/mL) (Fig. 33b, c). Concen-
tration dependent inhibition of BM-MSCs proliferation (MTT assay)
were also observed. Mean maximal decreases in proliferations were
19.35 % (150 μg, 24 h) and 28.49 % (300 μg, 24 h) for PM2.5 μm re-
spectively (Fig. 33d). Mean maximal decreases in proliferations were
23.71 % (50 μg, 48 h), 31.73 % (150 μg, 72 h) and 38.46 % (300 μg,
72 h) for PM10μm respectively (Fig. 33e).
Conclusions
Particulate matter at concentrations of 2.5 μm and 10 μm inhibit BM-
MSCs proliferation in vitro leading to cell death. The actual mechanism
that caused BM-MSCs cell death in the present study needs further
investigations.
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Background
The identification of charge clusters (runs of charged residues) in pro-
teins and their mapping within the sequence is an important step to-
ward a comprehensive analysis of how these particular motifs mediate,
via electrostatic interactions, various molecular processes such as pro-
tein sorting, translocation, docking, orientation and binding to DNA
and to other proteins. Few algorithms that specifically identify these
charge clusters have been designed and described in the literature [1].
In this study, 197 distinctive human viral proteomes were screened for
the occurrence of charge clusters (CC) using a new computational tool.
Results
373 CC have been identified within the 2549 viral protein sequences
screened. The number of protein sequences that are CC-free is 2176
(85.3 %) while 150 and 180 proteins contained positive charge (PCC)
and negative charge clusters (NCC), respectively. The NCCs (211 de-
tected) were more prevalent than PCC (162). PCC-containing proteins
are significantly longer than those having NCCs (p = 2. 1016). The most
prevalent virus families having PCC and NCC were Herpesviridae
followed by Papillomaviridae. However, the single-strand RNA group
has on average three times more NCC than PCC. According to the
Fig. 34 (abstract P93) a - Primary cultures of SF-MSCs; b - SF-MSCs
Stemness characterization; c - SF-MSCs proliferation and inflammatory
gene expression in SF-MSCs from normal and osteoarthritis; d - In vitro
model system and work flow; e - IPA analysis of diseases and biological
functions in OA
BMC Genomics 2016, Volume 17 Suppl 6 Page 56 of 78functional domain classification, a significant difference in distribution
was observed between PCC and NCC (p = 2. 10-8) with the occurrence
of NCCs being more frequent in C-terminal region while PCC more
often fall within functional domains. Only 29 proteins sequences con-
tained both NCC and PCC. Moreover, 101 NCC were conserved in 84
proteins while only 62 PCC were conserved in 60 protein sequences. To
understand the mechanism by which the membrane translocation
functionalities are embedded in viral proteins, we screened our PCC for
sequences corresponding to cell-penetrating peptides (CPPs) using two
online databases: CellPPd and CPPpred. We found that all our PCCs,
having length varying from 7 to 30 amino-acids were predicted as
CPPs. Experimental validation is needed to improve our understanding
of the role of PCCs in viral infection process.
Conclusions
Screening distinctive cluster charges in viral proteomes suggested a
functional role of these protein regions and might provide potential
clues to improve the current understanding of viral diseases.
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Background
Arthritic diseases are major causes of disability in the elderly popula-
tion throughout the world, including the Middle East and the King-
dom of Saudi Arabia. Osteoarthritis (OA) is a degenerative disease of
the synovial joint, where matrix metalloproteinases, inflammatory cy-
tokines and reactive oxygen species orchestrate the cartilage degrad-
ation process [1]. As early detection and intervention have better
prognosis it is important to identify the expressed biomarkers at vari-
ous stages of OA. Use of experimental model systems to assay such
biomarkers will greatly aid in understanding their role in diagnostic,
prognostic and therapeutic management of OA.
Materials and methods
Screening for biomarkers in OA was done using nomenclature of signal-
ling molecules and pathways involved in cartilage formation and degrad-
ation using Ingenuity Pathway Analysis (IPA) knowledgebase (Ingenuity
Systems, Qiagen, USA). Target molecules identified by IPA were further
analyzed using Fisher’s Exact Test (P < 0.05) and subjected to core analysis
to understand the diseases and biological functions. Human cartilage
and synovial fluid were collected following ethical approval [11-
557]. Primary cell cultures of synovial fluid MSCs (SF-MSCs) from normaland OA patients were established and characterized. Pharmacologicals/
nutraceutics that are known to influence OA will be evaluated at differ-
ent concentrations on both SF-MSCs and cartilage explants and prote-
omic analysis performed.
Results
SF-MSCs demonstrated characteristic fibroblastic morphology and
these cells were positive for the MSC related CD markers (Fig. 34a, b).
SF-MSCs showed slow growth and cell proliferation; and inflamma-
tory related genes (TNF, IL6) were increased in OA (Fig. 34c). Secreted
proteins will be analyzed using proteomic depicted workflow
(Fig. 34d). IPA analysis core analysis identified predominant mole-
cules (~200) associated with connective tissue disorders, inflamma-
tory diseases and skeletal/muscular disorders (Fig. 34e). These
potential targets/biomarkers will be evaluated using primary cultures
and explant in vitro models.
Conclusions
In vitro explant and primary cell cultures from controls and OA pa-
tients are excellent models for proteomics analysis and IPA predic-
tion analysis enables identification of biomarkers that have
diagnostic and prognostic value. Combination of biological and sys-
tems analysis helps to identify important molecules of interest for
analysis in a cost effect manner.
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An inhibitory neuronal transmission is chiefly mediated through
γ-aminobutyric acid (GABA) via GABAA receptors (GABAARs). The
GABAARs are heteropentameric chloride channel receptors,
expressed in neurons, and their deficiency could lead to epilepsy.
Therefore, the GABAARs might be considered as the primary tar-
gets against epilepsy. Several antiepileptic drugs, natural, and
synthetic compounds have been shown to enhance the GABAARs
action and reduce epileptic seizures [1, 2]. Hence, the objective
of present the study is to find out potential binding ligands with
anti-epileptic properties against the active sites of GABAAR sub-
unit γ-2.
Materials and methods
Homology model of GABAAR subunit γ-2 has been built, and
the docking studies were carried out to deduce the possible
binding ligands with anti-epileptic properties against GABAAR
subunit γ-2. For this purpose, four different plant derived com-
pounds, such as Chrysin, Rutin, Montanine, and Vitexin, were se-
lected. Their quantitative structure-activity relationships have
been investigated to find the inhibitory activity of these four
compounds.
Results
Our results have shown a maximum docking score for Chrysin
(79.6174) Kcal/mol along with maximum number of hydrogen bond
interactions at the active sites Thr87-O, Phe77-N, and Phe78-N. The
other three compounds including Rutin, Montanine, and Vitexin have
shown their interactions at active sites Leu29-O, Phe77-N, Arg22-N,
respectively.
Conclusions
We can conclude that Chrysin could be the best-fit ligand for
GABAAR subunit γ-2 and might be considered as an alternate treat-
ment for epileptic patients. However, both in vitro, and in vivo studies
are necessary for further characterization and validation to design ef-
fective anti-epileptic drugs (AEDs) in the near future.
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Background
Breast cancer is the most common type of cancer among
women worldwide. It ranks first amongst cancer in Saudi fe-
males with an incidence of 19.8 % [1]. Few studies have shown
that the knowledge, awareness, and protective measures against
this disease are very low in Saudi females [1, 2, 3]. Objective of
this study was to assess the level of awareness, knowledge, and
practices of breast cancer among Saudi females living in
Jeddah.
Materials and methods
This study was conducted through a self-administered 25-
questions regarding the level of awareness, knowledge, and prac-
tices about breast cancer. 200 females participated in this survey.
Questionnaires were distributed hand-by-hand and through the
creation of an online survey.
Results
Most of the contributors (76 %) were below 40 years, married
(92.5 %) or ever married (5.4 %). 64.8 % participants have three
or more children, and 9.4 % were without any children. 81.5 %
females have regular menstruation, 3.5 % with stopped menstru-
ation, 38 % faced abortion in their life, and 46.5 % have used
pills as contraceptives. 82.5 % got information about breast can-
cer through health professionals, 52.5 % through friends/neigh-
bors, 58.5 % through electronic media, and 61.5 % through print
media. 18 % has reported a positive family history of breast can-
cer, 78.6 % know about the incidence of breast mass, 73 % know
about an increase in the neighboring lymph nodes, 68.5 % know
about blood discharge from nipple, 66.3 % know about the
breast pain, and 43 % know about the nipple retraction. 42.1 %
were aware of the effect of hormonal replacement therapy, 56 %
know the smoking affect, 43.5 % do not know about breast self-
examination (BSE), 26.0 % aware of the procedure but never go
for it, and 13.5 % have applied it. Moreover, 80 % never go to
the health professionals for breast examination, and 84 % do not
know about mammography.
Conclusions
The study showed an inadequate knowledge about breast cancer
among Saudi females. This study could help to increase the aware-
ness and knowledge of breast cancer in the Saudi society. However,
extensive public awareness programs, campaigns, and seminars will
be required to significantly reduce the socio-economic burden of this
disease in KSA.
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Background
Diabetic retinopathy (DR) is one of the leading diabetic vascular com-
plications in eye, which results to the blindness. Inflammation plays
significant role in pathophysiology of DR. Earlier reports demon-
strated that inflammatory mediators like TNF-α, ICAM-1 and iNOS sig-
naling are implicated in the pathogenesis of DR complications. Hyper
activation of retinal microglia in DR could be one of the main causes
that trigger excess release of inflammatory cytokines, which further
activates MAPKinase casacade that results neuronal degeneration.
Sesamin (SES) is the main component of sesame seed and oil, and
has been reported as potent antioxidant and neuroprotective. Here,
we investigated therapeutic effect of SES as anti-inflammatory in
Streptozotocin (STZ) induced diabetic mice model.
Materials and methods
Eight weeks post diabetic establishment, mice received SES (30 mg/
kg BW, i.p, alternate day) for four weeks. Mice body weight and
Blood glucose level was measured. Microglia activation was deter-
mined by immunohistochemistry (Iba-1 antibody was used as micro-
glia marker). Retinal mRNA levels of Iba-1, Tumor necrosis factor-α
(TNF-α), Inducible nitric oxide synthase (iNOS) and Intercellular Adhe-
sion Molecule 1 (ICAM-1) were examined by real Time-PCR. Western
Blot analysis was done to assess the iNOS protein expression level in
different group of mice retinal samples.
Results
The results showed that SES significantly lowered the progression of
diabetic retinal injury by: 1) decreasing blood glucose level, 2) sup-
pressing microglia activation, 3) reducing retinal inflammatory media-
tors TNF-α and ICAM-1 levels and 4) quenching iNOS expression.
Conclusions
In conclusion, our results suggested that SES could be of therapeutic
benefit in slowing the progression of DR by ameliorating hypergly-
cemia and inflammation in diabetic retina.
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Background
Current global scenario faced with an infectious disease crisis, which has
been anticipated for decades. The fatal filoviruses, Ebola and Marburg is
one of the utmost virulent pathogens, which causes adverse viralhemorrhagic fever in humans and non-human primates and has
higher fatality rates up to 90 % have been reported [1]. There
are no approved vaccine or therapeutics described to counter
filovirus infection. Mortality after their infection is the result of se-
vere bleeding and multi-organ failure. The genome of Ebola virus
(EBOV) encodes a single polypeptide with enzymatic activity, viral
large (L) RNA-dependent RNA polymerase protein. Presently, with
fewer evidence is added about the L protein due to which it hin-
dered the development of antivirals. Viral protein 35 (VP35) is
capable of copping dsRNA and plays important roles in viral rep-
lication, pathogenesis and innate immune response. Therefore,
antifiloviral therapeutic efforts must comprise added targets for
the development of vaccines to counter their infection [2,3]. In
the current study, structure-based in silico screening method can
be used to recognize and characterize the small molecules target-
ing the binding pocket within VP35 glycoprotein.
Materials and methods
Proteins selected for the present study are VP35 glycoprotein PDB ID:
3FKE (Fig. 36), whose 3D structure was acquired from PDB [http://
www.rcsb.org/pdb/] with resolution range 1.40 Ǻ. Antiviral compounds
used for virtual screening were taken from PubChem database. The active
site residues in the target proteins were determined by using CastP. Lig-
and preparation was done using Discovery studio software and their bind-
ing affinity with target components were analysed using Autodock 4.0.
Results
Based on the binding affinity, we conclude that antiviral compound
perfectly blends with and ALA-291, PRO-292 amino acid residues in-
volved in this binding and their binding energy are -4.48 Kcal/mole. Re-
sults indicate that Idoxuridine can be used as best antiviral compounds
against Ebola virus. The outcome helps and provides an early outline
for the development of antifiloviral compounds against VP35 proteins.
Conclusions
Results indicate that Idoxuridine can be used as best antiviral compounds
against Ebola virus. The outcome helps and offers an early framework for
the development of antifiloviral compounds against VP35 proteins.
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Fig. 37 (abstract P98) Depicting the percentage of variants
determined and studied across the different subsets formed from
the exome data of the three populations
Table 20 (abstract P98) Denoting the number of genomic variants
(including SNPs and INDELs) determined across the three populations,
namely Asian, African and American considered for the study
Combination No. of SNP Novel SNP No. of Indel Novel Indel
Asian 58194 1078 6231 957
African 115886 17320 14723 7061
American 287662 66197 17148 7128
American, African 13042 3198 1072 564
Asian, African 3793 109 439 138
Asian, American 13903 440 1029 171
Asian, American, African 48127 425 3641 264
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Background
The protein coding genes consist only approx 1 % of the hu-
man genome, which anchorage 85 % of the mutations with
large effects on disease-related traits. The effective approaches
for the selective sequencing of completely coding regions, or
“whole exome” have a possible contribution to the understand-
ing human diseases [1]. Exome-sequencing is a cost-effective
and innovative tools for dissecting the genetic basis of diseases
[2]. These progresses have also set the stage for applying ex-
ome- and whole-genome sequencing to simplify clinical diagno-
sis and personalized medicine. Here we have performed SNP,
INDEL profiling and deduce their functional role by using whole
exome-sequencing of a wide range of Human populations from
HapMap projects.
Materials and methods
The Data set were acquired from NCBI Short Reads under ID
SRP004054.There are total 93 exomes data available from
African and American populations sequenced under HapMap
project.The 22 samples (9 exome samples from Asian, 6 exome
samples from American and 5 exome samples from African
population) were considered for the computational study. Genes
containing the novel variations were determined via Genome
analysis Toolkit [3].
Results
Around 15410 genes exhibited novel variants across the sample
groups originating from the three populations, primarily from
Asian, African and American ethnicity (Fig. 37), 425 novel SNPs
and 264 novel INDELS were determined across the three popula-
tions (Table 20). Further, 20,037 variants were observed in the
nucleus region, whereas 22,154 genomic variants were found in
the cytoplasm region. Genomic variants are responsible for the
individual differences and hence the novel variants determined
via the study will help in understanding their impact on bio-
logical processes.
Conclusions
The calling resulted in 105,050 novel variants across the three
populations. The novel variants determined via the computational
analysis is significant for decoding the interference and role of
the SNPs and INDELs on the genes and their related biological
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Abstract
Background
An important parameter for human genetic variation is known to be
natural selection. Natural selection is a theory that states that individ-
uals with certain genotypes best adapted to live in an area are more
likely than other individuals to survive and reproduce. Natural selec-
tion is however interlinked to genetic drift and gene flow. Interplay
amongst these influences evolution in natural populations. Direc-
tional selection leads to increase over time in the frequency of a
favoured allele. Previous reports suggest that G6PD-deficient alleles
show some signatures of selection. Glucose-6- Phosphate Dehydro-
genase (G6PD) deficiency is the most common enzyme deficiency of
human erythrocyte which affects more than 400 million people
worldwide. Previous studies have reported prevalence of G6PD defi-
ciency ranging from 0 % to 27 % amongst various castes, ethnic and
linguistic groups in India. Although few studies have reported the
prevalence of G6PD deficiency in populations of Gujarat these stud-
ies are limited to specific castes and regions of Gujarat. There is no
BMC Genomics 2016, Volume 17 Suppl 6 Page 60 of 78comprehensive information available about the prevalence of this
disease across the entire map of Gujarat. The focus of the present
study was therefore to determine the prevalence of G6PD deficiency
in population of Gujarat. Survey of 3467 samples suspected to be
G6PD deficient frequenting the hospitals and leading laboratories
across Gujarat were analyzed to confirm the deficiency.
Results
It was interesting to find drastic variation in the prevalence amongst
the tribal and urban population. Frequency varied from as high as
from 11.18 % in tribal populations to as low as 1.2 % in the urban
population. Urban areas such as Kutch, Bhuj, Lunawada and Kapadwanj
showing relatively high prevalence have been known to be inhabited
by tribal population.
Conclusions
Heterozygosity levels, linkage disequilibrium patterns and frequencies
of alleles segregating in a population play a vital role in the prevalence
of any genetic deficiency. However how this polymorphism is being
maintained is yet to be deciphered. Our study signals the need for
rigorous research to understand the pattern of natural selection and es-
tablishment of selection coefficients for the different genotypes.
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Background
Preterm birth (PTB), birth before the completion of 37 weeks of ges-
tation, is a significant global public health problem. About 15 million
babies are born preterm each year accounting for more than a mil-
lion deaths of children. During last two decades (1990–2010), PTB
rate has increased in almost all 65 countries for which consistent
data are available. Preterm neonates are more prone to low blood
sugar, jaundice, sepsis, intensive care hospitalization, pulmonary dys-
function, ophthalmological disorders, and long-term neurocognitive
deficits. Surviving children also encounter health problems more
frequently in early adulthood and even continuing into the next
generation. Global Burden of Disease estimates show that PTB ac-
counts for 3.1 % of all Disability Adjusted Life Years, higher than
HIV and malaria. Majority (70 %) of PTBs are spontaneous. About
half of these are without any apparent cause and other half
assigned to an increasing number of risk factors. Risks include
behavioral, sociodemographic, genetic, medical, environmental,
and biological factors that individually or in combination interact
during pregnancy resulting in PTB.
Materials and methods
A comprehensive evaluation of published studies on single nucleotide
polymorphisms (SNPs) conferring potential risk for PTB was done by per-
forming a targeted PubMed search for association of SNPs and PTB for
the years 2007-2015 and systematically reviewing all relevant studies.
Results
Our evaluation resulted in more than 150 studies identifying about
120 candidate genes with SNPs that have potential association with
PTB. These genes were related to diverse tissues including endocrine,
tissue remodeling, vascular, metabolic, immune, and inflammatory
systems. The majority of the potential associations were for theinflammation related genes. Many of the polymorphisms exhibited
inconsistency and remained inconclusive.
Conclusions
The challenge of the PTB is to identify high risk women and pro-
vide them a personalized medical care for reducing the burden
of PTB. Recent studies on functional candidate gene variants and
their association with PTB have thrown forward a large number
of potential predisposing genes. Inconsistencies in different stud-
ies preclude pinpointing of any definitive targets. Understanding
the complex genomic landscape of PTB needs lateral thinking
and multicenter studies using high-throughput approaches.
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Background
Genetic and congenital disorders are the main causes of increased
infant/child death, illnesses and handicap among Arab population.
Congenital heart diseases (CHDs) represent a major category of
world-wide birth defects. We had searched MEDLINE databases,
clinical-science journals and reports from the earlier reviews. We used
the search term “Congenital heart diseases”, “Saudi Arabia”, “Down
syndrome”, “Molecular genetics”.
Results
CHDs were reported in about 6–13 per 1000 live births and implicated
in increased incidence of early childhood mortality. CHDs represent one
of the most important health problems in Saudi Arabia. CHDs occur in
about 50 % of neonates born with Down Syndrome (DS) and almost
40 % of the DS children who survive. Increased incidence of CHDs in
children with DS in certain populations has been reported to be associ-
ated with widespread consanguinity. Exploration of genes and molecular
genetic pathways involved in heart development greatly helps to under-
stand the genetic basis of CHDs. Genetic variations that have not been
identified up-till now might contribute to this complex genetic disorder.
Conclusions
This study aims to highlight the importance of CHDs as a major
health problem in Saudi Arabia and to emphasize the role of molecular
genetics in the pathogenesis of CHDs in children with DS.
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Background
Breast Cancer (BC) is the most frequent cancer in women, producing the
second highest mortality globally. Although initially effective, current
BMC Genomics 2016, Volume 17 Suppl 6 Page 61 of 78treatments fail to prevent eventual resistance and relapse of the disease.
Recently, the concept of oncogenic addiction has gained immense sig-
nificance, wherein the cells excessively rely on particular pathways for
malignancy and resistance[1]. Several single molecule inhibitors, affect-
ing different aspects of neoplasticity, are rapidly entering clinical trials
and being explored for their therapeutic relevance. However, from trials
using single targeted agents, it is becoming evident that often single tar-
get agents are not sufficient and multiple components need to be tar-
geted to disrupt the neoplastic pathways in cells[2]. The aim of this work
was to study the effect of novel drug combinations targeting multiple
members of signaling pathways in BC cell lines.
Materials and methods
All small molecule inhibitors were purchased from Selleckchem
(Munich, Germany). The cytotoxicites of individual drugs were
assessed using Cell Titer Blue assay (Promega) on MCF-7 cells in qua-
druplicates. Fluorescence was measured on SpectraMax i3 MiniMax
300. The IC50 values for each drug was determined using Graphpad
Prism 6. Two drugs combination experiments were perfomed at IC50
value for each drug with dose ranges above and below IC50 as de-
scribed by Chou and Talalay [3]. Combination Index (CI) values were
calculated using compusyn software. CI = 1 indicates additive effect,
CI < 1 indicates synergism, CI > 1 indicates antagonism.
Results
Here we report the observation of additive, but not synergistic effect on
combination of curcumin, a BCL2 inhibitor and PP242, an active site mTOR
inhibitor with CI of 1.06 (ED75), 1.00 (ED90) and 0.97138 (ED95). The com-
bination of PP242 with BH3 mimetic inhibitors of Bcl-2 such as ABT-199
and ABT-737 showed antagonism with CI > 1 at all doses studied.
Conclusions
Combination treatment with curcumin and PP242 exerts an additive
antitumoral effect on MCF-7 cells. Alterations in the signaling path-
ways that results in additive effects are currently being investigated.
Furthermore, we aim to test more combinations in our lab, targeting
complementary pathways, that can potentially diffuse the robust ma-
lignant signaling in BC.
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Abstract
Background
In cancer, oncogenes or tumor suppressor genes lose or gain vital func-
tions leading to the aberrant expression of oncogenic pathways and ma-
lignant transformation. The treatment of cancer is extremely difficult due
to inherent complexity of the disease as well as limitations of current
chemotherapy and target-based anticancer drugs in terms of toxicity andresistance development. Therefore, novel therapeutic approaches are re-
quired. MicroRNAs (miRNA) have emerged as master regulator of gene
expression in cells. Their deregulation is associated with cancer initiation
and progression. Downregulated miRNAs may be delivered to tumors in
order to repair lost gene expression. In this review we highlight the spe-
cific role of miR-143 and miR-145 in various cancers and their down-
stream targets. We also critically evaluate them as possible RNA medicine
for the treatment of cancer in the light of recent reports.
Results
MicroRNAs regulate various cancer-specific processes including angiogen-
esis, invasion, migration, apoptosis, metastasis, and chemo-resistance.
MicroRNAs can function as either tumor suppressors or oncogenes. The
tumor suppressor miRNAs are usually down-regulated in cancer. The
observation that certain miRNAs acting as tumor suppressors are down-
regulated in many cancer types has led to the concept of miRNA replace-
ment therapy. The downregulation of miRNAs could be overcome by
introducing exogenous synthetic oligonucleotides known as miRNA
mimics to restore the lost gene regulatory network and signaling path-
ways. MiRNA mimics may be delivered to the cells by using modern ad-
vanced delivery techniques. Mir-143 and miR-145 encoding genes,
located on chromosome 5 position 33 as a cluster, are co-transcribed to
regulate a variety of cellular pathways. These two miRNAs have been re-
ported to be regularly downregulated in many cancer types including
breast, bladder, pancreatic, prostrate and colorectal cancer and act as
tumor suppressor through inhibition of various downstream targets.
Conclusions
While there is a substantial amount of evidence that suggests a pos-
sible use of miR-143 and -145 for combination replacement therapy
in cancers in which both miRNAs are downregulated but recent re-
ports also have revealed that they can promote tumor growth by
stimulating cell proliferation. Therefore, a cautious approach is re-
quired to use them as therapeutic intervention in cancer.
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Background
Pregnant women often suffer with gastrointestinal problems [1] and
gut microbiota is one of the contributing factors [2]. The gut microbiota
variate with geography, diet, gender and age [3]. Any aberration in the
natural composition of gut microbiota can lead to obesity, high risk of
infections, inflammation and miscarriages [2]. In this study, Illumine
MiSeq deep sequencing was carried out to analyze gut microbiota
composition and richness during pregnancy among Saudi females.
Statistical, alpha and beta diversity analysis, were performed to identify
pregnancy-induced changes in gut microbiota of local population.
Results
Around 2.971 million filtered sequences were obtained that were
coded for 17 bacterial phyla, 98 families, 230 genera and 454 different
bacterial species. The phyla Firmicutes, Proteobacteria, Bacteriodetes and
Actinobacteria are dominating healthy Saudi women that substantially
modulate during pregnancy. The phyla Firmicutes and Actinobacteria
enriched with pregnancy whereas Bacteroidetes significantly decreased
during second (p = 0.008) and thrid trimester (p = 0.037) (Fig. 38a). The
Prevotellaceae is the second most dominant family that significantly
BMC Genomics 2016, Volume 17 Suppl 6 Page 62 of 78(p≤ 0.05) reduced with pregnancy. Among the dominant species (dens-
ity > 2 %), Prevotella copri significantly (p ≤ 0.01) decreased. The species
Faecalibacterium prausnitzii and Faecalibacterium sp. enriched with
pregnancy. Additionally, third trimester significantly (p≤ 0.05) enriched
with Bacteroides vulgatus and Alistipes finegoldii (Fig. 39). The statistical
analysis indicated that species diversity significantly decreased in 1st tri-
mester (p = 0.01), second and third trimesters (p = 0.05) (Fig. 38b).
Conclusions
Pregnancy significantly modulated gut microbiota structure and di-
versity. The dominant species remained constant with modulated
richness among the groups.Acknowledgements
The authors are thankful to King Abdulaziz city of science and technology
for supporting this work under the grant no. 84-34- ﻁﺁ .References
1. O’Brien B, Zhou Q: Variables related to nausea and vomiting during
pregnancy. Birth 1995, 22:93-100.
2. Khan I, Yasir M, Azhar EI, Kumosani T, Barbour EK, Bibi F, Kamal MA:
Implication of gut microbiota in human health. CNS Neurol Disord Drug
Targets 2014, 13(8):1325-33.
3. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras
M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B,
Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC,
Knights D, Knight R, Gordon JI: Human gut microbiome viewed across
age and geography. Nature 2012, 486(7402):222-7.Fig. 38 (abstract 104) a Average percentile densities of detected
phyla b Venn and Euler diagrammatic representation of shared and
unique operational taxonomic unites (OTUs) among the control
non-pregnant and pregnant groups of different trimesters.
Fig. 39 (abstract 104) Multivariate principal coordinate analysis of
species enrichment. The total variance is 3.594 which is assigned to
PC1 = 2.8017, PC2 = 0.4242, PC3 = 0.2207 and PC3 = 0.1472. NP
stands for non-pregnant group; 1st-Trim stands for 1st trimester; 2nd-
Trim stands for 2nd trimester and 3rd-Trim stands for 3rd trimester.P105
Exploration of anticancer targets of selected metabolites of
Phoenix dactylifera L. using systems biological approaches
Fazal Khan1,2,3, Gauthaman Kalamegam1, Peter Natesan Pushparaj1, Adel
Abuzenada1,2, Taha Abduallah Kumosani3, Elie Barbour4
1Center of Excellence in Genomic Medicine Research, King Abdulaziz
University, Jeddah, Saudi Arabia; 2Center of Innovation in Personalized
Medicine, King Fahd Medical Research Center, King Abdulaziz University,
Jeddah, Saudi Arabia; 3Biochemistry Department, Faculty of Science;
Production of Bioproducts for Industrial Applications Research Group;
and Experimental Biochemistry Unit, King Fahd Medical Research Center
King, Abdulaziz University, Jeddah, Saudi Arabia; 4Department of
Agriculture, Faculty of Agricultural and Food Sciences, American
University of Beirut (AUB), Beirut, Lebanon; adjuncted to Biochemistry
Department, King Abdulaziz University, Jeddah, Saudi Arabia
Correspondence: Gauthaman Kalamegam (kgauthaman@kau.edu.sa) –
Center of Excellence in Genomic Medicine Research, King Abdulaziz
University, Jeddah, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):P105
Background
Cancer is one of the major cause of death world-wide. Wide spectrum
of anticarcinogenic agents exists including synthetic chemicals, natural
compounds, small molecules and stem cells. Natural compounds have
great appeal as they are both cost-effective and have less or no side ef-
fects. Camptothecin, cisplatin, quercetin and etoposide are some of the
plant derived potential anticancer agents for cancer treatment [1].
Phoenix dactylifera L. (Date fruit) is claimed to have medical benefits
such as hepatoprotective, nephroprotective, antioxidant, anti-
inflammatory and anticancer properties. These beneficial properties
may be due to the presence of flavonoids, carotenoids, phytosterols,
polyphenols, β-D-glucans, procyanidins and anthocyanidins [2]. We at-
tempt to screen some of the important metabolites of date fruit using
in silico analysis to identify potential targets which may develop into
novel therapeutics.
Materials and methods
Based on the literature search eight important compounds that are
present in date fruits namely luteolin, β (1→ 3) D-glucan, apigenin,
carotenoids, lutein, proanthocyanidins, stigmasterol were selected for
exploration of molecular targets utilizing Ingenuity Pathway Analysis
(IPA) (Ingenuity System, Qiagen, USA). Furthermore, we performed core
analysis of the molecules (Fisher’s Exact Test, P < 0.05) regulated by
these compounds by IPA to decipher top canonical pathways, diseases
and biological functions as well as toxicological functions.
Results
IPA analysis revealed targeted proteins and pathways related to cancer
signaling (Fig. 40a). Especially the luteolin, quercetin and β (1→ 3) D-
glucan share common target and pathways controlling antioxidant sys-
tem (SOD, CAT, glutathione and NOS), cell growth and differentiation
(TGFβ, MAPK, ERK, AKT, PI3K & VEGF), apoptosis (bax, bcl2, p53, TNF-alfa,
caspases) and metastasis (MMP1, 2, 9 & 13)(Fig. 40b, c). Carotenoids and
lutein mainly are involved with reactive oxygen species management.
Proanthocyanidins are identified to target developmental, differentiation
(MAPK, Jnk) and autophagy (ATG5, ATG7) related genes.
Conclusions
IPA analysis of important metabolites of date fruit targeted specifically
the cell growth and differentiation pathways including the process of
metastasis and apoptosis. Secondary metabolites of date fruit may thus
have anticancer properties which need further validation using bio-
logical systems. Given the nutritional benefits of date fruits, their daily
intake may additionally provide a prophylactic or synergistic effects
against cancers.
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Background
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease
of the childhood with a high risk of disability in Egyptian children. JIA
has many genetic factors affecting its pathogenesis including CD226
and CD40 genes. These genetic factors vary in different races proved
by previous studies on European and Chinese populations. The as-
sociation between JIA and CD226 and CD40 is yet to be evaluated
in non-European populations including Egypt. So we studied the
association of CD226 rs1883832 (-1C > T) and CD40 rs1883832
(-1C > T) gene polymorphism and disease susceptibility and severity
of in an Egyptian cohort.
Subjects and methods
In this case control study we recruited 79 Egyptian children with JIA
and 93 healthy controls. We studied CD226 rs763361 (C > T) using the
tetra amplification refractory mutation system - polymerase chain reac-
tion assay (ARMS-PCR) for detection of polymorphism while for CD40
rs1883832 (-1C > T) we used restriction fragment length polymorphism
(RFLP).
Results
The statistical results showed that the rs763361 (C > T) SNP in the
CD226 gene is significantly associated with JIA group as regard to
TT genotypes (p = 0.0001). The frequency of the T allele was signifi-
cantly higher in JIA patients in comparison with the control group
(p = 0.0001). Also this allele was significantly higher in patients with
moderate and sever JIA when compared to controls (p = 0.003).
This allele correlated to the disease severity (OR = 2.4). Study of
CD40 rs1883832 (-1C > T) showed that the distribution of the C al-
lele was significantly higher in JIA patients (p = 0.003). Also it was
significantly higher in patients with moderate and sever JIA when
compared to controls (p = 0.01).Conclusions
These results demonstrate a genetic association between the CD226
and CD40 gene polymorphism and JIA with an impact on disease
severity in an Egyptian cohort.
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Background
Autism spectrum disorder (ASD) is a group of multifactorial neurode-
velopmental conditions resulting in mental disability. Estimated
prevalence of ASD in Arab countries varies widely between 1.4 and
29 per 10,000 children. Early diagnosis and intervention, can substan-
tially improve outcome and reduce demands within the health care
system. Several studies reported a significant genetic background,
with a certain risk for heritability, and a 4:1 male to female ratio.
Materials and methods
Examination of study participants shall be conducted according to
the criteria of the Diagnostic_ and Statistical_ Manual of Mental
Disorders, (DSM-IV-TR). Furthermore, defined in-and exclusion cri-
teria shall apply. Whole exome sequencing shall be performed on
the Illumina next sequencing platform at the King Fahad Medical
Research Center, including methodology for sample preparation
and quality control assessment, and production sequencing. Inform-
atics upstream data analysis and interpretation shall be employed at
the The Centre for Applied Genomics, The Hospital for Sick Children,
Toronto, Canada.
Results
This project has started to recruit study participants according to
the criteria outlined above. Literature review identified a number of
case-control studies on biomarkers in ASD patients from Saudi
Arabia which may support interpretation of our anticipated results.
We propose that application of whole exome sequencing shall not
only lead to the identification of possible pathogenic impairments
in known ASD-related genes as listed in the Autism Database,
(AutDB http://autism.mindspec.org/autdb/Welcome. do), but shall
also result in identification of suspected ASD-related genes and
ASD-related biological networks and pathways. Furthermore, we
attempt to unravel novel genes not yet known to be related to ASD
but may have a regional prevalence. This study aims also to contribute
to leverage the involvement of the Canadian project partners in the
international Autism Sequencing Consortium, which aims to decode
approximately 10,000 autistic genomes. Furthermore, a major compo-
nent of this project is to transfer expertise in exome sequencing from
the Canadian to our Jeddah facility.
BMC Genomics 2016, Volume 17 Suppl 6 Page 64 of 78Conclusions
We assume that by detecting the genetic causes in a part of the
study probands and by identifying affected biological networks and
pathways, our study shall strengthen with its cutting-edge approach
already existing ASD research in Saudi Arabia.
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Background
Alzheimer’s disease (AD), is pathologically hallmarked by misfolding
of amyloid-β peptide (Aβ); which favors conversion from a native,
often soluble form, to a nonnative, often insoluble structure and
subsequent aggregation [1, 2]. Myriad of different biophysical and
structural techniques have been employed to elucidate the second-
ary structure, conformational dynamics, aggregation propensity and
morphology of Aβ [3, 4].
Materials and methods
We adopted a reductionist strategy and co-crystallised central core
fragment of Aβ(16-21) with phospholipase A2 (PLA2) and report the
complex structure at 1.2 Å resolution (PDB id: 3JQL) determined by
X-ray crystallography. The X-ray intensity data were collected on
EMBL beamline X-11 at DESY, Hamburg with λ = 0.98 Å, using MAR
CCD detector. The data were processed using the programs DENZO
and SCALEPACK [5]. The crystals belong to space group P41 with
unit cell parameters a = b = 42.0 Å, c = 64.1 Å containing four mole-
cules in the unit cell. Good electron density for the peptide was ob-
served at the active site of PLA2.
Results
All six residues of hexapeptide Lys-Leu-Val-Phe-Phe-Ala can be
traced from their electron densities and positioned well in the
substrate-binding hydrophobic channel of PLA2. Final Rcryst and
Rfree factors for the complete data in the resolution range of 20.0 -
1.1 Å were 0.18 and 0.192 respectively. Significant interactions are
observed involving Nζ of terminal lysine of the peptide with Asp49
Oδ1 and Tyr28 O of the active site and also with active site water
molecule OW172 which in turn interacts with active site residues
(Fig. 41).
Conclusions
Our finding establishes possibility of interaction between Aβ and
PLA2 in vivo and sheds light on structure adopted by central hexa-
peptide. PLA2 inhibits the aggregation of Aβ by interacting with the
peptide and keeping the two peptide chains apart. The selected
peptide includes a pentapeptide sequence necessary for Aβ-Aβ
binding and aggregation and can form fibrils on its own indistin-
guishable from those formed by full-length Aβ and probably forms
the core of the fibril. This may potentially aid in future therapeutic
interventions for AD.
Acknowledgements
Authors acknowledge the support from the Department of Biophysics, AIIMS,
New Delhi, India.References
1. Lansbury PT Jr.: Evolution of amyloid: What normal protein folding
may tell us about fibrillogenesis and disease. Proc Nat Acad Sci USA
1999, 96:3342-3344.
2. Tomaselli S, Esposito V, Vangone P, van Nuland NA, Bonvin AM, Guerrini
R, Tancredi T, Temussi PA, Picone D: The alpha-to-beta conformational
transition of Alzheimer’s Abeta-(1-42) peptide in aqueous media is
reversible: a step by step conformational analysis suggests the
location of beta conformation seeding. Chembiochem 2006, 7(2):257-67.
3. Coles M, Bicknell W, Watson AA, Fairlie DP, Craik DJ: Solution structure
of amyloid beta-peptide (1-40) in a water-micelle environment. Is the
membrane-spanning domain where we think it is? Biochemistry 1998,
37:11064-11077.
4. Das U, Hariprasad G, Ethayathulla AS, Manral P, Das TK, Pasha S, Mann A,
Ganguli M, Verma AK, Bhat R, Chandrayan SK, Ahmed S, Sharma A, Kaur
P, Singh TP, Srinivasan A: Inhibition of Protein Aggregation:
Supramolecular Assemblies of Arginine Hold the Key. PLoS One 2007,
2(11):e1176.
5. Otwinowski Z, Minor W: Processing of X-ray diffraction data collected
in oscillation mode. Methods Enzymol 1997, 276:307-326.P109
Differential expression profiling between meningiomas from
female and male patients
Reem Alotibi1, Alaa Al-Ahmadi1, Fatima Al-Adwani1,2, Deema Hussein3,
Sajjad Karim1,4, Mona Al-Sharif2, Awatif Jamal5, Fahad Al-Ghamdi5,
Jaudah Al-Maghrabi5,6, Saleh S Baeesa7, Mohammed Bangash7, Adeel
Chaudhary1,4, Hans-Juergen Schulten1,4, Mohammed Al-Qahtani1,4
1Center of Excellence in Genomic Medicine Research, King Abdulaziz
University, Jeddah, Saudi Arabia; 2Department of Biology, King Abdulaziz
University, Jeddah, Saudi Arabia; 3King Fahad Medical Research Center,
King Abdulaziz University, Jeddah, Saudi Arabia; 4KACST Technology
Innovation Center in Personalized Medicine, King Abdulaziz University,
Jeddah, Saudi Arabia; 5Department of Pathology, Faculty of Medicine,
King Abdulaziz University Hospital, Jeddah, Saudi Arabia; 6Department of
Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
Saudi Arabia; 7Division of Neurosurgery, Department of Surgery, King
Abdulaziz University Hospital, Jeddah, Saudi Arabia
Correspondence: Hans-Juergen Schulten (hschulten@kau.edu.sa) –
KACST Technology Innovation Center in Personalized Medicine, King
Abdulaziz University, Jeddah, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):P109
Fig. 42 (abstract P110) a, b - 3D neurospheres (3D-NS) with and
without GFs; c- Change in 3D-NS diameter; d, e - Immunohisto-
chemical images showing neuronal redistribution (arrows) in
GFs(-) 3D-NS
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Meningiomas arise from the meningothelial cap cells of the arachnoi-
dal membrane and have a predominance of about 70 % in females.
Hormones are regarded as a predisposition factor as a subset of
meningiomas express hormone-receptors; however, the molecular
mechanism underlying the female predominance are not thoroughly
understood [1].
Materials and methods
RNA isolation and array sample processing for Affymetrix HuGene 1.0
ST array hybridization has been described earlier [2]. Whole transcript
expression profiles were generated from 10 female and four from male
patients. A set of differentially expressed genes (DEGs) was generated
based on established criteria [2]. Bioinformatics software packages were
utilized to interpret data sets.
Results
Microarray expression analysis identified nearly 100 genes that were
differentially expressed between meningiomas from female and male
patients. More than 10 % of the DEGs were transcribed from the Y
chromosome. Among the autosomal located genes that were higher
expressed in meningiomas from females were rhotekin 2 (RTKN2),
and neuritin 1 (NRN1) and that were lower expressed were fibroblast
growth factor 10 (FGF10), mucin 12, cell surface associated (MUC12),
Top upstream regulators include the inositol 1,4,5-triphosphate recep-
tor (ITPR) and (E)-2,3′,4,5′-tetramethoxystilbene. A top associated net-
work function was entitled Post-Translational Modification, Cellular
Development, Cellular Growth and Proliferation.
Conclusions
This microarray expression analysis identified a number genes and
biofunctions which may provide molecular clues for the predomin-
ance of female meningioma patients. Candidate genes include, be-
sides others, the critical RhoA effector RTKN2 and NRN1 that is
known to be associated with astrocytoma progression [3]. Further
studies have to assess the functional involvement of the identified
genes as drivers of meningioma initiation and/or progression in fe-
male patients.
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Background
Neurospheres (NS) serves as a good in vitro model system to study
neurodevelopmental alterations induced by neurotoxicants on funda-
mental processes of brain development [1]. The objective of thisstudy was to investigate the proliferation, migration and differenti-
ation patterns of neural stem cells within 3D neurospheres.
Materials and methods
Normal human neural progenitor (NHNP) cells were derived from
male and female abortuses (16 weeks) following ethical commit-
tee approval and cultured using DMEM:F12 media supplemented
with B27, EGF (20 ng/ml), FGF (20 ng/ml). Free floating 3D-NS
were generated from HNHP cells and cultured in the presence or
absence of growth factors (GFs) for up to 44 days (Fig. 42a, b).
Effects of GFs withdrawal on 3D-NS was ascertained by studying
the changes in (i) neurosphere diameter; (ii) proliferation follow-
ing immunohistochemistry (IHC) staining with proliferation marker
Ki67 using FACS; and (iii) cellular composition and localisation
using IHC markers for nestin (neural stem cells, Tuj1 (neuronal
cells) and GFAP (glial cells).
Results
Upon withdrawal of GFs the diameter of 3D-NS increased for up to
7 days from 0.86 μM to 0.98 μM (Fig. 42c). Thereafter, there was ei-
ther shrinkage or increase by 12 % from its original size. In the pres-
ence of GFs, cell proliferation was mainly observed in the periphery
of the sphere. IHC identified that nestin positive cells were restricted
to the outer region of the 3D-NS, while Tuj1 and GFAP positive cells
were localized in the inner region (Fig. 42d). However, following
withdrawal of GFs, cellular redistribution was evident as demon-
strated by migration of the neuronal (Tuj1 + ve) and glial cells (GFAP
+ Ve) to the outer region (Figure E). Nestin positive cells at the outer
region of 3D-NS decreased and appeared as a thin outer circle
(Fig. 42e).
Conclusions
3D-NS represent self-organized and dynamic structures in which
the migration, proliferation and differentiation of stem cells can
be analysed. 3D-NS model thus serve as an excellent in vitro
biological tool to study the brain developmental stages, cellular
redistribution, the effect of various known neurotxicants and
screening of new pharmacological agents. This will greatly help
to understand scientific inquiries and development of novel
therapeutics.
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Fig. 43 (abstract P112) An Overlapping canonical genes in EOC
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Background
Familial hypercholesterolemia (FH) is an autosomal dominant
disease, predominantly caused by mutation in the low-density
lipoprotein receptor (LDLR) gene. Herein, we describe genetic
analysis of severely affected homozygous FH patients who were
mostly resistant to statin therapy and were managed on an apher-
esis program.
Results
Screening for the LDLR mutations was performed by exon se-
quencing analysis. We identified a recurrent missense mutation
c.1731G > T, p.(W577C) in exon 12 of the Ldlr gene in the pro-
bands and their relatives in an apparently unrelated Saudi fam-
ilies. All the probands were homozygous for the mutation, which
is located in the EGF-precursor homology domain of the LDLR
protein, and show severe FH phenotype. To the best of our know-
ledge this is the first report of a mutation in the Ldlr gene from
the Arab population, including the Saudi population. We also de-
scribe a three dimensional homology model of LDLR structure
and examine the consequence of the recurrent missense
mutation p.(W577C), as this could affect the LDLR structure in a
region involved in dimer formation, and protein stability.
Conclusions
This finding of a recurrent missense mutation causing FH in the
Saudi population could serve to develop a rapid screening pro-
cedure for FH, and the 3D-structure analysis of the mutant LDLR,
may provide a mechanistic model of the LDLR function.
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Background
Epithelial ovarian cancer is the leading gynaecological malignancy
[1] which carries high mortality rate if diagnosed at late stage. As
disease symptoms at early stage are obscure and the presentscreening methods and biomarkers lack sensitivity for early detection
of EOC more cases are unfortunately diagnosed at late stage of disease.
Therefore, it is very much necessary to identify new diagnostic/prog-
nostic biomarkers to favour early detection. Towards this cause, we at-
tempt to identify the top canonical pathways, molecular mechanisms,
disease associations and toxicological functions in EOC using systems
biology.
Materials and methods
Genes and molecules involved in EOC were analyzed using Ingenu-
ity Pathway Analysis (IPA) (Ingenuity System, Qiagen, USA) to get
the global overview of signaling mechanisms in cancer and their
cross associations with other diseases and functions. Core analysis
of the commonly implicated genes were then performed (Fisher’s
Exact Test, P < 0.05).
Results
IPA analysis of molecules involved in EOC identified the top canon-
ical pathways that were also associated with prostate cancer signal-
ling (31.4 %), regulation of the Epithelial-Mesenchymal Transition
(EMT) pathway (19.0 %), molecular mechanisms of cancer (13.1 %)
and pancreatic adenocarcinoma signaling (25.0 %). There was
97.2 % (684/704) overlap of EOC molecules. The top up-stream reg-
ulators identified to be involved in EOC are beta-estradiol; EGF,
TP53, TGFB1 and SP1. Molecules involved in cell survival/death, cell
cycle and cell growth/proliferation were 345, 183 and 353 respect-
ively. Overlapping canonical pathways in EOC as identified by IPA
are depicted in Fig. 43. Of the 51 genes identified for their involve-
ment in molecular mechanisms the most commonly involved genes
and their biomarker applications are listed in Table 21.
Conclusions
Early detection of ovarian cancer is crucial for both treatment
and prognosis. IPA enabled us to identify top canonical genes,
top up-stream regulators and molecular mechanisms as well as
the biomarker applications of most commonly involved genes.
Important candidate biomarkers needs validation using biological
screening of samples to ascertain their expression/inhibition pat-
terns which could then be used to develop diagnostic and prog-
nostic assays/kits.
Acknowledgements
We sincerely thank the Chair “Abdullah Basalamh of the women’s Tumors”,
King Abdulaziz University for supporting this study.
References
1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin
2012, 62:10–29.
Table 21 (abstract P112) Genes and their biomarker applications.
Gene Symbol Biomarker Application(s)
ABL1 Efficacy, Response to therapy
APC Diagnosis, disease progression, efficacy, prognosis, safety
BCL2 Diagnosis, efficacy, prognosis,
CDH1
CDK4 Diagnosis, disease progression, efficacy, prognosis
CHEK1 Diagnosis
JAK2 Efficacy
KRAS Diagnosis, efficacy, prognosis, response to therapy
PIK3CA Efficacy, prognosis, response to therapy
TP53 Diagnosis, disease progression, efficacy, prognosis, response to therapy
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Background
Crohn’s disease (CD) is a chronic inflammatory disease affecting the
digestive tract with extraintestinal manifestations and associated
immune disorders. CD is generally classified into three entities de-
pending on disease location: ileum, colon and ileocolon with or
without complications (stricture, penetrating and perianally pene-
trating) [1]. The causes of inflammation are multiple implying a
genetic susceptibility, a dysbiosis, autoimmune and environmental
factors. To date there have been a genome-wide meta-analysis per-
formed in CD patients leading to 71 susceptibility loci [2]. Our aim
is to investigate the Crohn’s disease phenotype in North Tunisian
population and to establish a correlation with genotypes for CD-
associated polymorphisms (IL23R, JAK2 and SMAD3).
Results
The study included 91 patients with Crohn’s disease composed of
47 males and 44 females. Mean age is 41 years (41.12 ± 14.71). The
diagnosis of CD was determined by standard clinical, radiological,
endoscopic and histological criteria. CD is located in the terminal
ileum in 35 %, colon in 19 % and ileocolon in 46 %. More than half
of patients (52 %) had a non-structuring non-penetrating pheno-
type, 19 % a structuring, 16 % a penetrating and 13 % perianally
penetrating phenotype.
Conclusions
We are in the process of acquiring additional biological samples
(blood, serum and biopsy) of the control group and of the patients
with Crohn’s disease and ulcerative colitis to investigate candidate
genes polymorphisms and cytokine expression profiles. By our on-
going study we will be better able to treat CD by targeting specific
cellular pathways at a molecular level.
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Background
Understanding the molecular mechanisms of action of drug candidates
is pivotal in drug discovery and development [1, 2]. More importantly,
knowing the toxicological functions can help in evaluating the risk of
genotoxicity and carcinogenesis [1-3]. Besides, it can help in the ra-
tional screening for novel candidate compounds targeting canonical
pathways and novel gene networks. In the present study, we investi-
gate, 20 different drug candidates and environmental agents, for both
efficacy and toxicity using cutting-edge in silico approaches.
Materials and methods
In order to study the mechanisms of action of 20 different com-
pounds important in both experimental therapeutics and molecu-
lar toxicology, we have used Ingenuity Pathway Analysis (IPA)
knowledgebase (Ingenuity Systems, Qiagen, USA) to obtain their
molecular targets in mammalian cells and tissues. The list of target
molecules for each compound was further clarified using Fisher’s
Exact Test and Benjamini Hochberg Multiple Testing Correction (P
< 0.05) and subjected to core analysis using IPA to decipher top
canonical pathways, novel molecular networks, biological and toxi-
cological functions regulated by these agents. Furthermore, we
have used the multiple comparison module in IPA to compare all
the core analyses results to generate hierarchical clusters (2-fold
cut-off) for top canonical pathways, diseases and biological and
toxicological functions.
Results
We have identified unique toxicological effects, such as hepatotox-
icity, cardiotoxicity and nephrotoxicity, for Arsenite, Etoposide, Ara-C,
Camptothecin, and Cisplatin (Fig. 44a). Furthermore, these com-
pounds potently regulate cell death and apoptosis of tumor cell lines
(Fig. 44b). However, most of the compounds significantly regulate
the Molecular Mechanisms of Cancer, P53 Signaling, Apoptosis Sig-
naling, Aryl Hydrocarbon Receptor Signaling in mammalian systems
(Fig. 44c).
Conclusions
Our in silico study has deciphered an array of canonical pathways
and novel gene networks regulated by anti-cancer drugs and envir-
onmental agents. Establishing the in silico- based characterization of
known as well as novel compounds may provide novel cues for fur-
ther investigations using in vitro and in vivo systems and helps in the
effective design and development of drugs for the management of
cancer and other debilitating diseases.
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Background
Breast cancer (BC) is the second most common cancer worldwide.
Incidence rates in BC are increasing steadily in Arab countries with
different age structure from US and Europe. Epidemiological studies
showed 50 % of BC patients in Arab countries are below the age of
50 years compared to only 25 % in US. Young age BC patients ex-
hibit high mortality rate with early disease relapse. There is an urge
need to specify a new prognostic factor in BC young patients that
can help in the selection of appropriate therapy and the assessment
of patients’ risk. In this study as a starting point, we used Compara-
tive Genomic hybridization (CGH) arrays to evaluate copy number
changes in twenty breast cancer patient samples. Many cytogenetic
alterations were detected in our study correlated with published
studies. The most frequent aberration was amplification of chromo-
some1q, which was confirmed by FISH technique. Second, we used
3D digital PCR to validate amplification of 1q using two different
probes in 75 BC patient samples. Finally, we assessed the correlation
between the chromosomal amplification of 1q and the clinical fea-
ture of the disease.Results
8 of twenty BC patients examined with CGH arrays had amplified 1q,
and confirmed with FISH technique. In concordance with CGH arrays
results, 32 % of seventy-five BC patients examined with 3D digital
PCR showed 1q amplification. BC patient’s samples with 1q amplifica-
tion had correlation with large tumor size (p=. 013). Also, Univariate
Kaplan–Meier survival test revealed that there is a significant associ-
ation of 1q amplification and less disease free survival duration in
young BC patients (p = .028).
Conclusions
This study presents 1q amplification as the most frequent aberration
in BC patient’s samples. In addition, the study features 1q amplifica-
tion association with young BC patients (<50) with poor prognosis as
indicated by less disease free survival time and large tumor size. In
conclusion, 1q amplification could serve a prognosis marker for
young BC patients’ sample.
P116
Disorders of sex chromosomes in a diagnostic genomic medicine
unit in Saudi Arabia: Prevalence, diagnosis and future guidelines
Basmah Al-Madoudi1, Bayan Al-Aslani1, Khulud Al-Harbi1, Rwan
Al-Jahdali1, Hanadi Qudaih1, Emad Al Hamzy1, Mourad Assidi1,2,
Mohammed Al Qahtani1
1Diagnostic Genomic Medicine Unit, Center of Excellence in Genomic
Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia;
2Center of Innovation in Personalized Medicine, King Abdulaziz
University, Jeddah, Saudi Arabia
Correspondence: Mourad Assidi (mourad.assidi@gmail.com) – Center
of Innovation in Personalized Medicine, King Abdulaziz University,
Jeddah, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):P116
Background
Disorders of Sex Chromosomes (DSCs) includes all cases of X and/or
Y structural abnormalities or mosaicism which are associated with
ambiguity in sex determination [1]. They include mainly the sex
chromosome aneuploidies (SCAs) which are common disorders af-
fecting 1 out of 400 newborns [2]. This high incidence among popu-
lation is associated to a low abortion rate (compared to autosomal
aneuploidies) [3] and encompass a range of chromosomal abnormal-
ities mainly Klinefelter’s syndrome, Turner’s syndrome, XYY or Jacob’s
syndrome and Triple X or Superwoman syndrome with an incidence
range at birth from 1/500 to 1/2000 [2, 3]. These DSCs have direct
impact on biological sex determination, embryonic development and
require some medical, social and educational care [4]. In Saudi Ara-
bia, a systematic screening for DSCs is not implemented yet and only
referred cases receive this diagnostic service. The objective is to as-
sess the prevalence of most common DSCs in a Genomic Diagnostic
Unit in KSA, determine the characteristics of the target population,
and provide recommendations toward more comprehensive and
multidisciplinary care for patients with DSCs. This study was per-
formed using blood samples from 2256 consent patients referred to
DGMU at CEGMR for subsequent cytogenetic or molecular analyses.
Results
Cytogenetic data analysis revealed an incidence of chromosomal ab-
normalities of 18.35 % among all cases referred to DGMU. Only 10.62 %
of these affected subjects have DSCs. Half of these sex chromosome
abnormalities were numerical, while the structural disorders and mosai-
cism were 18.18 % and 31.8 %, respectively. Turner’s and Klinefelter’s
syndromes are the most common DSCs in our patient cohort (Fig. 45).
Surprisingly, only 25 % of the DSCs were infants (Table 22) indicating a
serious delay of diagnosis.
Conclusions
We reported a high incidence of DSCs (10 %) in Saudi population with
a late first diagnosis for these serious abnormalities mainly at adoles-
cence and adulthood suggesting a lack of awareness in the Kingdom
that need to be prioritized. This delay might have serious personal,
educational, societal and psychological impacts on affected subjects.
Therefore, implementation of a routine clinical service for newborn
aneuploidy screening and a prevention program included in the pre-
marital testing is highly recommended.
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Medicine 2015, 36(12):9677-9683.Table 22 (abstract P116) Distribution of DSCs patient according to
their age
Age category Proportion (%)
Adult (≥15years) 47.73
Children (2-14 years) 27.27
Infant (less than 2 years) 25.00
Fig. 45 (abstract P116) Proportion of the main DSCs in our SCAs
cohort (%)
Fig. 46 (abstract P117) a Cytotoxicity of WYE354 (WYE) and
Sunitinib (SUT) in K562 and the combination of these inhibitors at
48hrs. b Combination index plot showing CI values at different doses
of WYE and SUT when combined. c Annexin V staining showing total
% apoptotic cells using three different doses of WYE and SUT. Results
represent mean of three independent experiments and unpaired t test
is performed to determine the statistical significance between treated
groups vs controlP117
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Background
Acute Myeloid Leukemia (AML) is a clonal heterogeneous disease of
myeloid progenitors which results in the accumulation of immature
blast cells in the peripheral blood and bone marrow. Although there
has been significant improvements in the survival of AML cases over
the past few decades, a majority of the older AML cases and those with
relapsed or secondary AML, continue to show poor outcome. The main
causes attributed to failure of conventional chemotherapy in AML are
treatment related mortalities and drug resistance [1]. Recent clinicaltrials in targeted therapy of AML has shown development of resistance
against single agents. Combining single agents with existing therapies
or novel combinations of new agents has therefore become imperative.
In this study we evaluated the effect of co-inhibition of mTOR and re-
ceptor tyrosine kinases (RTK) in AML cell lines.
Materials and methods
Cell viability was assessed using Cell-Titre Blue kit (Promega) as per
manufacturer’s protocol, after 48 hours of incubation with drug/s. Com-
bination index (CI) values were calculated for synergism by CompuSyn
software based on dose response curve analysis [2]. To determine the
total apoptotic cells, cells were stained with Annexin V (BD bioscience)
and analyzed on flow cytometer (BD FACS Aria III).
Results
Inhibitor of mTOR WYE-354, and pan RTK inhibitor sunitinib synergis-
tically inhibit acute myeloid leukemia cell lines K562 and HL60. CI
values for K452 are; 0.792 (ED50), 0.661 (ED75) and 0.557 (ED90). Ac-
cording to median effect principle CI < 1 represents synergism, CI = 1
represent additive, whereas CI > 1 represent antagonsim. Combin-
ation of these inhibitors significantly induce apoptosis (p = 0.0009 for
ED75 and <0.0001 for ED90) in comparison with individual inhibitor
in leukemic cell lines.
Conclusions
In this study we report that combination of RTK inhibitors with mTOR
inhibitors show synergistic inhibition of AML cell lines and therefore
offers a promising approach to deal with AML.
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Fig. 47 (abstarct P118) Genetic variance between E-rank - improved
and unimproved SNVs groups. (Wilcoxon test P < 10-16; error bars =
standard error of mean)
Table 23 (abstract P118) Functionally important SNVs with improved







SNV class – Gene name
rs3894194 28.79 22.79 14 Missense - GSDMA
rs20541 40.08 34.15 13 Missense - IL13
rs11557467 28.64 20 11 Missense - ZPBP2
rs1877031 50.5 35.5 8 Missense - STARD3
rs10192157 27 21 6 Missense - IL1RL1
GSDMA gasdermin A, IL13 interleukin 13, ZPBP2 zona pellucida binding protein
2, STARD3 StAR-related lipid transfer domain containing 3, IL1RL1 interleukin1
receptor-like1
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Background
Genome wide association studies (GWAS) have become standanrd
tool to identify disease-associated loci. GWAS use frequencies of
single nucleotide variants (SNVs), to prioritize variants with the
highest P-values that discriminate between cases and controls.
However, not all SNVs occur at functionally equivalent positions,
and it is important to consider the strength of functional import-
ance of positions when prioritizing variants. We conducted a re-
analysis of GWAS data by using the E-rank approach [1] that
integrates evolutionary dimension into P-value in order to exam-
ine if additional bona-fide variant can be discovered.
Materials and methods
We used data from an asthma GWAS of ~550,000 SNVs (PMID:
20860503) [2]. For these variants, E-ranks and P-ranks were ob-
tained from myPEG server. For the top 5000 E-rank variants, we
obtained their replication which was reported to be significant in
45 sthma-related studies. This was done by querying the Genome-
Wide Repository of Associations between SNPs and Phenotypes
(GRASP v2.0) [3]. Written codes in “R” were used to compare E-rank
and P-rank with replication and to estimate the genetic variance (GV)
explained for each SNV according to this formula: GVi = 2 × log(ORi)2 x
MAFi (1-MAFi) [4].
Results
Of the top 5000 E-rank variants, 2926 were shared with the top
5000 P-rank variants. These shared variants were replicated in
many studies, on average. Of the remaining, the average replica-
tion was 1.13 for E-ranks and 1.02 for P-ranks. We estimated the
total heritability explained by increasing number of SNVs under
an additive model and found that E-rank SNVs explain greater
heritability than P-rank alleles (Wilcoxon test P < 10-16 ) (Fig. 47).
Also, comparing E-rank and P-rank for the top replicated SNVs in
multiple Asthma GWAS resulted in finding functionally missense
SNVs that have improved average values of E-rank than P-rank
(Table 23).
Conclusions
Our results show the usefulness of evolutionary ranking method
of SNPs as an aid to P-values in assessing and identifying the
most replicated SNPs that are functionally important. Since E-
ranking approach requires the use of original full GWAS data and
the MAF values, further efforts are needed to make them publi-
cally available.
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Frequency and/or type of mutations in genes encoding isocitrate de-
hydrogenase 1 (IDH1), isocitrate dehydrogenase 2 (IDH2), and epidermal
growth factor receptor (EGFR) vary between histological types of primary
brain tumors. BRAF mutations in brain tumors have also been assessed
in recent years [1]. We investigated the frequency of mutations in
these genes in a series of primary brain tumors from the western
Saudi Arabian region.
Materials and methods
The series of primary brain tumors consisted in the majority of as-
trocytomas, oligodendrogliomas, glioblastoma multiformes (GBMs),
and a variety of minor histological types. Genomic DNA extraction,
PCR conditions and cycle sequence reactions basically followed our
standard protocols [2]. Gene specific PCR primers were used to flank
mutational hotspots regions in IDH1 exon 4, IDH2 exon 4, EGFR exons 3
and 7, and BRAF exon 15.
Results
Sequence analysis identified IDH1 R132H mutations in six of 40
(20 %) assessed brain tumors, namely in two oligodendrogliomas
grade II, one oligodendroglioma grade III, two astrocytomas grade II,
and one GBM. One IDH2 R172 mutation (R172K) was identified in an
oligodendroglioma grade II. No BRAF exon 15 and EGFR exons 3 and 7
mutations were identified in 54 and 31 assessed primary brain tumors,
respectively.
Conclusions
In our series, IDH1 mutations were identified in a considerable number
of the major glioma types which is consistent with other mutational
studies. Mutations in other assessed genes were rare or absent which
may be attributed to the fact that IDH2 and BRAF mutations are less
common or more common in not assessed histological types, and only
a minority of known EGFR aberrations were analyzed. Taken together,
identifying critical gene mutations in brain tumors is gaining clinical
relevance as, for example IDH1 and IDH2 mutations bear predictive and
prognostic preposition.
Acknowledgements
This study was supported by King Abdulaziz City for Science and Technology
(KACST) grant AT-32-98.
References
1. Berghoff AS, Preusser M: BRAF alterations in brain tumours:
molecular pathology and therapeutic opportunities. Current opinion
in neurology 2014.
2. Schulten HJ, Al-Maghrabi J, Al-Ghamdi K, Salama S, Al-Muhayawi S,
Chaudhary A, Hamour O, Abuzenadah A, Gari M, Al-Qahtani M:
Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and
CTNNB1 in medullary thyroid carcinoma. Anticancer Res 2011,
31[1]:4179-4183.P120
Expression profiles distinguish oligodendrogliomas from
glioblastoma multiformes with or without oligodendroglioma
component
Alaa Alamandi1, Reem Alotibi1, Deema Hussein2, Sajjad Karim1,3, Jaudah
Al-Maghrabi4,5, Fahad Al-Ghamdi4, Awatif Jamal4, Saleh S Baeesa6,
Mohammed Bangash6, Adeel Chaudhary1,3, Hans-Juergen Schulten1,3,
Mohammed Al-Qahtani1,3
1Center of Excellence in Genomic Medicine Research, King Abdulaziz
University, Jeddah, Saudi Arabia; 2King Fahad Medical Research Center,
King Abdulaziz University, Jeddah, Saudi Arabia; 3KACST Technology
Innovation Center in Personalized Medicine, King Abdulaziz University,
Jeddah, Saudi Arabia; 4Department of Pathology, Faculty of Medicine,
King Abdulaziz University Hospital, Jeddah, Saudi Arabia; 5Department of
Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
Saudi Arabia; 6Division of Neurosurgery, Department of Surgery, King
Abdulaziz University Hospital, Jeddah, Saudi Arabia
Correspondence: Hans-Juergen Schulten (hschulten@kau.edu.sa) –
Center of Excellence in Genomic Medicine Research, King Abdulaziz
University, Jeddah, Saudi Arabia
BMC Genomics 2016, 17(Suppl 6):P120Background
Oligodendrogliomas (ODGs) and glioblastoma multiformes (GBMs) are
common gliomas that in case of GBMs are afflicted with unfavorable
prognosis. Microarray expression profiling in gliomas may become an
adjunct clinical assessement tool for these heterogenous tumors.
Materials and methods
Whole transcript HuGene 1.0 ST arrays (Affymetrix Incorp) were
employed [1], to generate expression profiles from five ODGs and four
GBM. Three of the GBMs had an ODG component whereas one had no
ODG component. A set of differentially expressed genes (DEGs) was
generated based on a false discovery rate (FDR) p-value≤ 0.05 and a
fold change > 2. Software packages (Partek Genomics Suite version 6.6,
Partek Inc., MO; Ingenuity Pathway Analysis, Ingenuity Systems, Red-
wood City, CA) were utilized to interpret data sets.
Results
Principal component analysis indicated that GBMs were more
heterogenous in their expression profiles than ODGs. In particular, the
number of DEGs between the GBM without ODG component and the
five ODGs exceed 1000 genes whereas the respective numbers for each
of the GBM with ODB component exceeded not 100 genes. Compar-
able upregulated genes in GBMs included matrix metallopeptidase 13
(collagenase 3)s (MMP13), and neurotensin (NTS). Comparable downreg-
ulated genes included reticulon 3 pseudogene 1 (RTN3P1) and G
protein-coupled receptor 37 like 1 (GPR37L1). TGFB1 was noticed as a
top upstream regulator.
Conclusions
As ODGs follow a favorable clinical course, differential expression profil-
ing between ODG and GBM may add on sub-classifying GBM, accord-
ing to their ODG component, into different assessment groups. The
identified DEGs contain biomarkers as MMP13 that is known to be
expressed in cancer stem-like cells of glioblastoma where it correlates
with cell invasiveness [2]. In summary, this study suggests that micro-
array expression analysis is capable to distinguish individual cases of
GBM based on the ODG component which may gain relevance for clin-
ical assessment of gliomas.
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Common benign lesions of the thyroid are goiters and hyper-
plastic lesions that; however, may bear a certain risk for neoplas-
tic transformation. Hyperplastic lesions are also regarded as a
subcategory of goiter. In a previous study we investigated the
expression profiles in these diseases and found that they share
similar expression profiles [1]. In the current study we regarded
goiters and hyperplastic lesions as one entity aiming to identify
subgroups that cluster separately based on differentially expressed
profiles.
Material and methods
The study group comprised goiters and hyperplastic lesions from
more than 30 patients and a number of PTC and normal/unaffected
thyroid samples as reference. Sample processing and hybridization
to HuGene 1.0 ST arrays was performed as reported earlier [2]. Bio-
informatics software packages were employed to interpret data
sets.
Results
Based on distance metrics, hierarchical cluster analysis stratified
goiters and hyperplastic lesions into a number of subgroups. Two
clearly separated subgroups (A and B) were selected to investi-
gate their expression profiles in more detail. Among the most sig-
nificantly upregulated genes in group A compared to group B
were RNA, 5S ribosomal pseudogene 456 (RNA5SP456).and among
the most downregulated genes were bromodomain and WD re-
peat domain containing 3 (BRWD3) and polypyrimidine tract bind-
ing protein 2 (PTBP2). Furthermore, the regulatory factor for X-box
(RFX5) was significantly associated with the data set.
Conclusions
Inclusion of both malignant PTCs and normal/unaffected thyroid
samples in hierarchical cluster analysis supported to identify dif-
ferential expressed subgroups in goiters and hyperplastic lesions.
BRWD3 is a known serological biomarker in breast cancer patients
[3]. PTBP2 is a critical splicing factors in regulation of alternative
splicing of pre-mRNA and is implicated in proliferation and migra-
tion of cancer cells [4]. Further studies are necessary to assess in
how far the identified gene sets bear the capacity for neoplastic
transformation.
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Background
Chronic lymphocytic thyroiditis, also referred to as Hashimoto’s thyroid-
itis, is found in the background of about 30 % of papillary thyroid carcin-
omas (PTCs) [1]. The predisposition effect of this autoimmune condition
is not thoroughly investigated on the transcriptional expression level.
Materials and methods
We analyzed retrospectively microarray expression profiles of 26
thyroid lesions including thyroiditis cases, and PTCs with or without
coexisting thyroiditis. Normal/unaffected thyroid samples served as
control. The processed samples were hybridized to HuGene 1.0 ST
microarrays (Affymetrix, Inc., Santa Clara, CA). Sets of differentially
expressed genes were generated on basis of a p-value ≤ 0.05 and a
fold change > 2.
Results
More than 150 genes were differentially expressed between PTCs
with coexisting thyroiditis and PTCs without coexisting thyroiditis
and nearly 90 of these genes were also differentially expressed
between thyroiditis cases and PTCs without coexisting thyroiditis.
Comparably upregulated genes between the two PTC groups in-
cluded nearly 50 immunoglobulin genes and comparably downreg-
ulated genes were, for example gamma-glutamylcyclotransferase
(GGCT), and zinc finger, CCHC domain containing 16 (ZCCHC16).
One of the genes that was not differentially expressed between
thyroiditis and PTCs with coexisting thyroiditis was the bone mar-
row stromal cell antigen 2 (BST2).
Conclusions
This study detected a number of differentially expressed genes that are
related to thyroiditis or to PTC with coexisting thyroiditis. For example,
BST2 was originally cloned from a rheumatoid-arthritis-derived synovial
cell line and is known as a viral immune sensing molecule. BST2 overex-
pression in oral cavity cancer is known to be associated with nodal me-
tastasis and poorer prognosis [2]. Furthermore, a fusion containing the
extracellular domain of BST2 exhibited anti-inflammatory and anti-
remodelling effects in an experimental asthma model [3]. In conclusion,
among the candidate genes for further investigation is for example
BST2 in order to elucidate its functions in cancer and autoimmune
diseases.
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Background
The widespread use and misuses of antibiotics in both clinical and
non clinical environments play vital role in mobilization, appear-
ance and concentration of highly efficient resistance system in bac-
teria. For better understanding, surveillance studies of antimicrobial
resistance is necessary to detect emerging resistances and to sup-
port management of infections in hospitals and other community
sewage water pants.
Materials and methods
Samples of pre and post treated water were collected from King
Abdulaziz Hospital and community waste water treatment plant
Jeddah. DNA was extracted by PowerMax® Soil and PowerWater®
DNA Isolation kit. The extracted DNA was purified by Gel Electro-
phoreses and then the samples were sequenced by using V3-V4
hyper-variable region of 16S rRNA gene (MiSeq Illumina, USA).
Results
From 16S rRNA gene sequence we obtain 1.5 million reads from 4
samples, and each sample was process in triplicate utilizing the
amplicon sequencing (MiSeq Illumina). After sequence, processing
and filtration, 1.48 million of high quality sequence reads (>200 bp)
were obtained and assigned to bacteria domain with an average
number of 123986.9 ± 49707.3 sequence reads per replicate per
sample. Total 32 different phyla were identified. Phylum Proteobac-
teria was most dominant in both community (76 ± 0.55 %) and hos-
pital waste (51.7 % ± 2.6). Density of Proteobacteria was significantly
decreased to 23.5 % ± 1.3 and 40.8 % ± 2.3 after filtration in both
samples. Bacteroidetes concentration was significantly increased
from 21.9 ± 0.4 % to 70.8 ± 1.6 % and from 13.5 ± 1.4 % to 17.4 ±
3.6 % with filtration in community and in the hospital sewage respect-
ively. Similarly, concentration of Firmicutes and Phylum Actinobacteria
concentration was significantly increased with filtration in both sam-
ples. We analyzed that species specific richness, and 1651 OTUs were
found at species taxonomic level classification in sequence reads. Few
pathogenic i.e Shigella sonnei, Vibrio cholera, Legionella pneumophila,
Coxiella burnetii, Chlamydia pneumonia and Staphylococcus aureus were
present in low concentration.
Conclusions
The taxonomical diversity of bacterial species in waste water plants
illustrates their resistance mechanism.P124
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Background
Helicobacter pylori, a common bacterial pathogen of humans, infects
gastric mucosa and is implicated in the etiology of several chronic
diseases. Increasing evidence point H. pylori as class I carcinogen
where chemical signals are secreted in the digestive tube. This mo-
lecular crosstalk generally promotes colonization by bacteria. This
pathogen infects 3 billions people worldwide and can lead to severe
diseases, including gastric ulcers and ultimately cancers. The secreted
chemotaxic peptides help bacterial infection and function of atypical
protein signal transduction system of H. pylori. The H. pylori species
exhibit unusual high levels of genetic variation between strains. Inter-
estingly, the genome of North African isolates of H. pylori has not yet
been sequenced. North African isolates of H. pylori seems genetically
BMC Genomics 2016, Volume 17 Suppl 6 Page 74 of 78different from the Asian isolates based on the susceptibility to affect
the population with gastric cancer. Previous studies encountered dif-
ficulties to show the impact of H. pylori on gastric tumorigenesis and
gastric microbiome due to low bacterial load in the stomach and
sample availability.
Material and methods
To address the limitation highlighted above, we established a proced-
ure to isolate metagenomic DNA from faecal samples and conducted
PCR with H. pylori 16S rRNA specific primers followed by sequencing.
Gastric mucosal biopsies were acquired from Tunisian patients in order
to conduct anatomopathological examinations. All tissues used in this
study were collected in order to examine the natural history of H. pylori
infection in patients with and without gastric cancer.
Results
Ongoing results show individuals with gastric cancers are more prevalent
among women under the age of 50. Gastric H. pylori infection is highly
associated with diffuse pathological variant and adenocarcinoma are
most often found in the gastric antrum of the stomach. Individuals with
adenocarcinoma are classified poorly differentiated according to hist-
ology and location.
Conclusions
Our ongoing studies will unravel the extent of diversity of H. pylori pop-
ulations possibly explaining why infection appears to be distinct across
different samples. The application of cutting edge molecular technolo-
gies, mainly through whole genome sequencing, omic approaches and
metabarcoding to the study of human associated pathogenic bacteria
will make advances in our understanding of this field.
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Background
Cancer syndrome is considered a genetic disorder in which inherited
DNA polymorphisms in one or more genes make the individual suscep-
tible to cancer development. It has been estimated that familial cancer
syndromes comprises 5 to 10 percent of all types of cancer. In addition
to the high risk of developing cancer, cancer syndromes often lead to
the development of various independent primary tumours. These syn-
dromes are usually caused by mutations in tumour suppressor genes,
oncogenes and DNA repair genes. The very common examples of can-
cer syndromes are the hereditary breast-ovarian cancer syndrome and
hereditary non-polyposis colon cancer (Lynch syndrome).
Materials and methods
The advent of Next Generation Sequencing has resulted in an era of
high throughput DNA sequencing, which has a major influence in
both clinical care and cancer research. In particular, targeted rese-
quencing is an efficient approach for mutation detection at a low
cost and high turnover. Taking the importance of NGS in diagnosing
inherited mutations of multiple genes, we have designed the Oncos-
can panel which will allow the simultaneous screening of 74 cancer
genes using the Ampliseq™ technology.
Results
The oncoscan panel is covering 95.22 % of 74 targeted genes with
1626 amplicon, size ranging between 125 to 175 bp and generating
192.96 kb of DNA sequence. Our results show that the panel is useful
in identifying heritable susceptibility to several forms of cancerincluding breast and colon cancer. Additionally, we have identified
novel mutations in familial breast cancer cases affecting DNA repair
pathways other than BRCA1 and BRCA2.
Conclusions
Importantly, we suggest that the panel is also useful in identifying
Lynch syndrome cases in which female patients manifest breast can-
cer as well as colon cancer and other tumours.
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Background
X-linked intellectual disability (XLID) is a heterogeneous disorder for
which many of the causative genes are still unknown [1]. So far, more
than one hundred genes of the X chromosome have been associated
with intellectual disability (ID). O-linked N-acetyl-Glucosamine-Transfer-
ase (OGT) gene is well known to be involved in endocrine alterations by
the resistance of insulin in muscles and adipocytes and therefore the ini-
tiation of diabetes. It is reported to be involved also in cancer, brain de-
velopment, and neurodegenerative diseases [2]. We performed X-exome
sequencing in three brothers with non-syndromic XLID and develop-
mental delay. Sanger sequencing was accomplished to confirm novel
mutations. X-chromosome inactivation was executed in the mother.
Affected boys had a severe ID and mild dysmorphic features. The het-
erozygous mother had mild cognitive impairment. Her X-chromosome
inactivation pattern was not skewed. We identified a novel missense mu-
tation (c. 1193G >A) in the OGT gene. This mutation was inherited by
the affected males, and segregated with the abnormal phenotype.
Rusults
A single missense mutation (c.1193G > A) was identified by X-exome
sequencing of two patients, according to our filters this mutation is
considered to be pathogenic. This mutation is absent from public data-
bases of control individuals. Sanger sequencing was performed to con-
firm this novel mutation in all three affected boys as well as in the
mother, also the unaffected brother X-exome sequencing revealed no
mutation. This substitution is predicted to be deleterious by SIFT soft-
ware (score: 0) and polyphen score was one which considered to be
damaging. In addition by Mutation Taster, a disease-causing variant
was predicted, scoring a p-value of one.
Conclusions
Effect of OGT alteration of brain development has been confirmed,
nevertheless so far this gene has not been attested to be related to ID.
The mutation within OGT segregating in all affected males, the pheno-
type of our patients could be linked to the new missense mutation of
the OGT gene nevertheless, our single case cannot be generalized and
despite evidence of OGT gene effect on neuronal physiology and brain
development, more studies with additional cases are warranted to shed
light on the cognitive role of the OGT gene.
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Background
Lately, there is an increase in the number of the patients with nu-
clear genetic defects of the mitochondrial ATP synthase. The TMEM70
gene mutation is one of the most common nuclear encoded genes
that affect the ATP synthase. Here, we report a 9-month-old Saudi
girl presenting with lactic acidosis, 3-Methylglutaconic aciduria, cata-
ract, hypertrophic cardiomyopathy and encephalopathy. The patient
was genetically tested for Methylglutaconic Aciduria Nuclear Gene
panel/sequencing and deletion/duplication analysis.
Results
She was positive for homozygous deletion of c.578_579 delCA in
exon 3 of the TMEM70 gene.
Conclusions
This is consistent with a diagnosis of ATP synthase deficiency. This
case report hopefully helps in the diagnosis of future cases, provid-
ing important information regarding diagnosis and prognosis and as
well as optimal managements for such cases.
Consent to publish
Written informed consent for publication of their clinical details and/
or clinical images was obtained from the patient/parent/guardian/
relative of the patient. A copy of the consent form is available for re-
view by the Editor of this journal.
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Background
Milk is a specific diet of mammalian neonates. Besides its nutri-
tional value, milk is rich in antimicrobial proteins, immunoglobulins,
growth factors and plays a key role in enhancing immune system
of infants. Milk-derived proteins and peptides play a significant role
in the prevention and treatment of various human metabolic disor-
ders and have significant therapeutic importance. These include
lactoperoxidase, lactoferrin, peptidoglycan recognition protein etc.
Lactoperoxidase, one of the essential constituents of milk plays a
significant role during the early stages of neonatal life. In addition
to improving the immune system of infants, lactoperoxidase also
has antimicrobial activity. Lactoperoxidase has huge industrial ap-
plications and is commonly known as lactoperoxidase system. The
system is well-established and commonly adopted in industries for
preventing microbial growth. Similarly, lactoferrin and peptidogly-
can recognition proteins also exhibit antimicrobial activity and are
of immense medical importance. The aim of the current study is to
purify antimicrobial protein from camel milk.
Materials and methods
Milk was purchased from the local camel farms in Jeddah. Milk was
processed to separate the fats by centrifugation (skimming) at 1500 g
for 10 min. The fat free milk was subjected to a linear gradient of
0.0 M-0.5 M NaCl in 50 mM Tris-HCl at pH 7.8.Results
The acidic and basic proteins from camel milk were separated. We
are currently making attempts to purify different fractions of proteins
from camel milk.
Conclusions
Camel is the most important agricultural animal in the Saudi
Kingdom. Camel milk derived constituents are of tremendous poten-
tial industrial applications. These proteins could be explored for med-
ical applications like drug designing.
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Background
Colorectal cancer is one of the most prevalent cancers in the world
population and its incidents are increasing every year. Numerous cut-
ting edge approaches are being applied to find the basis underlying
this lethal disorder [1]. Integrative analysis of multiple –omics is
promising to provide new biomarkers and targets for cancer.
Materials and methods
We carried out integrated analysis of cytogenetic and exon array
data using colorectal cancer patient samples.
Results
Patient wise tumor-normal comparison at cytogenetic level yielded a
high priority list of 144 driver genes. Of these, 11 genes were found to
be novel in their association with colorectal cancer. We analyzed these
genes at exon level and found ATP8B1 to be significantly altered in ex-
pression. At cytogenetic level, ATP8B1 had a GISTIC score of 2.326 and
was found in the region of heavy loss. ATP8B1 showed significant fold
changes at the gene and exon level. It was downregulated by more
than two fold at gene level (with a p value <0.01). ATP8B1 had no prior
knowledge of association with colorectal cancer as inferred from In-
genuity Pathway analysis. Further characterization of ATP8B1 and asso-
ciated genes is underway to get better insights into its functional
aspect and eventual use as a biomarker for colorectal cancer.
Conclusions
In conclusion we have first time reported association of ATP8B1 gene
associated with colorectal cancer using integrative analysis of mul-
tiple –omics technique.
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Background
Hepatitis C virus the main reason of chronic liver ailment and liver
cancer globally and is distributed into six discrete genotypes
through the world with numerous subtypes in each genotype (1-6).
The response and extent of interferon treatment is genotype spe-
cific and host restriction. Number of cellular genes are involved in
this process including TBXA2R (G-protein coupled receptor), TRAF2
(adapter protein), LTbeta which is a membrane protein, NFkappaB2
and RelA (transcriptional factors), SNARK and MKK7 (protein kinases)
and two diligently associated TNF/lymphotoxin pathway. A reported
polymorphisms (SNPs) in these and other genetic factor are in-
volved in viral clearance and chornicity. Genetic studies have also
identified several SNPs round the interferon λ3 interleukin-28B,
which are sturdily related with SVR to PEG-IFN and RBV cure for
chronicity. In this study we examined SNP in IL10 and IL28B in HCV-
GT3 infected individuals.
Materials and methods
A total of 349 patients of chronic hepatitis have been included
in this genetic susceptibility study. The infected individuals were
diagnosed anti-HCV positive and then confirmed by HCV Poly-
merized Chain Reaction (PCR) qualitative test. All these selected
patients had been diagnosed for HCV and taken the standard
treatment of interferon and ribavirin from 20 weeks to 36 weeks.
The end product of PCR was confirmed by gel electrophoresis.
The following restriction enzymes Ear I/, Rsa 1 and Mae III were
used to digest the PCR product. This study focused only on pa-
tients who were non-responsive and had relapsed from conven-
tional therapy.
Results
Our study proposes that both the interleukin genes interleukin 28B
and IL-10 are found mutual in 2 foremost castes of the province Pun-
jab. We determined that HCV GT-3a is precisely communal (84.0 %)
amongst group of responders whereas GT-1a is more acquainted in
relapser (66.2 %) as well as resistant (54.0 %). Genotype 4was ex-
cluded, the remaining 5 major genotypes, known as 1a (61.40 %), 2a
(0.50 %), 2b (20.00 %), 3a (13.70 %) and an unidentified (4.40 %) were
reported amongst the twelve various groups of Pakistan. Our find-
ings designate that IL-10 and IL-28 genes may be intricate in the
clearance of HCV GT3 in Asian population.
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Background
Endocrine disrupting chemicals (EDCs) contaminating our ecosys-
tems are increasingly shown to impact the reproductive health
in human population. Di-(2-ethylhexyl)phthalate (DEHP) is a high
production volume EDC used as a plasticizer in personal and in-
dustrial products such as dolls, toys, medical tubing, floor tiles,
upholstery, food packaging plastics, cosmetics etc. Constant
leaching from these products leads to the ubiquitous presence
of DEHP in the environment. Clinico-epidemiological reports have
incriminated DEHP and its metabolites in reproductive developmental
abnormalities in neonates, endometriosis and miscarriage in women,
and abnormal spermiogram in men. Experimental studies in rats also
induce similar developmental and reproductive abnormalities.
Many EDCs have agonistic and antagonistic interactions with the
steroid receptors. Binding of DEHP and its metabolites to progester-
one receptor (PR) represents a potential interfering mechanism for
the steroid target tissues. Progesterone plays a central role in di-
verse reproductive events including ovarian function and preg-
nancy. We present here a study on the structural binding of DEHP
and its metabolite mono (2-ethylhexyl)phthalate (MEHP) with PR
using in silico approaches.
Materials and methods
The crystal structure of human PR (Id: 1SQN) was retrieved from
Protein Data Bank as a template for docking DEHP and MEHP. The
structures of DEHP and MEHP were obtained from PubChem data-
base. Docking of DEHP and MEHP into the binding site of PR was
performed using AutoDock 4.2 with Lamarckian Genetic Algorithm
to predict the bound conformation. The interacting residues for the
ligand-receptor binding were visualized using Chimera.
Results
Docking of DEHP and MEHP with PR displayed good binding affinity
values and exhibited both hydrophobic and hydrophilic interactions.
The PR residues involved in hydrogen bonding interactions were
Glutamine-725 and Arg-766, and Phe-778 made Pi-Pi interactions
with aromatic ring in both ligands. Altogether 22 residues contrib-
uted in hydrophobic interactions in ligand-receptor complex.
Conclusions
The study suggested that DEHP and its metabolite, MEHP occupy im-
portant residues in interactions with PR. These interactions appar-
ently compete with progesterone for PR binding sites and, hence,
likely disrupt the progesterone signaling resulting in abnormal repro-
ductive function. Current study enhances our understanding of
underlying molecular mechanisms of endocrine disrupting activity of
DEHP and its metabolites.Acknowledgements
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Table 24 (abstract P133) The top 10 networks associated with the
functions affected upon treatment of Caco-2 cells with 20 μM




1 37 28 Cancer, Cellular Development, Cellular Growth,
and Proliferation
2 36 27 Cell Death, Cellular Assembly and Organization,
Cellular Function, and Maintenance
3 33 26 Cellular Development, Embryonic Development,
Cellular Growth, and Proliferation
4 30 24 Cell Cycle, Embryonic Development, Connective
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Background
Hepatitis C virus (HCV) infection presents a significant health prob-
lem worldwide. In the Kingdom of Saudi Arabia (KSA), liver cancer
is a major problem and there is an increase in the prevalence of
viral induced cirrhosis. Based on genetic differences of HCV isolates,
it is classified into at least 7 genotypes (1–7) with many additional
subtypes within each genotype and GT-4 is predominant in KSA.
Single Nucleotide polymorphism (SNP) are most common cause of
variation in viral and host genome and linked with specific disease
subjected to known sequence specific polymorphic sites (muta-
tions) in genomes that trigger mutation and disease progression.
Several SNPs also contribute in the HCV infection outcomes. During
HCC development, mutations are scored with in the Core, NS4B,
NS5B and hyper variable region of E2 which are somehow associ-
ated with lack of strong inflammatory immune response.
Materials and methods
Guanosine Triphosphatase (GT) activity encoded in NS4B protein’s
nucleotide binding motif (NBM) serves as single nucleotide variable
in the evolution process of HCV and associated viral life cycle. The
transforming activity of NS4B from HCV GT4 was analyzed using the
mutants. Phylogenetic data on clustering of subtypes for E1 & NS5B
genes was performed to identify the variation in viral genomes.
Results
The pathogenicity was progressively inhibited and completely abro-
gated by increasing genetic impairment with the nucleotide binding
motif (NBM) of NS4B. This transformation ability of NS4B in NIH3TC
cells was independent of co-transfection with activated H-ras. Phylo-
genetic data on clustering of subtypes for E1 & NS5B genes revealed
that genome types (1-6) differ around 30-35 % while the subtypes
differ only about 20-25 %.
Conclusions
HCV GT4 encoded NS4B has both in vitro and in vivo tumorigenic po-
tential and this transforming activity is mediated by its NBM as single
nucleotide variable factor. Moreover, results suggest that pharmaco-
logical inhibition of this motif may be exploited to inhibit HCV repli-
cation but also the associated hepatocellular carcinoma (HCC).
Further studies should help in the development of non-invasive tech-
niques for evaluating the NBM distribution, patient’s condition and
the risk of HCC development.Tissue Development, and Function
5 29 24 DNA Replication, Recombination, and Repair,
Cancer, and Genetic Disorder
6 27 23 Cancer, Hematological Disease, Cellular Function
and Maintenance
7 26 24 Cell Death, Cell Cycle, and Cancer
8 26 22 Cell Morphology, Cellular Assembly and
Organization, Nervous System Development and
Function
9 26 22 Cellular Compromise, Cellular Function and
Maintenance, Energy Production
10 25 25 Cancer, Hematological Disease, Immunological
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Microarray studies play an important role in identification and clas-
sification the genes whose expressions are impacted by chemother-
apies for colorectal cancer. Therefore, the application of gene
expression profiling using microarray of DNA could potentially use
to predict the response to treatments. The anticancer mechanisms
of chelidonine (alkaloid) were tested on colon cancer using Caco-2
cell line.
Materials and methods
Caco2 cells were treated with 20 μM chelidonine for 48 h. RNA iso-
lation and cDNA synthesis, hybridization, data quality assessment,
filtering, normalization, and subsequent analysis were performed
by procedure that meet or exceed the MIAME-criteria of microarray
analysis [1]. The numbers of significantly up and down regulated
genes in treated Caco-2 cell were subjected to correspondence
cluster analysis [2]. Among the differentially expressed genes we se-
lected highly P-value genes for Ingenuity Pathway Analysis Know-
ledge database (version 6.5) (www.ingenuity.com) to identify the
biological responses of treated colon adenocarcinoma.
Results
The top 10 networks of the molecules that have impact on the diver-
sity of biological functions in treated colon cancer with chelidonine
are summarized in Table 24. These molecules have an important role
in modulation of cancer, cell cycle, cell death, cellular proliferation,
and cellular function. Biomarker Analysis shows that chelidonine able
to modulate many biomarkers that involved in molecular mechanism
of cancer, apoptotic signaling, and PXR signaling (Fig. 50).
Conclusions
Our results provide new insights into chelidonine-related signaling
activities, which may facilitate the development of chelidonine-based
anticancer strategies and/or combination therapies.
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Fig. 50 (abstract P133) The cancer molecular mechanisms in Caco-2
cells after treatment with 20 μM chelidonine for 48 hr. Red colored for
up-regulated genes, green for down-regulated genes
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Background
Many infertile couples worldwide resort to donated gametes to over-
come their infertility problems, however many others cannot for cul-
tural or religious reasons. They have no other options but probably to
keep trying In Vitro Fertilization (IVF) treatment using their own gam-
etes. We wanted to see if we would be able at some point to help such
cases fulfil their dreams.
Subjects and methods
Four infertility cases with a history of many unsuccessful IVF trials; eight,
seven, six, and four, respectfully; suggestively because of very poor
fertilization and/or poor embryo development due to sever male factor
that ranged from azoospermia to severe oligoteratoasthenozoospermia.
A short ovarian stimulation (OS) protocol was employed with all cases.
Follicles growth was monitored by ultrasound examinations until the
eggs were retrieved. The cumulus oocyte complexes (COCs) were incu-
bated in culture medium then denuded before the intracytoplasmic
sperm injection (ICSI). Normally fertilized eggs were kept in culturing
conditions till the embryos were transferred to each patient’s uterus.
Fourteen days later, the patient’s blood serum hCG was analyzed for
pregnancy. Six weeks later the ultrasound exam was done for detecting
the viable gestational sacs. Informed consents were collected from all
patients prior to any data collection.
Results
All four cases were finally successful with normal live births in three
cases and a 16-week ongoing pregnancy in the fourth case.Conclusions
In some complex infertility cases, when the use of donor-gametes is
not optional, probably hopelessness in IVF treatment with autolo-
gous gametes is not an option as well.
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Background
Oxidative damage to DNA and other biological processes can be dis-
rupted by ROS. The organophosphates are known to produce oxida-
tive stress by inhibiting enzymes and antioxidants. Incorporating
flow cytometry in assessing DNA damage, cell cycle, mitochondrial
membrane potential and apoptosis due to endogenous cysteine pro-
teases- get credence.
Materials and methods
Detection of DNA strand break was performed by alkaline comet assay
involving; single cell suspension, lysis, electrophoresis, image analysis
and comet measurements. Detection of apoptosis and analysis of cell
cycle used leukocyte cells; involving RNase digestion after incubation
by propidium iodide and analyzed on flow cytometer. The fluorescence
intensity of SubG1 cell fraction gave clue for apoptotic cell population.
Number of events were scored for cell cycle analysis. Flow cytometric
measurements were facilitated by Rh 123 dye in ΔΨm study. Two OPs -
dichlorovos (DCV) and dimethoate (DM) were explored using standard
protocol.
Results
Digitized comet images showed nuclei with increasing degree of DNA
damage in exposed cells. The mean value of frequencies of olive tail
moments and tail lengths indicated genotoxicity. Image analysis and
comet measure results show nuclei with damage. There was a statisti-
cally significant increase by DCV. DM, also inflicted highly significant
DNA damage. The single cell DNA not repaired, owing to excessive
ROS production. The subG1 cells provided clue for cells undergoing
apoptosis/necrosis- increased considerably. Comet images showed
damage to nucleus. Cell cycle analysis confirmed decreased G2/M cell
cycle arrest. The conspicuous ΔΨm loss, was a cellular event in the
mitochondrial driven apoptosis.
Conclusions
Results contribute to understanding the acute exposition of OPs on
cell survival and carcinogenicity. Clinical interest in evaluating the
damage to humans, involuntarily exposed to chemical stressors, is
further vindicated.
